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Abstract 
Understanding the molecular basis of the diverse morphological forms found 
within and across species is a longstanding goal in evolutionary biology. One 
especially relevant class of cis-regulatory elements are enhancers. This is because 
mutations affecting enhancers tend to be tissue- or stage-specific, which allows 
adaptation to proceed with relatively less harmful side effects in other organs or 
tissues. 
In Chapter 2 I explore how enhancers help drive morphological selection 
response within-species. We scanned the genomes of the Longshanks mice, which 
are mice selectively bred over 20 generations, for a 13% increase in tibiae. Against a 
backdrop of polygenic response, we found the bone repressor Nkx3-2, and 
specifically its enhancers, to be among the strongest contributor towards increased 
tibia length. I used transgenics to compare the enhancer activity of the F0 and F17 
alleles at 3 candidate enhancers (two near the Nkx3-2 gene; and one near the limb 
developmental regulator gene, Gli3). We found that both loss-of-function (Nkx3-2) 
and gain-of-function (Gli3) alleles contributed to the selection response. 
 In Chapter 3, we explored an approach to study macro-evolutionary variations 
across species. One of the major barriers to such study is the inability to perform 
direct genetic crosses due to hybrid sterility. We tackle the species barrier problem 
by inducing mitotic recombination in vitro in hybrid embryonic stem cells (including 
cross-species hybrids between Mus musculus and Mus spretus). This was achieved 
via Blm inhibition by the small molecule ML216. We further show, that the resultant 
mitotic recombinant cells can be used for genetic mapping by connecting tioguanine 
drug resistance to variations at the Hprt locus. Furthermore, in vitro recombinant 
stem cells can be used for rederivation of animals through laser-assisted morula 
injection, thus allowing the acquisition of morphological data.  
Here, through a multidisciplinary approach, we show that enhancer modulation 
contributes to morphological diversity and selection response within-species and 
provide a new methodology for enhancer study across-species, thus enabling the 
study of evolutionary developmental variations in genetic backgrounds that would 
otherwise be challenging to obtain. Overall, these studies highlight the relevance of 
enhancers in morphological diversification and provide new tools for their study. 
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Zusammenfassung  
Das Verständnis der molekularen Grundlage der unterschiedlichen inner- und 
zwischenartlichen Morphologien ist ein langjähriges Ziel der Evolutionsbiologie. Eine 
zentrale Klasse von cis-wirkenden Elementen sind Enhancer. Dies liegt 
insbesondere daran, dass Mutationen in Enhancern in der Regel spezifisch für ein 
Gewebe oder Entwicklungsstadium sind und deshalb eine Anpassung ermöglichen, 
die nur wenige negative Effekte auf andere Organe und Gewebe hat.   
In Kapitel 2 untersuche ich den Beitrag von Enhancern zur morphologische 
Selektion innerhalb einer Art. Dafür wurden die Genome von „Longshanks“-Mäusen 
untersucht, deren Tibialänge über 20 Generationen um 13% selektiv erhöht wurde. 
Im Rahmen dieser polygenen Selektion, trug der Knochen-Repressor Nkx3-2, und 
speziell seine Enhancer, den größten Anteil zu der Verlängerung der Tibiaknochen 
bei. Experimente mit Transgenen zum Testen der Aktivität von Enhancerkandidaten 
(zwei nahe Nkx3-2; einer nahe des Regulatorgens für Gliedmaßen, Gli3) in F0 und 
F17 Allelen zeigten, dass sowohl der Funktionsverlust (Nkx3-2) als auch der 
Funktionsgewinn (Gli3) dieser Allele zu der Selektionsantwort beitrugen. 
In Kapitel 3 untersuchten wir mithilfe eines neuen Ansatzes die makro-
evolutionären Unterschiede zwischen Arten, deren Kreuzung aufgrund von 
Hybridsterilität auf herkömmlichen Wege nicht möglich ist.  Durch Induktion von in 
vitro mitotischer Rekombination in embryonalen Hybridstammzellen der beiden 
Mausspezies Mus musculus und Mus spretus, konnte das Sterilitätsprobelm der 
Hybride umgangen werden. Dies konnte durch die Inhibierung von Blm mit Hilfe des 
Moleküls ML216 erreicht werden. Durch Verbindung von Variationen im Hprt Lokus 
mit der Resistenz gegen das Medikament Thioguanine wurde gezeigt, dass 
mitotisch-rekombinante Zellen für genetische Kartierung geeignet sind. Darüber 
hinaus können diese Zellen mittels laserbasierter Morula-Injektionen zur Entstehung 
von Embryonen und somit zum Gewinn morphologischer Daten genutzt werden.  
Dieser interdisziplinäre Ansatz zeigt, dass die Modulation von Enhancern zur 
morphologischen Vielfalt und Selektionsantwort innerhalb von Arten beiträgt und 
liefert eine neue Methode zur zwischenartlichen Enhancer-Analyse. Diese ermöglicht 
die Untersuchung evolutionär bedingter Variationen auch vor herausfordernden 
genetischen Hintergründen. Insgesamt zeigt diese Studie die Relevanz von 
Enhancern in der morphologischen Diversifizierung und bietet neue Analyseansätze. 
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Chapter 1: Aims and introduction 
 
Understanding the role of genetic and molecular mechanisms in the evolution 
of morphological diversity within and between species is a longstanding goal in 
evolutionary and developmental biology1-3. Owing to the importance and pleiotropism 
of genes required for proper body development and patterning, changes to protein 
coding sequences themselves can be fatal3,4. Furthermore, such genes are deeply 
conserved and shared across divergent taxa. These observations lead to the so-
called “cis-regulatory hypothesis of morphological evolution”, which proposes that 
morphology evolves primarily through tweaking the cis-regulatory networks that 
control developmental gene expression, leading to alterations of pattern 
(heterotopy), timing (heterochrony), or level of expression of genes1,2,4-9 (although 
cases where coding changes cause phenotypic alterations have been reported10-13).  
In my dissertation research, I explored how enhancers, a category of cis-
regulatory elements, contribute to intra- and inter-species morphological diversity. 
Here, I tackle these questions in two different ways: by exploring how enhancers 
contribute to morphological variation at the micro-evolutionary scale in the context of 
a mouse artificial selection experiment; and by developing a technique that opens 
the possibility to map how enhancers affect macro-evolutionary changes across 
species barriers.  
In Chapter 2, taking advantage of an artificial selection experiment, called 
Longshanks, where mice were selected for longer tibia, we identified multiple loci 
across the genome that contribute to tibia length increase. Furthermore, for two 
genes related to tibia length, I found that both enhancer gain- and loss-of-function 
mutations can contribute to selection response, with as few as 3 SNPs being enough 
to alter enhancer activity.  
In Chapter 3, I contributed to an effort to address one of the major barriers to 
the study of enhancers across species: hybrid sterility, which prevents crosses 
between species to be generated. We circumvented the species barrier problem by 
inducing stem cell mitotic recombination in vitro in F1 hybrid embryonic mouse stem 
cells, such as from a cross between Mus musculus and Mus spretus. We further 
show that the mitotic recombinant cells can be used for genetic mapping and, 
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excitingly, rederivation of animals through laser-assisted morula injection, thus 
allowing the acquisition of morphological data. 
 The aforementioned studies provide further support to the cis-regulatory 
hypothesis by showing that enhancer alterations can contribute to intraspecies 
morphological diversity and opening new research possibilities to investigate the cis-
regulatory hypothesis at the interspecies level. 
 
 
1.1 Morphological evolution and enhancers: 
 
The magnitude and nature of genomic changes required for morphological 
evolution have not yet been clearly defined under a single paradigm14, and research 
continues to gauge the importance, impact, and frequency of deletions, de novo 
creation, or modification of existing regulatory elements, epistatic interactions 
between such elements and associated pleiotropic effects4,15-18. To tackle these 
questions the scientific community employs powerful population genetic tools that 
allow the association of genotype to phenotype, such as evolve and re-sequence 
experiments19, quantitative trait loci mapping (QTL)20,21, and genome-wide 
association studies (GWAS)22; as well as genome wide regulatory elements 
screening techniques (such as ChIP-seq23 and ATAC-seq24). When coupled, 
population genetics and regulatory-element screening offer a powerful approach to 
address the role of cis-regulation in morphological evolution.  
Several categories of cis-regulatory elements that contribute to phenotypic 
diversity have been reported, including promoters25,26, enhancers27-31, silencers32 
and potentially insulators33,34. Enhancers are particularly relevant to the genesis of 
intra- and inter-species morphological diversity28,29, but to gauge their importance we 
need to look into how enhancers orchestrate gene expression. As stated above, 
developmental genes are often pleiotropic, i.e., mutations in such genes affect many 
downstream phenotypes because they control patterning of multiple body 
structures4,35. A classic example of pleiotropy in vertebrates comes from Hox gene 
clusters, which are required for the proper patterning and development of the axial 
skeleton36, limbs37, reproductive tract38, central nervous system39 and muscle40. 
Other relevant examples, referenced in Chapter 2, are: the Nkx3-2 gene that is 
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required for the development of the spleen41,42, pancreas41, and axial and limb 
skeleton42,43; and the Gli3 gene, whose function is essential for proper development 
of the limbs44,45, eyes46, brain47, and craniofacial structures48. Given their roles in 
development and the precise spatiotemporal control of gene expression required, it 
is no surprise that coding mutations in pleiotropic genes lead to severe 
morphological defects at birth or even perinatal lethality (as reported for Nkx3-242,49 
and Gli350,51).  
Much of the control of gene expression during development can be attributed to 
enhancers, which act in a tissue and time specific manner through recruitment of 
specific sets of transcriptional factors9,28,29,52. Indeed, several pleiotropic 
developmental genes have been shown to possess elaborate enhancer networks 
that control the timing and space of expression. These include the HoxD cluster 
whose early and late limb expression is controlled by different sets of enhancers53, 
and the complex Shh enhancer network that orchestrates specific limb and central 
nervous system expression patterns54. The HoxD and Shh enhancer networks also 
demonstrate another crucial feature of enhancers: modularity, i.e., each enhancer 
contributes independently and cumulatively to overall gene expression9,54-56. 
Furthermore, some enhancers exist as groups of redundant elements, as shown for 
Gli357 and Shox257 limb enhancers, thus providing developmental robustness57. 
Enhancers’ tissue/organ specificity, modularity, and redundancy make them great 
targets for evolution, as these characteristics allow for tissue/organ-specific gene 
expression changes while simultaneously buffering the risk of lethality and facilitating 
the accumulation of genetic variation58. Several vertebrate and invertebrate studies 
have highlighted how impactful enhancer modification can be on species 
morphology28-31. Research performed in Drosophila showed that both intra- and 
inter-species morphological diversity can be attributed to gene expression variation 
caused by enhancer sequence alteration27,30,31. In vertebrates, enhancer deletion 
can significantly alter morphological traits such as the presence/absence of a pelvic 
spine in natural populations of stickleback fish29 and the absence of limbs in 
snakes28. To understand how enhancer sequence and activity divergence mediate 
intra- and inter-species morphological diversity, it is essential to first understand their 
functional and structural organization. 
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1.2 Enhancer structure and control of transcriptional output: 
 
Understanding enhancer function and structure is crucial to comprehend how 
enhancer sequence alteration can affect gene transcription, and lead to the 
development of novel techniques for enhancer study. 
Enhancers are DNA sequences that make contact with gene promoters to 
initiate and/or amplify gene transcription in a distance- and orientation-independent 
manner, often spanning and skipping whole genes in between the enhancer and 
promoter52,59,60. These cis-regulatory elements range in size from tens61 to 
hundreds29,52,60 of base pairs, and are comprised of protein binding sites (such as for 
transcriptional factors and RNA polymerase II) and spacer elements62-65. An 
enhancer’s “syntax” is the arrangement of these binding sites and spacer elements, 
which can affect the activity of the enhancer. A report on a tissue-specific enhancer 
in the Ciona genus of sea squirts showed that fully optimizing the enhancer’s syntax 
can lead to a drastic alteration of enhancer activity, even causing the enhancer to be 
active in ectopic tissues/organs62. Surprisingly, robust tissue specificity was achieved 
with optimal spacing and low affinity biding sites62. This shows that there is ample 
ground for tweaking the transcriptional output and tissue specificity of an enhancer 
by altering its syntax, i.e., changing the number, type, affinity, spacing, and 
orientation of its transcription factor binding sites58,62.  
An additional feature of enhancers is the absence of nucleosomes in the 
enhancer “body”, possibly due to displacement by transcription factors. 
Nucleosomes flanking enhancers also undergo post-translational modifications such 
as mono- or tri-methylation at the lysine 4 residue of the histone subunit H3 
(abbreviated as “H3K4me” or “H3K4me3”) 66-68, or acetylation at the lysine 27 
residue (“H3K27ac”)69. Identifying these features associated with chromatin 
accessibility or remodeling have enabled the development of techniques for genome-
wide screening of enhancers, e.g., transposase accessible chromatin followed by 
sequencing (ATAC-seq)24, which finds open chromatin regions, and chromatin 
immunoprecipitation sequencing (ChIP-seq)23, which locates DNA regions 
associated with specific proteins or histone modifications. Additional reports have 
shown that the presence of RNA polymerase-II at enhancers leads to their 
bidirectional transcription into a class of non-coding RNAs known as eRNAs 
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(enhancer RNA)70,71. This latter signature can be captured most efficiently by 
polymerase run-on assays that can provide a read-out of active transcription, e.g., 
global run-on sequencing  (GRO-seq)72.  
To increase a gene’s transcriptional output, proper and specific contact must be 
established between the enhancer and the target gene’s promoter. The enhancer’s 
syntax-determined assembly of DNA-protein complexes is crucial for this enhancer-
promoter contact; as such, tweaking enhancer-promoter communication offers 
another method for enhancer-mediated change in gene transcription. Enhancer-
promoter affinity can even influence how ubiquitous or restricted gene expression 
is76,77. Furthermore, enhancer-promoter communication may require the interaction 
between specific transcriptional factors (biochemical compatibility)75,76. The 
mechanism of communication between enhancers and promoters is actively 
researched, and four models have been proposed73,74: linking, tracking, looping, and 
phase separation  (Table 1 provides a brief description of each model). Studies 
exploring enhancers’ impact on morphology often overlook how enhancer sequence 
alteration affects enhancer-promoter contacts, and thus the significance of enhancer-
promoter affinity alteration in the evolution of vertebrate morphological diversity 
remains poorly understood. 
 
Table 1: Models of enhancer-promoter communication. 
Model Description Range 
Linking73,74,78,
79 
A chain of transcriptional proteins establishes direct 
enhancer-promoter link. 
Very short range. 
Between promoter and 
proximal enhancer 
elements. 
Tracking80-82 
Enhancer-promoter contact is formed by unidirectional 
migration of the enhancer and its associated protein 
complexes towards the promoter. Intervening chromatin 
forms a loop. 
15 kbp or less. 
Looping73,74,83 
Enhancer-promoter contact through looping of the 
intervening DNA sequence. Initial loop is hypothesized to 
result from random chromatin collision and stabilized by 
high protein-protein affinity. 
Up to 1 Mbp. 
Phase 
separation84-
86 
Specific to "super-enhancers". Forms membraneless 
liquid-liquid phase separated areas of high concentration 
of transcriptional factors. 
Large range. 
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1.3 Techniques for enhancer identification and characterization: 
 
  A plethora of methodologies for enhancer identification and characterization is 
available to the scientific community. These techniques can be categorized into three 
groups: DNA based, RNA based, and chromatin based.  
Methods based on DNA sequencing include enhancer reporter assays87,88, 
which determine an enhancer’s area of activity, and techniques for enhancer 
identification such as the enhancer trap assay87, massively parallel reporter assays 
(MPRAS)89, self-transcribing active regulatory region (STARR-seq)90, and cross-
species sequence comparison91.  
RNA based methods include deep transcriptome-wide sequencing (RNA-
seq71), and RNA run-on assays that provide a snapshot of actively transcribed 
regions, such as GRO-seq72, precision run-on sequencing (PRO-seq)92, and 
chromatin run-on sequencing (ChRO-seq)93.  
Chromatin based methods include characterization of open or closed chromatin 
by screening for either: nucleosome free regions, e.g., ATAC-Seq24, DNAse I 
hypersensitive sites sequencing (DNAse-seq)94, and formaldehyde-assisted isolation 
of regulatory elements (FAIRE-Seq)93; or nucleosome bound regions, e.g., 
micrococcal nuclease digestion and sequencing (MNase-seq95). Other chromatin 
based techniques include 3D chromatin conformation capture (3C96 and derivative 
techniques, such as 4C97 and Capture-C98), which identify DNA-DNA contacts, and 
identification of genomic regions associated with transcription factors, RNA 
polymerase II, or histone modifications, e.g., ChIP-seq23,99, chromatin interaction 
analysis with paired-end tag (Chia-PET)100 and in silico transcriptional factor binding 
site analysis101.  
To date, no single method can simultaneously identify enhancers, report their 
strength, and describe their in vivo tissue/organ areas of activity; as such, a 
combination of multiple techniques is required for a thorough characterization of 
enhancers. Table 2 summarizes the techniques used in this thesis. In Chapter 2, we 
characterized enhancers with a genome-wide screen for regulatory regions using 
ChIP-seq and ATAC-seq data, followed by enhancer reporter assays to 
simultaneously determine if the identified regions were true enhancers and to 
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measure their respective in vivo activity. We also used 4C and in situ hybridization to 
link the identified enhancers with their target genes, thus providing an extensive 
characterization of enhancer activity. 
 
Table 2: Techniques used for enhancer identification and characterization. 
Method Objective Advantages Limitations 
ATAC-seq (Assay 
for transposase-
accessible 
chromatin) 
Genome-
wide open 
chromatin 
mapping. 
Low input required, even down 
to a single cell. Simple and 
fast. 
Does not allow for type-specification of 
the open chromatin regions. Biased 
towards small fragments. May lead to 
false positives due to unintentional 
closed-chromatin tagmentation. 
ChIP-seq 
(Chromatin 
Immuno-
precipitation) 
Determine 
genome-
wide specific 
DNA-protein 
association. 
Can be used for genome-wide 
scans of DNA associated with 
transcriptional factors, histone 
modifications and other 
relevant proteins. 
Dependent on antibody quality. High GC-
content biased. High sequencing 
coverage required. Can have high 
background noise caused by cell-type 
specific variation. 
3C (Chromosome 
conformation 
capture) and 
derivative 
methods (4C, 
Capture-C) 
Identification 
of contacts 
between 
different 
DNA regions. 
Links regulatory elements to 
their targets. 
Long and laborious protocol. Tendency 
for high noise. 
STARR-seq (Self-
transcribing active 
regulatory region) 
Genome-
wide screen 
of enhancer 
activity. 
High-throughput. No positional 
integration effects. 
Simultaneously assess 
enhancer activity and strength. 
Epissomal assay. Labor intensive. 
Transgenic 
reporter assay 
Visualize 
regulatory-
element's 
driven 
expression 
domains 
Can be used in vivo and in 
vitro. Allows detailed 
characterization of regulatory-
elements activity. 
High-cost. Subject to integration-site 
effects. 
ISH (In situ 
hybridization) 
techniques 
Visualize 
physical 
location of 
specific 
targets. 
Permits visualization of 
endogenous gene expression 
patterns or physical proximity 
between DNA elements. 
Probes can be re-used. 
Time-consuming and laborious. Low 
sensitivity and resolution. Dependent on 
probe quality. 
 
 
1.4 The vertebrate limb as a model to study enhancers’ impact on 
morphological diversity:  
 
To assess how enhancer variation contributes to morphological diversity, a 
suitable model system should display both intra- and inter-species variation, be 
readily available and easy to manipulate. The vertebrate limb fits these requirements 
as various species-specific morphological adaptations have occurred in the course of 
evolution in response to various locomotory requirements28,102. Such adaptations 
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also show striking convergence across distant taxa, such as swimming (e.g. fish and 
whales), flying (e.g., birds and bats), running (e.g. antelopes, wolfs), and hopping 
(e.g. jerboa and kangaroos). In addition, the major genetic pathways involved in limb 
development have already been identified in vertebrates103, and their mechanisms of 
action and impact on the patterning of all limb axes are well understood103. 
Furthermore, despite sharing the same core developmental program, the fore- and 
hindlimb can display striking morphological differences (e.g. bats and jerboa), hinting 
at fore- and hindlimb-specific genetic adaptations, which remain largely unexplored. 
Lastly, a large array of methodologies for limb studies is available ranging from 
morphometric analysis102, to in vivo techniques (such as enhancer reporter 
assays60), to genome-wide characterization of regulatory landscapes (such as 
ATAC-seq24,104 and ChIP-seq105). In Chapter 2 we use the mouse limb as a model to 
study the impact of enhancers in intra-species morphological diversification and 
selection response. 
 
 
1.5 Summary of findings and conclusions: 
 
A long-standing goal in evolutionary biology is to understand the molecular 
basis of the diverse morphological forms found within and across species. In 
Chapter 2 we explored how cis-regulatory elements, such as enhancers, may shape 
morphological traits at the micro-evolutionary scale. To identify loci that contribute to 
morphological variation in the mouse hindlimb, we scanned the genomes of the 
Longshanks mice, which were selectively bred over 20 generations for longer tibiae. 
Briefly, outbred CD-1 mice were separated into three closed populations with 14 
mating pairs each and maintained as two selected lines (Longshanks 1, LS1; and 
Longshanks 2, LS2) and one control line. The control group was randomly bred, 
while LS1 and LS2 were selected for having the longest tibia length relative to body 
mass. After 20 generations, we observed an average tibia length increase of 13.1% 
and 12.7% respectively in LS1 and LS2, while the control line showed no significant 
tibia length change (see Chapter 2, Fig.1, p.31). We sequenced all breeders from 
generations 0 (F0) and 17 (F17) of the selection experiment and identified 8 major 
loci likely contributing to selection response (see Chapter 2, Fig.2, p.34 and Table1, 
	   15	  
p.36). Through chromatin profiling (combination of ChIP-seq, ATAC-seq and 4C) of 
two relevant regions where impactful coding changes were not found (Nkx3-2 and 
Gli3), we identified possible enhancers contributing to the increase in tibia length in 
Longshanks mice. We used in vivo enhancer reporter assays to compare the activity 
of the F0 and F17 enhancer alleles at 3 candidate enhancers (designated N1 and N3 
near the Nkx3-2 gene and G2 near the Gli3 gene) and found that both loss-of-
function (N1 and N3) and gain-of-function (G2) alleles contributed to the selection 
response, with as few as 3 SNPs being sufficient to alter enhancer activity (see 
Chapter 2, Fig.4 p.40 and Fig.4-S1, p.96). Furthermore, using stickleback enhancer 
reporter assays, we found that the mouse N1 enhancer is functionally conserved in 
fishes, hinting at deep conservation of Nkx3-2 dependent bone maturation 
mechanisms (see Chapter 2, Fig.5, p.45). We demonstrate that combining 
multidisciplinary techniques is crucial to identify and assay genetic elements that 
contribute to morphological selection response at high resolution (in this case down 
to individual SNPs), and thus to understand the impact of enhancers on intra-species 
morphological diversity.  
Overall, in the context of the Longshanks selection experiment, we found that 
tibia length is a polygenic trait, and that enhancers contributed to morphological 
selection response. Furthermore, both gain and loss of enhancer function can 
contribute to morphological evolution. We also found that cis-regulatory mechanisms 
were associated with selected alleles at a genome-wide scale, providing further 
support to the cis-regulatory hypothesis of morphological evolution (see Chapter 2 
Fig.3-S1, p.93). Future work should determine whether the identified genes and 
enhancers that control tibia length are also involved in limb morphology variation at 
the macro-evolutionary scale by employing techniques for genome-wide enhancer 
screening (such as STARR-seq) or more focused methods (such as cross-species 
sequence comparison of target enhancers and enhancer reporter assays). 
To date, a major barrier to the identification of the genetic basis of 
morphological evolution arises from the inability to perform mapping experiments 
across sufficiently diverged taxa due to cross-species hybrid sterility. In Chapter 3 
we show an approach that can overcome this problem by generating in vitro mitotic 
recombinant stem cells (IVR) from mice by suppressing the Bloom syndrome DNA 
helicase (Blm) using a small inhibitory molecule called ML216 (see Chapter 3 Fig.1 
p.120). We applied this technique to F1 crosses between mouse strains (Mus 
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musculus BL6 x 129) and species (Mus musculus x Mus castaneus - BL6/CAST; and 
Mus musculus x Mus spretus - BL6/SPRET) and successfully obtained IVR stem cell 
colonies. Whole genome sequencing of recombinant BL6/129 and BL6/CAST clones 
revealed that one or few recombination events occurred per recombinant clone and 
that recombination tended to happen near the telomeric ends of chromosomes. 
However, integration of a selection cassette caused recombination events to occur 
between the centromere and the cassette integration site (see Chapter 3, Fig.2, 
p122). 
Mapping traits in BL6/SPRET hybrids through traditional breeding is 
challenging due to F1 hybrid male sterility and reduced female fertility106; as such, 
applying classic mapping methodologies, though possible, is difficult. To determine if 
IVR cells can be used for mapping, we subjected F1 BL6/SPRET stem cells to in 
vitro recombination using ML216 and tested the resulting recombinant cells for 
tioguanine drug resistance. Following drug exposure we used FACS and whole 
genome sequencing (“Flow-mapping”) on these cells and were able to map drug 
resistance to the Hprt  (hypoxanthine-guanine phophoribosyltransferase) locus in 21 
days or less (see Chapter 3, Fig.3, p.126).  Furthermore, through laser-assisted 
morula injection of BL6/SPRET mitotic recombinant and non-recombinant stem cell 
clones, we obtained morphological data for individual clones. Using high-resolution 
X-ray micro computed tomography (microCT), we observed that embryos derived 
from non-recombinant BL6/SPRET stem cells showed normal development at 
embryonic day 14.5 (E14.5), while 4 out of 11 embryos derived from IVR stem cell 
clones showed severe craniofacial malformation and neural tube closure defects 
(see Chapter 3, Fig.4, p.128 and Fig.S8, p.162). Overall, we highlight the utility of 
blm inhibition to enable genetic mapping across species pairs that suffer from hybrid 
sterility. Recombinant stem cell clones open the door to explore fundamental 
evolutionary questions of morphological and developmental diversity that would 
otherwise be impaired by traditional breeding strategies. Future work should focus 
on increasing the mitotic recombination rate of the stem cells derived from cross-
species F1 crosses, and explore if recombinant clones can be used for mapping cell-
type specific traits through in vitro differentiation. 
In my dissertation, I studied the role of enhancers in intra-species 
morphological variation, and showed that enhancer activity alteration helps to drive 
morphological diversity, thus contributing to selection response. Furthermore I 
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helped to develop a novel method to overcome species barriers and open the door 
to research enhancer activity in previously hard-to-obtain cross-species genomic 
combinations. Overall, these studies illuminate the relevance of enhancers in 
morphological diversification and provide new tools for their study. 
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2.2.1 Abstract:  
 
Evolutionary studies are often limited by missing data that are critical to 
understanding the history of selection. Selection experiments, which reproduce rapid 
evolution under controlled conditions, are excellent tools to study how genomes 
evolve under selection. Here we present a genomic dissection of the Longshanks 
selection experiment, in which mice were selectively bred over 20 generations for 
longer tibiae relative to body mass, resulting in 13% longer tibiae in two replicates. 
We synthesized evolutionary theory, genome sequences and molecular genetics to 
understand the selection response and found that it involved both polygenic 
adaptation and discrete loci of major effect, with the strongest loci tending to be 
selected in parallel between replicates. We show that selection may favor de-
repression of bone growth through inactivating two limb enhancers of an 
inhibitor, Nkx3-2. Our integrative genomic analyses thus show that it is possible to 
connect individual base-pair changes to the overall selection response. 
 
2.2.2 Introduction:  
 
Understanding how populations adapt to a changing environment is an urgent 
challenge of global significance.  The problem is especially acute for mammal 
populations, which are often small and fragmented due to widespread habitat loss.  
Such populations often show increased inbreeding, leading to the loss of genetic 
diversity (1).  Because beneficial alleles in mammals typically come from standing 
genetic variation rather than new mutations like in microbes, this loss of diversity 
would ultimately impose a limit on the ability of small populations to adapt.  
Nonetheless, mammals respond readily to selection in many traits, both in nature 
and in the laboratory (2-5).  In quantitative genetics, such traits are interpreted as the 
overall effect from a large set of loci, each with an infinitesimally small (and 
undetectable) effect (“infinitesimal model”).  Broadly speaking, the infinitesimal model 
has performed remarkably well across a wide range of selection experiments, and 
the model is the basis for commercial breeding (6).  However, it remains unclear 
what type of genomic change is associated with rapid response to selection, 
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especially in small populations where allele frequency changes can be dominated by 
random genetic drift.   
While a large body of theory exists to describe the birth, rise and eventual 
fixation of adaptive variants under diverse selection scenarios (7-12), few empirical 
datasets capture sufficient detail on the founding conditions and selection regime to 
allow full reconstruction of the selection response.  This is particularly problematic in 
nature, where historical samples, environmental measurements and replicates are 
often missing.  Selection experiments, which reproduce rapid evolution under 
controlled conditions, are therefore excellent tools to understand response to 
selection—and by extension—adaptive evolution in nature (4). 
Here we describe an integrative, multi-faceted investigation into an artificial 
selection experiment, called Longshanks, in which mice were selected for increased 
tibia length relative to body mass (13).  The mammalian limb is an ideal model to 
study the dynamics of complex traits under selection: it is both morphologically 
complex and functionally diverse, reflecting its adaptive value; and limb development 
has been studied extensively in mammals, birds and fishes as a genetic and 
evolutionary paradigm (14).  The Longshanks selection experiment thus offers the 
opportunity to study selection response not only from a quantitative and population 
genetics perspective, but also from a developmental (15) and genomic perspective.  
By design, the Longshanks experiment preserves a nearly complete archive of 
the phenotype (trait measurements) and genotype (via tissue samples) in the 
pedigree.  Previously, Marchini et al. investigated how selection was able to 
overcome correlation between tibia length and body mass and produced 
independent changes in tibia length during the first 14 generations of the 
Longshanks experiment (13).  Importantly, that study focused on the phenotypes and 
inferred genetic correlations indirectly using the pedigree.  The current genomic 
analysis was initiated when the on-going experiment reached generation 17 and 
extends the previous study by integrating both phenotypic and genetic aspects of the 
Longshanks experiment.  By sequencing the initial and final genomes, the current 
analysis benefits from direct and highly resolved genetic information.  Here, with 
essentially complete information, we wish to answer a number of important questions 
regarding the factors that determine and constrain rapid adaptation: Are the 
observed changes in gene frequency due to selection or random drift?  Does rapid 
selection response of a complex trait proceed through innumerable loci of 
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infinitesimally small effect, or through a few loci of large effect?  What type of 
signature of selection may be associated with this process?  Finally, when the same 
trait changes occur independently, do these depend on changes in the same gene(s) 
or the same pathways (parallelism)?  
 
2.2.3 Results: 
 
Longshanks selection for longer tibiae 
At the start of the Longshanks experiment, we established three base 
populations with 14 pairs each by sampling from a genetically diverse, commercial 
mouse stock [Hsd:ICR, also known as CD-1; derived from mixed breeding of 
classical laboratory mice (16)].  In two replicate “Longshanks” lines (LS1 and LS2), 
we bred mice by pairing 16 males and females (and excluding sibling pairs) with the 
longest tibia relative to the cube root of body mass for each sex.  This corresponds 
to 15–20% of all offspring [only details essential to understanding our analysis are 
summarized here.  See (13) for a detailed description of the breeding scheme].  We 
kept a third Control line (Ctrl) using an identical breeding scheme, except that 
breeders were selected at random.  In LS1 and LS2, we observed a strong and 
significant response to selection in tibia length [0.29 and 0.26 Haldane or standard 
deviations (s.d.) per generation, from a selection differential of 0.73 s.d. in LS1 and 
0.62 s.d. in LS2].  Over 20 generations, selection for longer relative tibia length 
produced increases of 5.27 and 4.81 s.d. in LS1 and LS2, respectively (or 12.7% 
and 13.1% in tibia length), with a modest decrease in body mass [-1.5% in LS1 and -
3.7% in LS2; Student’s t-test, P < 2×10-4 and P  < 1×10-8, respectively; Fig. 1B & C; 
Fig. 1 – figure supplement 1; n.b. this relationship was in part biased by the F1 
generation, which were fed a different diet and phenotyped three weeks later than 
later generations, see (13) for details].  By contrast, Ctrl showed no directional 
change in tibia length or body mass (Fig. 1C; Student’s t-test, P > 0.05).  This 
approximately 5 s.d. change in 20 generations is rapid compared to typical rates 
observed in nature [(17), but see (18)] but is in line with responses seen in selection 
experiments (3, 5, 19, 20).  
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Fig. 1.  Selection for Longshanks mice produced rapid increase in tibia length.  
(A and B) Tibia length varies as a quantitative trait among outbred mice derived from 
the Hsd:ICR (also known as CD-1) commercial stock.  Selective breeding for mice 
with the longest tibiae relative to body mass within families has produced a strong 
selection response in tibia length over 20 generations in Longshanks mice (13%, 
blue arrow, LS1).  (C) Both LS1 and LS2 produced replicated rapid increase in tibia 
length (blue and red; line and shading show mean ± s.d.) compared to random-bred 
Controls (grey).  Arrowheads along the x-axis mark sequenced generations F0 and 
F17.  See Fig. 1 – figure supplement 1 for body mass data.  Lower panel: 
Representative tibiae from the Ctrl, LS1 and LS2 after 20 generations of selection. 
(D) Analysis of sequence diversity data (linked variants or haplotypes: lines; variants: 
dots) may detect signatures of selection, such as selective sweeps (F17 in LS1 and 
LS2) that result from selection favoring a particular variant (dots), compared to 
neutral or background patterns (Ctrl).  Alternatively, selection may elicit a polygenic 
response, which may involve minor shifts in allele frequency at many loci and 
therefore may leave a very different selection signature from the one shown here.  
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Simulating selection response: infinitesimal model with linkage   
The rapid but generally smooth increase in tibia length in Longshanks is 
typically interpreted as evidence for a highly dispersed genetic architecture with no 
individually important loci contributing to the selection response.  This is classically 
described under quantitative genetics as the infinitesimal model.  Crucially, the 
appropriate null hypothesis for the genomic response here should capture “polygenic 
adaptation” rather than a neutral model.  We therefore developed a simulation that 
faithfully recapitulates the artificial selection experiment by integrating the trait 
measurements, selection regime, pedigree and genetic diversity of the Longshanks 
selection experiment, in order to generate an accurate expectation for the genomic 
response.  Using the actual pedigree and trait measurements, we mapped fitness 
onto tibia length 𝑻 and cube-root body mass 𝑩 as a single composite trait 𝑙𝑛 𝑻𝑩! .  
We estimated 𝜙 from actual data as −0.57, such that the ranking of breeders closely 
matched the actual composite ranking used to select breeders in the selection 
experiment, based on 𝑻 and 𝑩 separately (13) (Fig. 1 – figure supplement 2A).  We 
assumed a maximally polygenic genetic architecture using an “infinitesimal model 
with linkage” (abbreviated here as HINF), under which the trait is controlled by very 
many loci, each of infinitesimally small effect (see Supplementary Notes for details).  
Results from simulations seeded with actual genotypes or haplotypes showed that 
overall, the predicted increase in inbreeding closely matched the observed data (Fig. 
1 – figure supplement 2B).  We tested models with varying selection intensity and 
initial linkage disequilibrium (LD), and for each, ran 100 simulated replicates to 
determine the significance of changes in allele frequency (Fig. 1 – figure supplement 
2C–E).  This flexible quantitative genetics framework allowed us to explore possible 
changes in genetic diversity over 17 generations of breeding under strong selection.  
In simulations, we followed blocks of genomes as they were passed down the 
pedigree. In order to compare with observations, we seeded the initial genomes with 
single nucleotide polymorphisms (SNPs) in the same number and initial frequencies 
as the data.  We observed much more variation between chromosomes in overall 
inbreeding (Fig. 1 – figure supplement 2B) and in the distribution of allele 
frequencies (Fig. 2 – figure supplement 1B) than expected from simulations in which 
the ancestral SNPs were initially in linkage equilibrium.  This can be explained by 
linkage disequilibrium (LD) between the ancestral SNPs, which greatly increases 
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random variation.  Therefore, we based our significance threshold tests on 
simulations that were seeded with SNPs drawn with LD consistent with the initial 
haplotypes (Fig. 1 – figure supplement 2C & E; see Supplementary Notes).      
Because our simulations assume infinitesimal effects of loci, allele frequency 
shifts exceeding this stringent threshold suggest that discrete loci contribute 
significantly to the selection response.  An excess of such loci in either a single LS 
replicate or in parallel would thus imply a mixed genetic architecture of a few large-
effect loci amid an infinitesimal background.   
 
Sequencing the Longshanks mice reveals genomic signatures of selection 
To detect the genomic changes in the actual Longshanks experiment, we 
sequenced all individuals of the founder (F0) and 17th generation (F17) to an 
average of 2.91-fold coverage (range: 0.73–20.6×; n = 169 with <10% missing F0 
individuals; Supplementary File 1).  Across the three lines, we found similar levels of 
diversity, with an average of 6.7 million (M) segregating SNPs (approximately 
0.025%, or 1 SNP per 4 kbp; Supplementary File 2; Fig. 2 – figure supplement 1A & 
Fig. 2 – figure supplement 2).  We checked the founder populations to confirm 
negligible divergence between the three founder populations (across-line FST on the 
order of 1×10-4), which increased to 0.18 at F17 (Supplementary File 2).  This is 
consistent with random sampling from an outbred breeding stock.  By F17, the 
number of segregating SNPs dropped to around 5.8 M (Supplementary File 2).  This 
13% drop in diversity (0.9M SNPs genome-wide) is predicted by drift.  Our simulation 
confirmed this and moreover, showed that selection contributed negligibly to the drop 
in diversity (Supplementary Notes, Fig. 1 – figure supplement 2B, D).  
We conclude that despite the strong selection on the LS lines, there was little 
perturbation to genome-wide diversity.  Indeed, the changes in diversity in 17 
generations were remarkably similar in all three lines, despite Ctrl not having 
experienced selection on relative tibia length (Fig. 2 – figure supplement 1A).  
Hence, and consistent with our simulation results (Fig. 1 – figure supplement 2B, D), 
changes in global genome diversity had little power to distinguish selection from 
neutral drift despite the strong phenotypic selection response. 
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Fig. 2.  Widespread genomic response to selection for increased tibia length.   
Allele frequency shifts between generations F0 and F17 in LS1, LS2 and Ctrl lines 
are shown as ∆z2 profiles across the genome (plotted here as fraction of its range 
from 0 to π2).  The Ctrl ∆z2 profile (grey) confirmed our expectation from theory and 
simulation that drift, inbreeding and genetic linkage could combine to generate large 
∆z2 shifts even without selection.  Nonetheless the LS1 (blue) and LS2 (red) profiles 
show a greater number of strong and parallel shifts than Ctrl.  These selective 
sweeps provide support for the contribution of discrete loci to selection response 
(arrowheads, blue: LS1; red: LS2; purple: parallel; see also Fig. 1 – figure 
supplement 2E, Fig. 2 – figure supplement 2, Fig. 2 – figure supplement 3) beyond a 
polygenic background, which may explain a majority of the selection response and 
yet leave little discernible selection signature.  Candidate genes are highlighted 
(Table 1).  An additional a priori candidate limb regulator Gli3 is indicated with a 
black arrowhead. 
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We next asked whether specific loci reveal more definitive differences between 
the LS replicates and Ctrl (and from infinitesimal predictions).  We calculated ∆z2, the 
square of arc-sin transformed allele frequency difference between F0 and F17; this 
has an expected variance of 1/2Ne per generation, independent of starting 
frequency, and ranges from 0 to π2.  We averaged ∆z2 within 10 kbp windows (see 
Methods for details), and found 169 windows belonging to eight clusters (i.e., loci) 
that had significant shifts in allele frequency in LS1 and/or LS2 (corresponding to 9 
and 164 clustered windows respectively at P ≤ 0.05 under HINF, max LD; ∆z2 ≥ 0.33 π2; 
genome-wide ∆z2 = 0.02  ± 0.03 π2; Fig. 2; Fig. 1 – figure supplement 2D, Fig. 2 – 
figure supplement 2, Fig. 2 – figure supplement 3; see Methods for details) and 8 
windows in 3 clusters in Ctrl (genome-wide ∆z2 = 0.01  ± 0.02 π2).  The eight loci 
each overlapped between 2 to 179 genes and together contained 11 candidate 
genes with known roles in bone, cartilage and/or limb development (e.g., Nkx3-2 and 
Sox9; Table 1; Fig. 2 – figure supplement 3, Fig. 3 – figure supplement 1).  Four out 
of the eight loci contain genes with a “short tibia” or “short limb” knockout phenotype 
(Table 1; P ≤ 0.032 from 1000 permutations, see Methods for details).  Of the 
broader set of genes at these loci with any limb knockout phenotypes, only fibrillin 2 
(Fbn2) is polymorphic for SNPs coding for different amino acids, suggesting that for 
the majority of loci with large shifts in allele frequency, gene regulation was likely 
important in the selection response (Fig. 3 – figure supplement 1; Supplementary 
File 3; see Supplementary Notes for further analyses on enrichment in gene 
functions, protein-coding vs. cis-acting changes and clustering with loci affecting 
human height).   
Taken together, two major observations stand out from our genomic survey.  
One, a polygenic, infinitesimal selection model with strong LD amongst marker SNPs 
performed better than moderate LD or no LD (Fig. 1 – figure supplement 2E); and 
two, we nevertheless find more discrete loci in LS1 and LS2 than in Ctrl, beyond the 
significance threshold set by the infinitesimal model (Fig. 2; Fig. 2 – figure 
supplement 2).  Thus, we conclude that although the genetic basis of the selection 
response in the Longshanks experiment may be largely polygenic, evidence strongly 
suggests discrete loci with major effect, even when each line is considered 
separately. 
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Table 1.  Major loci likely contributing to selection response.  These 8 loci show 
significant allele frequency shifts in ∆z2 and are ordered according to their estimated 
selection coefficients according to (21).  Shown for each locus are the full hitchhiking 
spans, peak location and their size covering the core windows, the overlapping TAD 
and the number of genes found in it.  The two top-ranked loci show shifts in parallel 
in both LS1 and LS2, with the remaining six showing line-specific response (LS1: 1; 
LS2: 5).  Candidate genes found within the TAD with limb, cartilage, or bone 
developmental knockout phenotype functions are shown, with asterisks (*) marking 
those with a “short tibia” knockout phenotype (see also Fig. 2 – figure supplement 3 
and Supplementary File 3 for full table). 
 
  
	   37 
 
 
Fig. 3.  Selection response in the Longshanks lines was largely line-specific, 
but the strongest signals occurred in parallel.   
(A) Allele frequencies showed greater shifts in LS2 (red) than in Ctrl (grey; left panel; 
diamonds: peak windows; dots: other 10 kbp windows; see Fig. 3 – figure 
supplement 2 for Ctrl vs. LS1 and Supplementary Notes for details).  Changes in the 
two lines were not correlated with each other.  In contrast, there were many more 
parallel changes in a comparison between LS1 (blue) vs. LS2 (red; middle panel; 
adjacent windows appear as clusters due to hitchhiking).  The overall distribution 
closely matches simulated results under the infinitesimal model with maximal linkage 
disequilibrium (HINF, max LD; right heatmap summarizes the percentage seen in 100 
simulated replicates), with most of the windows showing little to no shift (red hues 
near 0; see also Fig. 3 – figure supplement 2 for an example replicate).  Tick marks 
along the axes show genome-wide maximum ∆z2  shifts in each of 100 replicate 
simulations in LS1 (x-axis, blue) and LS2 (y-axis, red), from which we derived line-
specific thresholds at the P ≤ 0.05 significance level.  While the frequency shifts from 
simulations matched the bulk of the observed data well, no simulation recovered the 
strong parallel shifts observed between LS1 and LS2 (compare middle to right panel, 
points along the diagonal).  (B) Genome-wide ranking based on estimated selection 
coefficients s among the candidate discrete loci at P ≤ 0.05 under HINF, max LD.  While 
six out of eight total loci showed significant shifts in only LS1 or LS2, the two loci with 
the highest selection coefficients were likely selected in parallel in both LS1 and LS2 
(also see middle panel in A).  
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We next tested the repeatability of the selection response at the gene/locus 
level using the two LS replicates.  If the founding populations shared the same 
selectively favored variants, we may observe parallelism or co-incident selective 
sweeps, as long as selection could overcome random drift.  Indeed, the ∆z2 profiles 
of LS1 and LS2 were more similar to each other than to Ctrl (Fig. 2 & 3A; Fig. 3 – 
figure supplement 2; Pearson’s correlation in ∆z2 from 10 kbp windows: LS1–LS2: 
0.21 vs. LS1–Ctrl: 0.06 and LS2–Ctrl: 0.05).  Whereas previous genomic studies with 
multiple natural or artificial selection replicates focused mainly on detecting parallel 
loci (23-26), here we have the possibility to quantify parallelism and determine the 
selection value of a given locus.  Six out of eight significant loci at the HINF, max LD 
threshold were line-specific, even though all eight selected alleles were present in 
the F0 generation in both lines.  This prevalence of line-specific loci was consistent 
under different significance thresholds.  However, the two remaining loci that ranked 
first and second by selection coefficient were parallel, both with s > 0.3 (Fig. 3B; note 
that as outliers, the selection coefficient may be substantially overestimated, but their 
rank order should remain the same), supporting the idea that the probability of 
parallelism can be high among those loci with the greatest selection advantage (27).  
Finding just two parallel loci out of 8 discrete loci may appear to be low, given the 
genetic similarity in the founding generation and the identical selection applied to 
both Longshanks replicates.  However, one should bear in mind the very many 
genetic paths to increasing tibia length under an infinitesimal model, and that the 
effect of drift is expected to be very strong in these small populations.  In larger 
populations, the shift in the balance from drift to selection should result in selection 
being able to favour increasingly subtle variants and thus produce a greater 
proportion of parallel loci.  However, we expect the trend of parallelism being 
enriched among the top loci to hold.  In contrast to the subtle differences within each 
line in changes in global diversity over 17 generations (Fig. 2 and Fig. 2 – figure 
supplement 2), we found the signature of parallelism to be significantly enriched in 
the comparison between the selected replicates (𝜒2 test, LS1–LS2: P ≤ 1 ×10-10), as 
opposed to comparisons between each selected lines and Ctrl (LS1–Ctrl: P > 0.01 
and LS2–Ctrl: P > 0.2, both non-significant after correcting for multiple testing), or 
between simulated replicates (Fig. 3 – figure supplement 2; see Supplementary 
Notes for details).  Because the parallel selected loci between LS1 and LS2 have the 
highest selection coefficients and parallelism is not generally expected in our 
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populations, these loci provide the strongest evidence for the role of discrete major 
loci.  As such, the top-ranked parallel locus is the prime candidate for molecular 
dissection (see Fig. 4 – figure supplement 1 and Supplementary Notes “Molecular 
dissection of Gli3” for an additional a priori candidate locus with known limb 
function).  
 
Molecular dissection of the Nkx3-2 locus highlights cis-acting changes 
Between the two major parallel loci, we chose the locus on chromosome 5 
(Chr5) at 41–42 Mbp for functional validation because it showed the strongest 
estimated selection coefficient, its clear signature of selection was clear, and 
crucially for functional characterization, it contains only three genes, including Nkx3-
2 (also known as Bapx1), a known regulator of bone maturation (Fig. 2 & 4A) (29).  
At this locus, the pattern of variation resembles a selective sweep spanning 1 Mbp 
(Fig. 4A).  Comparison between F0 and F17 individuals revealed no recombinant in 
this entire region (Fig. 5 – figure supplement 1A, top panel), precluding fine-mapping 
using recombinants.  We then analyzed the genes in this region to identify the likely 
target(s) of selection.  First, we determined that no coding changes existed for either 
Rab28 or Nkx3-2, the two genes located within the topologically associating domain 
(TADs, which mark chromosome segments with shared gene regulatory logic) (22).  
We then performed in situ hybridization and detected robust expression of Nkx3-2 
and Rab28 in the developing fore- and hindlimb buds of Ctrl, LS1 and LS2 E12.5, in 
a domain broadly overlapping the presumptive zeugopod, the region including the 
tibia (Fig. 4 – figure supplement 2B).  A third gene, Bod1l, straddled the TAD 
boundary with its promoter located in the neighbouring TAD, making its regulation by 
sequences in the selected locus unlikely.  Consistent with this, Bod1l showed only 
weak or undetectable expression in the developing limb bud (Fig. 4 – figure 
supplement 2A).  We next combined ENCODE chromatin profiles and our own 
ATAC-Seq data to identify limb enhancers in the focal TAD.  Here we found 3 novel 
enhancer candidates (N1, N2 and N3) carrying 3, 1 and 3 SNPs respectively, all of 
which showed significant allele frequency shifts in LS1 and LS2 (Fig. 4B & C; Fig. 5 
– figure supplement 1A).   
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Fig. 4.  Strong parallel selection response at the bone maturation repressor 
Nkx3-2 locus was associated with decreased activity of two enhancers.   
(A) ∆z2 in this region of chromosome 5 showed strong parallel differentiation 
spanning 1 Mbp in both Longshanks but not in the Control line.  This 1 Mbp region 
contains three genes Nkx3-2, Rab28 and Bod1l (whose promoter lies outside the 
TAD boundary, shown as grey boxes).  Although an originally rare allele in all lines, 
this region had swept almost to fixation by generation 17 in LS2 (Fig. 5 – figure 
supplement 1A). (B) Chromatin profiles [ATAC-Seq, red, (28); ENCODE histone 
modifications, purple] from E14.5 developing limb buds revealed five putative limb 
enhancers (grey and red shading) in the TAD, three of which contained SNPs 
showing significant frequency shifts.  Chromosome conformation capture assays 
(4C-Seq) from E14.5 limb buds from the N1, N2 and N3 enhancer viewpoints (bi-
directional arrows) showed significant long-range looping between the enhancers 
and sequences around the Nkx3-2 promoter (heat-map from grey to red showing 
increasing contacts; Promoters are shown with black arrows and blue vertical 
shading).  (C) Selected alleles at 7 SNPs found within the N1–3 enhancers 
increased ~0.75 in frequency in both LS1 and LS2.  Selected alleles at 3 of these 
sites are predicted to lead to loss (red inhibition circles) of transcription factor binding 
sites in the Nkx3-2 pathway (including a SNP in N3 causing loss of 2 adjoining Nkx3-
2 binding sites) and thus reduce enhancer activity in N1 and N3.  (D, E) Transient 
transgenic reporter assays of the N1 and N3 enhancers showed that the F0 alleles 
drove robust and consistent expression at centers of future cartilage condensation 
(N1) and broader domains of Nkx3-2 expression (N3) in E12.5 fore- and hind limb 
buds (FL, HL; ti: tibia).  Fractions indicate number of embryos showing similar lacZ 
staining out of all transgenic embryos.  Substituting the F17 enhancer allele 
(replacing 3 positions each in N1 and N3) led to little observable limb bud expression 
in both the N1/F17 and N3/F17 embryos, suggesting that selection response for 
longer tibia involved de-repression of bone maturation through a loss-of-function 
regulatory allele of Nkx3-2 at this locus.  Scale bar: 1 mm for both magnifications. 
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Chromosome conformation capture assays showed that the N1–3 sequences 
formed long-range looping contacts with the Nkx3-2 promoter—a hallmark of 
enhancers—despite as much as 600 kbp of intervening sequence (Fig. 4B).  We 
next used transgenic reporter assays to determine whether these sequences could 
drive expression in the limbs.  Here, we were not only interested in whether the 
sequence encoded enhancer activity, but specifically whether the SNPs would affect 
the activity (Fig. 4C & D).  An examination of the predicted transcription factor 
binding sites showed that both the N1 and N3 enhancers contain multiple SNPs with 
consistent directional impact on the putative enhancer activity (Fig. 4C).  In contrast, 
the N2 enhancer contains only a single SNP and is predicted to have inconsistent 
effect on its activity.  We therefore excluded the N2 enhancer from further testing.  
We found that the F0 alleles of the N1 and N3 enhancers (3 SNPs each in about 1 
kbp) drove robust and consistent lacZ expression in the developing limb buds (N1 
and N3) as well as in expanded trunk domains (N3) at E12.5 (Fig. 4E).  In contrast, 
transgenic reporters carrying the selected F17 alleles of the N1 and N3 enhancers 
drove consistently weak, nearly undetectable lacZ expression (Fig. 4E).  Thus, 
switching from the F0 to the F17 enhancer alleles led to a nearly complete loss in 
activity (“loss-of-function”).  This is consistent with the role of Nkx3-2 as a repressor 
in long bone maturation (29).  It should be noted that even though our selective 
regime favored an increase in the target phenotype (tibia length), at the molecular 
level we expect advantageous loss- and gain-of-function variants to be equally likely 
favored by selection.  In fact, in an additional functional validation example at the 
Gli3 locus, we found a gain-of-function enhancer variant that may have been favored 
at that locus (see Fig. 4 – figure supplement 1 and Supplementary Notes “Molecular 
dissection of Gli3”). 
At the Nkx3-2 locus, we hypothesize that the F17 allele causes de-repression 
of bone formation by reducing enhancer activity and Nkx3-2 expression.  Crucially, 
the F0 N1 enhancer showed activity that presages future long bone cartilage 
condensation in the limb (Fig. 4E).  That is, the observed expression pattern recalls 
previous results that suggest that undetected early expression of Nkx3-2 may mark 
the boundaries and size of limb bone precursors, including the tibia (30) (Fig. 4 – 
figure supplement 2C).  Conversely, over-expression of Nkx3-2 has been shown to 
cause shortened tibia (even loss) in mice (31, 32).  In humans, homozygous 
frameshift mutations in NKX3-2 cause the rare disorder spondylo-megaepiphyseal-
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metaphyseal dysplasia (SMMD; OMIM: 613330), which is characterized by short-
trunk, long-limbed dwarfism and bow-leggedness (33).  The affected bones in SMMD 
patients broadly correspond to the expression domains of the two novel N1 (limbs) 
and N3 (limbs and trunk) enhancers.  Instead of wholesale loss of Nkx3-2 
expression, which would have been lethal in mice (34) or likely cause major defects 
similar to SMMD patients (33), our in situ hybridization data did not reveal qualitative 
differences in Nkx3-2 expression domains between Ctrl or LS embryos (Fig. 4 – 
figure supplement 2B).  Taken together, our results recapitulate the key features of a 
cis-acting mode of adaptation: Nkx3-2 is a broadly expressed pleiotropic 
transcription factor that causes lethality when knocked out (34).  We found no amino 
acid changes between the F0 and F17 alleles that could impact protein function.  
Rather, selection favoured changes in tissue-specific expression by modular 
enhancers.  By combining population genetics, functional genomics and 
developmental genetic techniques, we were able to dissect a megabase-long locus 
and present data supporting the identification of up to 6 candidate quantitative trait 
nucleotides (QTNs).  In mice, this represents a rare example of genetic dissection of 
a trait to the base-pair level. 
 
Linking molecular mechanisms to evolutionary consequence 
We next aimed to determine the evolutionary relevance of the Nkx3-2 enhancer 
variants at the molecular and the population levels.  At the strongly expressed N3/F0 
“trunk and limb” enhancer, we note that the SNPs in the F17 selected allele lead to 
disrupted Nkx3-1 and Nkx3-2 binding sites [Fig. 4C & 5A; UNIPROBE database 
(35)].  This suggests that the selected SNPs may disrupt an auto-feedback loop to 
decrease Nkx3-2 activity in the limb bud and trunk domain (Fig. 5A).  Using a GFP 
transgenic reporter assay in stickleback fish embryos, we found that the mouse 
N1/F0 enhancer allele was capable of driving expression in the distal cells but not in 
the fin rays of the developing fins (Fig. 5A).  This pattern recapitulates fin expression 
of nkx3.2 in fish, which gives rise to endochondral radials (homologous to ulna/tibia 
in mice) (36).  Our results suggest that strong selection may have favored the 
weaker N1/F17 and N3/F17 enhancer alleles in the context of the Longshanks 
selection regime despite the deep functional conservation of the F0 variants. 
Using theory and simulations, we went beyond qualitative molecular dissection 
to quantitatively estimate the selection coefficient at the Nkx3-2 locus and its 
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contribution to the total selection response in the Longshanks mice.  We retraced the 
selective sweep of the Nkx3-2 N1 and N3 alleles through targeted genotyping in 
1569 mice across all 20 generations.  The selected allele steadily increased from 
around 0.17 to 0.85 in LS1 and 0.98 in LS2 but fluctuated around 0.25 in Ctrl (Fig. 
5B).  We estimated that such a change of around 0.7 in allele frequency would 
correspond to a selection coefficient s of ~0.24 ± 0.12 at this locus (Fig. 5 – figure 
supplement 1B; see Supplementary Notes section on “Estimating selection 
coefficient of the top-ranking locus, Nkx3-2, from changes in allele frequency”).  By 
extending our simulation framework to allow for a major locus against an infinitesimal 
background, we find that the Nkx3-2 locus would contribute 9.4% of the total 
selection response (limits 3.6 – 15.5%; see Supplementary Notes section 
“Estimating selection coefficient” for details) in order to produce a shift of 0.7 in allele 
frequency over 17 generations.  To avoid inflation stemming from estimating from 
outliers, we also independently estimated the contribution of the Nkx3-2 locus using 
a linear mixed animal model based on the full genotyped series mentioned above 
(see Supplementary Notes section “Estimating selection coefficient, animal model” 
for details).   Using this alternative approach, we estimated that each selected allele 
increases tibia length by 0.36% (N=1569, 95% conf. int.: .07% – 0.64%, P = 0.0171).  
Multiplying the effect with the increase in the allele frequency suggests that the 
Nkx3-2 locus alone would account for approximately 4% of the overall 12.9% 
increase in tibia length.  This lower estimate of around 4% is nonetheless within the 
bounds of the estimate from simulations.  Together, both approaches agree that the 
Nkx3-2 locus contribute substantially to the selection response.  
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Fig. 5. Linking base-pair changes to rapid morphological evolution.  
(A) At the Nkx3-2 locus, we identified two long-range enhancers, N1 and N3 
(circles), located 600 and 230 kbp away, respectively.  During development, they 
drive partially overlapping expression domains in limbs (N1 and N3) and trunk (N3), 
which are body regions that may correlate positively (tibia length) and possibly 
negatively (trunk with body mass) with the Longshanks selection regime.  For both 
enhancers, the selected F17 alleles carry loss-of-function variants (grey crosses).  
Two out of three SNPs in the N3 F17 enhancer are predicted to disrupt an auto-
feedback loop, likely reducing Nkx3-2 expression in the trunk and limb regions.  
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Conversely, the enhancer function of the strong N1 F0 allele is evolutionarily 
conserved in fishes, demonstrated by its ability to drive consistent GFP expression 
(green) in the pectoral fins (pf, outlined) and branchial arches (white arrowhead, left) 
in transgenic stickleback embryos at 11 days post-fertilization.  The N1 enhancer can 
recapitulate nkx3.2 expression in distal cells specifically in the endochondral radial 
domain in developing fins (black arrowheads, right).  Scale bar: 250 µm for both 
magnifications. (B) Allele frequency of the selected allele (minor F0 allele, q) at N3 
over 20 generations (blue: LS1; red: LS2; grey broken line: Ctrl; results from N1 were 
nearly identical due to tight linkage).  Observed frequencies from genotyped 
generations in the Ctrl line are marked with filled circles.  Dashed lines indicate 
missing Ctrl generations.  Open circles at generations 0 and 17 indicate allele 
frequencies from whole genome sequencing.  The allele frequency fluctuated in Ctrl 
due to random drift but followed a generally linear increase in the selected lines from 
around 0.17 to 0.85 (LS1) and 0.98 (LS2) by generation 17.  Shaded contours mark 
expected allelic trajectories under varying selection coefficients starting from 0.17 
(red horizontal line; the average starting allele frequency between LS1 and LS2 
founders).  The grey shaded region marks the 95% confidence interval under 
random drift.   
 
 
2.2.4 Discussion: 
 
A defining task of our time is to understand the factors that determine and 
constrain how small populations respond to sudden environmental changes.  Here, 
we analyze the replicated and controlled Longshanks experiment to characterize the 
genomic changes that occur as small experimental populations respond to selection.   
An important conclusion from the Longshanks experiment is that selection 
response can be steady and robust even in extremely bottlenecked populations.  
That is, we found that tibia length increased readily and repeatedly in response to 
selection even with as few as 14-16 breeding pairs per generation.  The sustained 
response was possible because the lines were founded with enough standing 
variation, and generation 17 was still only a fraction of the way to the expected limit 
for the selection response at ~2Ne generations (37), estimated here to be around 90 
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(see legend for Fig. 1 – figure supplement 2B; Supplementary Notes on “Estimating 
the selection coefficient”).  Although other selective breeding studies using a similar 
base population of mice encountered selection limits at around generation 20-25 
[possibly due to countervailing selection rather than loss of genetic variance for high 
voluntary wheel running behavior (38) and for nest-building behavior (39), here all 
evidence suggest that the Longshanks mice should continue to show increase in 
tibia length for many more generations. 
The estimated Ne of 46 in the Longshanks experiment, while small, is 
comparable to those in natural populations like the Soay sheep (40), Darwin’s 
finches (41) or Tasmanian Devils (5) (this last study documents a rapid and parallel 
evolutionary response to transmissible tumor).  These populations span a wide 
range of time in sustained bottlenecking, from the most recent in Tasmanian devils, 
to likely many millions of years in Darwin’s finches.  Accordingly, we also expect very 
different dynamics during short- vs. long-term selection response: for a short bout of 
selection, such as the 20 generations analyzed in this study, selection response 
depends overwhelmingly on standing genetic variation, with little to no contribution 
from de novo mutations (43, 44).  Over the long term, however, de novo mutations 
would contribute increasingly.  In the Longshanks experiment, we observe a robust 
early response to selection (Fig. 1B & Fig. 1 – figure supplement 1), and a gradual 
decrease in sequence diversity, consistent with the effect of drift (Fig. 1 – figure 
supplement 2B & Fig. 2 – figure supplement 1A, Supplementary File 2).  There has 
long been broad empirical support for adaptation from standing genetic variation in 
nature (24, 42, 45) and breeding (46).  At least in the short-run, our result 
demonstrating robust selection response in the Longshanks experiment provides 
grounds for some optimism regarding the ability of populations to respond rapidly to 
changes in their environment.  
By combining pedigree records with sequencing of founder individuals, our data 
had sufficient detail to allow precise modeling of trait response, with predicted shifts 
in allele frequency distribution that closely matched our results (e.g. Fig. 1 – figure 
supplement 2D).  Furthermore, we functionally validated loci that showed allele 
frequency shifts outside the model’s predictions and found key enhancers of major 
effect.  Connecting trait changes to allele frequency changes at specific loci has 
been a longstanding objective in selection experiments, with a number of remarkable 
early attempts (47).  To date, we know of only a few studies that attempt to explicitly 
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link traits with changes in allele frequencies (48-51) and none have systematically 
tested the underlying architecture against an infinitesimal background.   Here, our 
results imply a mixed genetic architecture with a few discrete loci of large effect amid 
an infinitesimal background.  It remains to be seen whether other evolve-and-
resequence (E&R) studies, with different selection pressures and population 
parameters may reveal similar results.   
To put our finding of a mixed genetic architecture into perspective, it is worth 
noting that the infinitesimal model is still the most predictive model by far in practical 
quantitative genetics, for diverse domesticated species from cattle to crops, despite 
its intrinsically unrealistic assumptions (52-54).  In general, current genomic data for 
many traits is consistent with a very large number of loci, each with a small effect.  
From a practical point of view, however, the use of an infinitesimal model does not 
preclude the presence or indeed the importance of few major effect loci.  Rather, it 
simply assumes that they are rare enough to allow reasonable model fit [(55), page 
878].  Here, we note that it is actually not clear how one might parameterize a 
generally applicable predictive oligogenic model with more than a single major effect 
locus.  In this study, while we consider the most likely genetic architecture to be a 
small number of major effect loci together with a polygenic background, we cannot 
reject other alternative models that could also account for the observed response, 
such as an effectively infinitesimal model with linkage, as well as models with a few 
major trait loci.   
Among other classical examples of complex traits, such as height or body 
weight, that may have been subjected to selection, we observe a range of genetic 
architectures in ways often tightly connected to their population size and/or selection 
history.  Height in humans is often cited as the classical complex trait under possible 
selection of unknown (and much debated) intensity [see (56-59)].  It shows high 
heritability and a highly dispersed genetic architecture (with the top-ranked locus 
accounting for only 0.8% of the variation explained in cosmopolitan European 
populations) (60, 61). In contrast, as few as 4 to 6 loci account for 83% and 50% of 
the variation in height in horses and dogs, respectively (62, 63).  In both horses and 
dogs, selection has been strong and sustained, and breed populations tend to be 
small.  Interestingly, and in line with our experiment, the major allele at the IGF1 
locus stems from a standing genetic variant, despite many factors that may 
theoretically favor large-effect de novo mutations (64).  In chickens, modern breeding 
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practice and selection from large populations yielded a highly polygenic genetic 
architecture for body weight, with some of the best empirical evidence for epistasis 
(65-68).  Similarly, results from many selection experiments in Drosophila suggest 
that the genetic architecture underlying selection response may involve many genes 
(69-72).  By contrast, the extreme tail of the effect size distribution (as inferred from 
∆z2) from the Longshanks experiment appears to account for a substantial part of the 
selection response, presumably due to the combined effects of relatively low 
diversity in commercial mouse stock and the small founding populations.  But unlike 
these previous QTL studies or selection experiments, in which either the genetic 
architecture of a trait or the selection value were estimated separately, sometimes 
from only few parental individuals or lines, E&R studies sample a much broader pool 
of alleles and continually compete them against each other.  Thus, our approach 
allowed simultaneous inference of genetic architecture and distribution of effect 
sizes, is more likely to be representative of the population at large, and is more akin 
to genome-wide association studies (GWAS), except that here we can also directly 
connect a trait to its selective value and capture the trajectory of any given allele.   
Parallel evolution is often seen as a hallmark for detecting selection (25, 73-
75).  We investigated the factors that contribute to parallelism in allele frequency 
shifts over 17 generations by contrasting the two Longshanks replicates against the 
Control line.  However, we observed little parallelism between selected lines and 
Ctrl, or between simulated replicates under selection, even though the simulated 
haplotypes were sampled directly from actual founders.  This underscores that 
parallelism depends on both shared selection pressure (absent in Ctrl) and the 
availability of large-effect loci that confer a substantial selection advantage (absent 
under the infinitesimal model; Fig. 3; Fig. 3 – figure supplement 2).  With increasing 
population size, selection would be better able to detect variants with more subtle 
effects. This would in turn lower the threshold beyond which the selection advantage 
of an allele would become deterministic, i.e., exhibit parallelism. 
Through in-depth dissection of the Nkx3-2 locus, our data show in fine detail 
how the selective value of standing variants depends strongly on the selection 
regime: the originally common F0 variant of the N1 enhancer show deep functional 
conservation and can evidently recapitulate fin nkx3.2 expression in fishes (Fig. 5A).  
Yet, in the Longshanks experiment selection strongly favored the weaker allele (Fig. 
5B).  In fact, our molecular dissection of two loci show that both gain-of-function 
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(Gli3) and loss-of-function (Nkx3-2) variants could be favored by selection (Fig. 4E & 
5A; Fig. 4 – figure supplement 1D).  Through synthesis of multiple lines of evidence, 
our work uncovered the key role of Nkx3-2, which was not an obvious candidate 
gene like Gli3 due to the lack of abnormal limb phenotype in the Nkx3-2 knockout 
mice.  To our surprise, the same loss of NKX3-2 function in human SMMD patients 
manifests in opposite ways in different bone types as short trunk and long limbs (33).  
This matches the expression domains of our N1 (limb) and N3 (limb and trunk) 
enhancers (Fig. 5A).  Evidently, in the absence of lethal coding mutations, the F17 
haplotype was doubly beneficial at both enhancers for the limb and potentially also 
trunk target tissues under the novel selection regime in the Longshanks selection 
experiment.  We estimate that these enhancer variants, along with any other tightly 
linked beneficial SNPs, segregate as a single locus, which in turn contributes ~10% 
of the overall selection response.  
Despite our efforts to uncover the mechanism underlying the selective 
advantage of the Nkx3-2 locus, much remains unknown.  For example, it remains 
unclear how such a major allele could segregate in the general mouse stock (and as 
the reference C57BL/6J allele, no less).  It could be that this allele has the same 
effect in the general mouse population but is conditionally neutral under non-
selective breeding and simply escaped notice.  However, our preliminary exploration 
in a panel of C57BL/6-by-DBA/2 (“BXD”) mice suggested otherwise: mapping of tibia 
length or mineral density did not reveal this locus as a major QTL determining tibia 
length (unpublished data kindly provided by Weikuan Gu), suggesting that this 
allele’s effect on tibia length may depend on the genetic background.  Alternatively, 
the broader C57BL/6 allele could be linked to a compensatory mutation that became 
uncoupled among the founders of the Longshanks lines.  Finally, although we do 
observe the specific N1 and N3 SNP positions as variable across the rodent and 
indeed the broader mammalian lineages, further work is needed to determine their 
effect, if any, on limb development. 
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2.2.5 Conclusion: 
 
Using the Longshanks selection experiment and synthesizing theory, empirical 
data and molecular genetics, we show that it is possible to identify some of the 
individual SNPs that have contributed to the response to selection on morphology.  
In particular, discrete, large-effect loci are revealed by their parallel response.  
Further work should focus on dissecting the mechanisms behind the dynamics of 
selective sweeps and/or polygenic adaptation by re-sequencing the entire selection 
pedigree, testing how the selection response depends on the genetic architecture, 
and the extent to which linkage places a fundamental limit on our inference of 
selection.  Improved understanding in these areas may have broad implications for 
conservation, rapid adaptation to climate change and quantitative genetics in 
medicine, agriculture and in nature. 
 
2.2.6 Material and Methods:  
 
Animal Care and Use  
All experimental procedures described in this study have been approved by the 
applicable University institutional ethics committee for animal welfare at the 
University of Calgary (HSACC Protocols M08146 and AC13-0077); or local 
competent authority: Landesdirektion Sachsen, Germany, permit number 24-
9168.11-9/2012-5.   
 
Reference genome assembly 
All co-ordinates in the mouse genome refer to Mus musculus reference mm10, 
which is derived from GRCm38.   
 
Code and data availability 
Sequence data have been deposited in the SRA database under accession 
number SRP165718 and GEO under GSE121564, GSE121565 and GSE121566.  
Non-sequence data have been deposited at Dryad. Analytical code and additional 
notes have been deposited in the following repository: 
https://github.com/evolgenomics/Longshanks. 
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Pedigree data 
Tibia length and body weight phenotypes were measured as previously 
described (13).  A total of 1332 Control, 3054 LS1, and 3101 LS2 individuals were 
recorded.  Five outlier individuals with a skeletal dysplasia of unknown etiology were 
removed from LS2 and excluded from further analysis.  Missing data in LS2 were 
filled in with random individuals that best matched the pedigree.  Trait data were 
analyzed to determine response to selection based on the measured traits and their 
rank orders based on the selection index. 
 
Simulations 
Simulations were based on the actual pedigree and selection scheme, following 
one chromosome at a time.  Each chromosome was represented by a set of 
junctions, which recorded the boundaries between genomes originating from 
different founder genomes; at the end, the SNP genotype was reconstructed by 
seeding each block of genome with the appropriate ancestral haplotype.  This 
procedure is much more efficient than following each of the very large number of 
SNP markers.  Crossovers were uniformly distributed, at a rate equal to the map 
length (76).  Trait value was determined by a component due to an infinitesimal 
background (Vg); a component determined by the sum of effects of 104 evenly 
spaced discrete loci (Vs); and a Gaussian non-genetic component (Ve).  The two 
genetic components had variance proportional to the corresponding map length, and 
the heritability was estimated from the observed trait values (see Supplementary 
Notes under “Major considerations”).  In each generation, the actual number of male 
and female offspring were generated from each breeding pair, and the male and 
female with the largest trait value were chosen to breed. 
SNP genotypes were assigned to the founder genomes with their observed 
frequencies.  However, to reproduce the correct variability requires that we assign 
founder haplotypes.  This is not straightforward, because low-coverage individual 
genotypes cannot be phased reliably, and heterozygotes are frequently mis-called as 
homozygotes.  We compared three procedures, which were applied within intervals 
that share the same ancestry: assigning haplotypes in linkage equilibrium (LE, or “no 
LD”); assigning the two alleles at heterozygous sites in each individual to its two 
haplotypes at random, which minimizes linkage disequilibrium but is consistent with 
observed diploid genotypes (“min LD”); and assigning alleles at heterozygous sites in 
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each individual to the “reference” and “alternate” haplotype consistently within an 
interval, which maximises linkage disequilibrium (“max LD”) (Fig. 1 – figure 
supplement 2C).  For details, see legend in Fig. 1 – figure supplement 2. 
 
Significance thresholds 
To obtain significance thresholds, we summarized the genome-wide maximum 
∆z2 shift for each replicate of the simulated LS1 and LS2 lines, averaged within 10kb 
windows, and grouped by the selection intensity and extent of linkage disequilibrium 
(LD).  From this distribution of genome-wide maximum ∆z2 we obtained the critical 
value for the corresponding significance threshold (typically the 95th quantile or P = 
0.05) under each selection and LD model (Fig. 3A; Fig. 1 – figure supplement 2E).  
This procedure controls for the effect of linkage and hitchhiking, line-specific 
pedigree structure, and selection strength.   
 
Sequencing, genotyping and phasing pipeline 
Sequencing libraries for high-throughput sequencing were generated using 
TruSeq or Nextera DNA Library Prep Kits (Illumina, Inc., San Diego, USA) according 
to manufacturer’s recommendations or using equivalent Tn5 transposase expressed 
in-house as previously described (77).  Briefly, genomic DNA was extracted from ear 
clips by standard Protease K digestion (New England Biolabs GmbH, Frankfurt am 
Main, Germany) followed by AmpureXP bead (Beckman Coulter GmbH, Krefeld, 
Germany) purification.  Extracted high-molecular weight DNA was sheared with a 
Covaris S2 (Woburn, MA, USA) or “tagmented” by commercial or purified Tn5-
transposase according to manufacturer’s recommendations.  Each sample was 
individually barcoded (single-indexed as N501 with N7XX variable barcodes; all 
oligonucleotides used in this study were synthesized by Integrated DNA 
Technologies, Coralville, Iowa, USA) and pooled for high-throughput sequencing by 
a HiSeq 3000 (Illumina) at the Genome Core Facility at the MPI Tübingen Campus.  
Sequenced data were pre-processed using a pipeline consisting of data clean-up, 
mapping, base-calling and analysis from software fastQC v0.10.1 (78); trimmomatic 
v0.33 (79); bwa v0.7.10-r789 (80); GATK v3.4-0-gf196186 modules BQSR, 
MarkDuplicates, IndelRealignment (81, 82).  Genotype calls were performed using 
the GATK HaplotypeCaller under the GENOTYPE_GIVEN_ALLELES mode using a 
set of high-quality SNP calls made available by the Wellcome Trust Sanger Centre 
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[Mouse Genomes Project version 3 dbSNP v137 release (83)], after filtering for sites 
segregating among inbred lines that may have contributed to the original 7 female 
and 2 male CD-1 founders, namely 129S1/SvImJ, AKR/J, BALB/cJ, BTBR T+ 
Itpr3tf/J, C3H/HeJ, C57BL/6NJ, CAST/EiJ, DBA/2J, FVB/NJ, KK/HiJ, MOLF/EiJ, 
NOD/ShiLtJ, NZO/HlLtJ, NZW/LacJ, PWK/PhJ and WSB/EiJ based on (16).  We 
consider a combined ~100x coverage sufficient to recover any of the 18 CD-1 
founding haplotypes still segregating at a given locus.  The raw genotypes were 
phased with Beagle v4.1 (83) based on genotype posterior likelihoods using a 
genetic map interpolated from the mouse reference map (76) and imputed from the 
same putative CD-1 source lines as the reference panel.  The site frequency spectra 
(SFS) were evaluated to ensure genotype quality (Fig. 2 – figure supplement 1A).  
 
Population genetics summary statistics 
Summary statistics of the F0 and F17 samples were calculated genome-wide 
(Weir–Cockerham FST , π, heterozygosity, allele frequencies p and q) in adjacent 10 
kbp windows or on a per site basis using VCFtools v0.1.14 (84).  The summary 
statistic ∆z2 was the squared within-line difference in arcsine square-root 
transformed MAF q; it ranges from 0 to π2. The resulting data were further processed 
by custom bash, Perl and R v3.2.0 (85) scripts.   
 
Peak loci and filtering for hitchhiking windows 
Peak loci were defined by a descending rank ordering of all 10 kbp windows, 
and from each peak signal the windows were extended by 100 SNPs to each side, 
until no single SNP rising above a ∆z2 shift of 0.2 π2 was detected.  A total of 810 
peaks were found with a ∆z2 shift ≥ 0.2 for LS1 and LS2.  Following the same 
procedure, we found 766 peaks in Ctrl.   
 
Candidate genes 
To determine whether genes with related developmental roles were associated 
with the selected variants, the topologically associating domains (TADs) derived from 
mouse embryonic stem cells as defined elsewhere (22) were re-mapped onto mm10 
co-ordinates.  Genes within the TAD overlapping within 500 kbp of the peak window 
(“core span”) were then cross-referenced against annotated knockout phenotypes 
(Mouse Genome Informatics, http://www.informatics.jax.org).  This broader overlap 
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was chosen to include genes whose regulatory sequences (e.g., enhancers), but not 
necessarily their gene bodies, fall close to the peak window.  We highlight candidate 
genes showing limb- and bone-related phenotypes, e.g., with altered limb bone 
lengths or epiphyseal growth plate morphology, as observed in Longshanks mice 
(15), of the following categories (along with their Mammalian Phenotype Ontology 
term and the number of genes): “abnormal tibia morphology/MP:0000558” (212 
genes), “short limbs/MP:0000547” and “short tibia/MP:0002764” (223 genes), 
“abnormal cartilage morphology/MP:0000163” (321 genes), “abnormal osteoblast 
morphology/MP:0004986” (122 genes).  Note that we excluded compound mutants 
or those conditional mutant phenotypes involving transgenes.  To determine if the 
overlap with these genes were significant, we performed 1000 permutations of the 
core span using bedtools v2.22.1 shuffle with the -noOverlapping option (86) and 
excluding ChrY, ChrM and unassembled scaffolds.  We then followed the exact 
procedure as above to determine the number of genes in the overlapping TAD 
belonging to each category.  We reported the quantile rank as the P-value, ignoring 
ties.  To determine other genes in the region, we list all genes falling within the entire 
hitchhiking window (Supplementary File 3).   
 
Identification of putative limb enhancers 
We downloaded publicly available chromatin profiles, derived from E14.5 limbs, 
for the histone H3 lysine-4 (K4) or lysine-27 (K27) mono-/tri-methylation or 
acetylation marks (H3K4me1, H3K4me3 and H3K27ac) generated by the ENCODE 
Consortium (87).  We intersected the peak calls for the enhancer-associated marks 
H3K4me1 and H3K27ac and filtered out peaks overlapping promoters [H3K4me3 
and promoter annotation according to the FANTOM5 Consortium (88)].   
 
Enrichment analysis 
To calculate enrichment through the whole range of ∆z2, a similar procedure 
was taken as in Candidate genes above.  For knockout gene functions, genes 
contained in TADs within 500 kbp of peak windows were included in the analysis.  
We used the complete database of annotated knockout phenotypes for genes or 
spontaneous mutations, after removing phenotypes reported under conditional or 
polygenic mutants.  For gene expression data, we retained all genes which have 
been reported as being expressed in any of the limb structures, by tracing each 
	   56 
anatomy ontological term through its parent terms, up to the top level groupings, 
e.g., “limb”, in the Mouse Genomic Informatics Gene Expression Database (89).  For 
E14.5 enhancers, we used a raw 500 kbp overlap with the peak windows because 
enhancers, unlike genes, may not have intermediaries and may instead represent 
direct selection targets.  
For coding mutations, we first annotated all SNPs for their putative effects 
using snpEff v4.0e (90).  To accurately capture the per-site impact of coding 
mutations, we used per-site ∆z2 instead of the averaged 10 kbp window.  For each 
population, we divided all segregating SNPs into up to 0.02 bands based on per-site 
∆z2.  We then tracked the impact of coding mutations in genes known to be 
expressed in limbs, as above.  We reported the sum of all missense (“moderate” 
impact), frame-shift, stop codon gain or loss sites (“high impact”).  A linear 
regression was used to evaluate the relationship between ∆z2 and the average 
impact of coding SNPs (SNPs with high or moderate impact to all coding SNPs). 
For regulatory mutations, we used the same bins spanning the range of ∆z2, 
but focused on the subset of SNPs falling within the ENCODE E14.5 limb enhancers.  
We then obtained a weighted average conservation score based on an averaged 
phastCons (91) or phyloP (92) score in ±250 bp flanking the SNP, calculated from a 
60-way alignment between placental mammal genomes [downloaded from the 
UCSC Genome Browser (93)].  We reported the average conservation score of all 
SNPs within the bin and fitted a linear regression on log-scale.  In particular, 
phastCons scores range from 0 (un-conserved) to 1 (fully conserved), whereas 
phyloP is the 𝑙𝑜𝑔!"  of the P-value of the phylogenetic tree, expressed as a positive 
score for conservation and a negative score for lineage-specific accelerated change.  
We favored using phastCons for its simpler interpretation.   
 
Impact of coding variants 
Using the same SNP effect annotations described in the section above, we 
checked whether any specific SNP with significant site-wise ∆z2 in either LS1 or LS2 
cause amino acid changes or protein disruptions and are known to cause limb 
defects when knocked out.  For each position we examined outgroup sequences 
using the 60-way placental mammal alignment to determine the ancestral amino acid 
state and whether the selected variant was consistent with purifying vs. diversifying 
selection.  The resulting 12 genes that matched these criteria are listed in 
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Supplementary File 4.  
 
Association with human height loci 
We downloaded the set of 697 SNPs associated with loci for human height (61) 
to test if these loci cluster with the selected loci in the Longshanks lines.  In order to 
facilitate mapping to mouse co-ordinates, each human SNP was expanded to 
100 kbp centering on the SNP and converted to mm10 positions using the liftOver 
tool with the multiple mapping option disabled (93).  We were able to assign 
positions in 655 out of the 697 total SNPs.  Then for each of the 810 loci above the 
HINF, no LD threshold in the selected Longshanks lines, the minimal distance to any of 
the mapped human loci was determined using bedtools closest with the -d option 
(86).  When a region actually overlapped, a distance of 0 bp was assigned.  To 
generate a permuted set, the 810 loci were randomly shuffled across the mouse 
autosomes using the bedtools shuffle program with the -noOverlapping option.  Then 
the exact same procedure as the actual data was followed to determine the closest 
interval.  The resulting permuted intervals followed an approximately normal 
distribution, with observed results falling completely below the range of permuted 
results, i.e., closer to height-associated human SNPs. 
 
In situ hybridization 
Detection of specific gene transcripts were performed as previously described 
in (94).  Probes against Nkx3-2, Rab28, Bod1l and Gli3 were amplified from cDNA 
from wildtype C57BL/6NJ mouse embryos (Supplementary File 5).  Amplified 
fragments were cloned into pJET1.2/blunt plasmid backbones in both sense and 
anti-sense orientations using the CloneJET PCR Kit (Thermo Fisher Scientific, 
Schwerte, Germany) and confirmed by Sanger sequencing using the included 
forward and reverse primers.  Probe plasmids have also been deposited with 
Addgene.  In vitro transcription from the T7 promoter was performed using the 
MAXIscript T7 in vitro Transcription Kit (Thermo Fisher Scientific) supplemented with 
Digoxigenin-11-UTP (Sigma-Aldrich) (MPI Tübingen), or with T7 RNA polymerase 
(Promega) in the presence of DIG RNA labelling mix (Roche) (University of Calgary).  
Following TURBO DNase (Thermo Fisher Scientific) digestion, probes were cleaned 
using SigmaSpin Sequencing Reaction Clean-Up columns (Sigma-Aldrich) (MPI 
Tübingen), or using Illustra MicroSpin G-50 columns (GE Healthcare) (University of 
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Calgary).  During testing of probe designs, sense controls were used in parallel 
reactions to establish background non-specific binding. 
 
ATAC-seq library preparation and sequencing pipeline  
ATAC-seq was performed on dissected C57BL/6NJ E14.5 forelimb and 
hindlimb.  Nuclei preparation and tagmentation were performed as previously 
described in (28), with the following modifications.  To minimize endogenous 
protease activity, cells were strictly limited to 5 + 5 minutes of collagenase A 
treatment at 37 ºC, with frequent pipetting to aid dissociation into single-cell 
suspensions.  Following wash steps and cell lysis, 50 000 nuclei were tagmented 
with expressed Tn5 transposase.  Each tagmented sample was then purified by 
MinElute columns (Qiagen) and amplified with Q5 High-Fidelity DNA Polymerase 
(New England Biolabs) using a uniquely barcoded i7-index primer (N701-N7XX) and 
the N501 i5-index primer.  PCR thermocycler programs were 72ºC for 4 min, 98ºC for 
30 s, 6 cycles of 98ºC for 10 s, 65ºC for 30 s, 72ºC for 1 min, and final extension at 
72ºC for 4 min.  PCR-enriched samples were taken through a double size selection 
with PEG-based SPRI beads (Beckman Coulter) first with 0.5X ratio of PEG/beads to 
remove DNA fragments longer than 600 bp, followed by 1.8X PEG/beads ratio in 
order to select for Fraction A as described in (95).  Pooled libraries were run on the 
HiSeq 3000 (Illumina) at the Genome Core Facility at the MPI Tübingen Campus to 
obtain 150 bp paired end reads, which were aligned to mouse mm10 genome using 
bowtie2 v.2.1.0 (96).  Peaks were called using MACS14 v.2.1 (97). 
 
Multiplexed chromosome conformation capture (4C-Seq)  
Chromosome conformation capture (3C) template was prepared from pooled 
E14.5 liver, forelimb and hindlimb buds (n = 5–6 C57BL/6NJ embryos per replicate), 
with improvements to the primer extension and library amplification steps following 
(98).  The template was amplified with Q5 High-Fidelity Polymerase (New England 
Biolabs GmbH, Frankfurt am Main, Germany) using a 4C adapter-specific primer and 
a pool of 6 Nkx3-2 enhancer viewpoint primers [and, in a separate experiment, a 
pool of 8 Gli3 enhancer-specific viewpoint primers; Supplementary File 6].  Amplified 
fragments were prepared for Illumina sequencing by ligation of TruSeq adapters, 
followed by PCR enrichment.  Pooled libraries were sequenced by a HiSeq 3000 
(Illumina) at the Genome Core Facility at the MPI Tübingen Campus with single-end, 
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150 bp reads.  Sequence data were processed using a pipeline consisting of data 
clean-up, mapping, and analysis based upon cutadapt v1.10 (99); bwa v0.7.10-r789 
(80) ; samtools v1.2 (100); bedtools (86) and R v3.2.0 (85).  Alignments were filtered 
for ENCODE blacklisted regions (101) and those with MAPQ scores below 30 were 
excluded from analysis.  Filtered alignments were binned into genome-wide BglII 
fragments, normalized to Reads Per Kilobase of transcript per Million mapped reads 
(RPKM), and plotted and visualized in R.   
 
Plasmid construction 
Putative limb enhancers corresponding to the F0 and F17 alleles of the Gli3 G2 
and Nkx3-2 N1 and N3 enhancers were amplified from genomic DNA of Longshanks 
mice from the LS1 F0 (9 mice) and F17 (10 mice) generations and sub-cloned into 
pJET1.2/blunt plasmid backbone using the CloneJET PCR Kit (Thermo Fisher 
Scientific) and alleles were confirmed by Sanger sequencing using the included 
forward and reverse primers (Supplementary File 7).  Each allele of each enhancer 
was then cloned as tandem duplicates with junction SalI and XhoI sites upstream of 
a β-globin minimal promoter in our reporter vector (see below).  Constructs were 
screened for the enhancer variant using Sanger sequencing.  All SNPs were further 
confirmed against the rest of the population through direct amplicon sequencing.   
The base reporter construct pBeta-lacZ-attBx2 consists of a β-globin minimal 
promoter followed by a lacZ reporter gene derived from pRS16, with the entire 
reporter cassette flanked by double attB sites.  The pBeta-lacZ-attBx2 plasmid and 
its full sequence have been deposited and is available at Addgene. 
 
Pronuclear injection of F0 and F17 enhancer-reporter constructs in mice 
The reporter constructs containing the appropriate allele of each of the 3 
enhancers were linearized with ScaI (or BsaI in the case of the N3 F0 allele due to 
the gain of a ScaI site) and purified.  Microinjection into mouse zygotes was 
performed essentially as described (102).  
At 12 d after the embryo transfer, the gestation was terminated and embryos 
were individually dissected, fixed in 4% paraformaldehyde for 45 min and stored in 
PBS.  All manipulations were performed by R.N. or under R.N.’s supervision at the 
Transgenic Core Facility at the Max Planck Institute of Cell Biology and Genetics, 
Dresden, Germany.  Yolk sacs from embryos were separately collected for 
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genotyping and all embryos were stained for lacZ expression as previously 
described (103).  Embryos were scored for lacZ staining, with positive expression 
assigned if the pattern was consistently observed in at least two embryos. 
 
Genotyping of time series at the Nkx3-2 N3 locus 
Allele-specific primers terminating on SNPs that discriminate between the F0 
from the F17 N3 enhancer alleles were designed (rs33219710 and rs33600994; 
Supplementary File 8).  The amplicons were optimized as a qPCR reaction to give 
allele-specific, present/absent amplifications (typically no amplification for the absent 
allele, otherwise average ∆Ct > 10).  Genotyping on the entire breeding pedigree of 
LS1 (n = 602), LS2 (n = 579) and Ctrl (n = 389) was performed in duplicates for each 
allele on a Bio-Rad CFX384 Touch instrument (Bio-Rad Laboratories GmbH, 
Munich, Germany) with SYBR Select Master Mix for CFX (Thermo Fisher Scientific) 
and the following qPCR program: 50ºC for 2 min, 95ºC for 2 min, 40 cycles of 95ºC 
for 15 s, 58ºC for 10 s, 72ºC for 10 s.  In each qPCR run we included individuals of 
each genotype (LS F17 selected homozygotes, heterozygotes and F0 major allele 
homozygotes).  For the few samples with discordant results between replicates, DNA 
was re-extracted and re-genotyped or otherwise excluded.  
 
Transgenic reporter assays in stickleback fish 
In sticklebacks, transgenic reporter assays were carried out using the reporter 
construct pBHR (74).  The reporter consists of a zebrafish heat shock protein 70 
(Hsp70) promoter followed by an eGFP reporter gene, with the entire reporter 
cassette flanked by tol2 transposon sequences for transposase-directed genomic 
integration.  The Nkx3-2 N1/F0 enhancer allele was cloned as tandem duplicates 
using the NheI and EcoRV restriction sites upstream of the Hsp70 promoter. 
Enhancer orientation and sequence was confirmed by Sanger sequencing.  
Transient transgenic stickleback embryos were generated by co-microinjecting the 
plasmid (final concentration: 10 ng/µl) and tol2 transposase mRNA (40 ng/µl) into 
freshly fertilized eggs at the one-cell stage as described in (74).   
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2.2.10 Supplementary Notes: 
 
Major considerations in constructing the simulations 
In the Longshanks experiment, the highest-ranking male and the highest-
ranking female from each family were chosen to breed with the highest-ranking mice 
from other families within a line (i.e., disallowing sibling mattings).  Thus, if we 
disregard non-Mendelian segregation, and the fraction of failed litters (15%), 
selection acts solely within families, on the measured traits.  Such selection does not 
distort the pedigree and allows us to follow the evolution of each chromosome 
separately. 
Our simulations track the inheritance of continuous genomes by following the 
junctions between regions with different ancestry.  In principle, we should simulate 
selection under the infinitesimal model by following the contributions to the trait of 
continuous blocks of chromosomes across the whole genome.  However, this is 
computationally challenging, since the contributions of all the blocks defined by every 
recombination event have to be tracked.  Instead, we follow a large number of 
discrete biallelic loci checking that the number is sufficiently large to approach the 
infinitesimal limit (Fig. 1 – figure supplement 2D).  We made a further slight 
approximation by only explicitly modelling discrete loci on one chromosome at a 
time.   We divided the breeding value of an individual into two components.  The first, 
Vg, is a contribution from a large number of unlinked loci, due to genes on all but the 
focal chromosome, as represented by the infinitesimal model.  The values of this 
component amongst offspring are normally distributed around the mean of the 
parents, with its variance being: 
 𝑉! = (𝑉!  /2)  (1−   β)  (1  −   𝐹!! − 𝐹!!) 
 
where: 𝑉! is the initial genetic variance, and  𝐹!! , 𝐹!!  are the probabilities of identity between distinct 
genes in each parent, 𝑖 , 𝑗 ; 𝐹!! , 𝐹!!  are calculated from the 
pedigree;  β is the fraction of genome on the focal chromosome. 
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The second component, Vs, is the sum of contributions from a large number, 𝑛, 
of discrete loci, evenly spaced along the focal chromosome (here we used 10,000), 
and contributing a fraction 𝛽 of the initial additive variance.  We choose these to 
have equal effects and random signs, ±α , such that initial allele frequencies 𝑝! = 𝑞! = !! , and equal effects α , such that 𝛽𝑉!,! = 2 𝛼!𝑝!,!𝑞!,!!!!! .  The initial 
population consists of 28 diploid individuals, matching the experiment, and loci have 
initial frequencies of 1, 4, 12 and 28 out of the diploid total of 56 alleles, in equal 
proportions.  Inheritance is assumed to be autosomal, with no sex-linkage.  This 
choice of equal effects approaches most closely to the infinitesimal model, for a 
given number of loci. 
The decrease in genetic variance due to random drift is measured by the 
inbreeding coefficient, defined as the probability of identity by descent, relative to the 
initial population.  We distinguish the identity between two distinct genes within a 
diploid individual, 𝐹!, from the probability of identity between two genes in different 
individuals, 𝐹!.  The overall mean identity between two genes chosen independently 
and at random from all  2𝑁 genes is: 
 
 𝐹 = !(!!!)!!!!!!!!! .   
 
The proportion of heterozygotes in the population decreases by a factor of 1− 𝐹!, the variance in allele frequency increases with 𝐹, and the genetic diversity, 
 𝔼 = [2𝑝𝑞] , decreases as 1− 𝐹.   
 
Fig. 1 – figure supplement 2B shows that in the absence of selection, the 
identity 𝐹! increases slower than expected under the Wright–Fisher model with the 
actual population sizes (compare light shaded lines with black lines).  These 
differences are a consequence of the circular mating scheme, which was designed 
to slow the loss of variation.  The dotted line show the average 𝐹, estimated from the 
loss of heterozygosity in 50 replicate neutral simulations, each with 104 loci on a 
chromosome of length R=1 Morgan.  These are close to the prediction from the 
pedigree (light shaded lines), validating the simulations.   
The thick colored line in Fig. 1 – figure supplement 2B shows 𝐹, estimated in 
the same way from simulations that include truncation selection on a trait with within-
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family variance 𝑉!/𝑉! = 0.584 (a value we abbreviate as 𝜃 = 1), which matches the 
observed selection response and parent-offspring regression.  The rate of drift, as 
measured by the gradient in 𝐹 over time, is significantly faster in simulations with 
selection, by 6.7% in LS1 and 9.8% in LS2 (Student’s t-test P ≤ 0.008 in LS1 and P ≤ 
0.0005 in LS2).  However, this effect of selection would not be detectable from any 
one replicate, since the standard deviation of the rate of drift, relative to the mean 
rate, is ~13% between replicates.  On average, the observed loss of heterozygosity 
fits closely to that expected from the pedigree (large dot with error bars), though 
there is wide variation among chromosomes (filled dots), which is substantially 
higher than seen in simulations seeded with SNP at linkage equilibrium (compare 
filled and open dots).   
We then performed 100 simulations, seeding each founding generation with 
actual genotypes and using actual pedigrees, selection pressure or heritability 
parameters (within-family heritability ℎ!  of the fitness dimension: 0.51).  A main 
conclusion from our modelling is that the overall allele frequencies were hardly 
perturbed by varying selection from random drift to even doubling the selection 
intensity.  Upon closer examination, it became clear that under the standard 
“infinitesimal” model, selection could generate a weak but detectable excess of allele 
frequency sweeps compared to strict neutrality with no selection (Fig. 1 – figure 
supplement 2D, SNP classes 1/56 and 4/56).  However, it would take many 
replicates (assuming no parallelism) for this excess to become statistically 
significant.  Taken at face value, this result echoes many “evolve-and-resequence” 
(E&R) experiments based on diverse base populations that show only weak 
evidence of selective sweeps at specific loci (23, 71).   
 
Broader patterns and analyses of parallelism 
On a broader scale, we also observed greater extent of parallelism globally 
than in the simulated results or with the empirical Ctrl line.  For example, out of the 
2405 and 2991 loci found above the HINF, no LD cut-off in LS1 and LS2, 398 were 
found in both lines (13%; 𝜒2 test, N~150,000 windows; 𝜒2=2901.4, d.f.=1, P ≤ 1 ×10-
10); whereas we found only 10 or 7 overlaps in Ctrl–LS1 or Ctrl–LS2 comparisons, 
respectively.  This difference is statistically significant (940 significant Ctrl loci at the 
HINF, no LD threshold; N~150,000 windows; Ctrl–LS1: 𝜒2=0.7; Ctrl–LS2: 𝜒2=6.0; both P 
= n.s.; see also Fig. 3 – figure supplement 2).  In fact, there was not a single window 
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out of a total of 8.4 million windows from the 100 replicates where both simulated 
LS1 and LS2 replicates simultaneously cleared the HINF, no LD threshold.   In contrast 
to our earlier analysis in single LS replicates, the parallel selected loci in both LS 
replicates loci may provide the strongest evidence yet to reject the infinitesimal 
model.  
 
Heritability estimate by an animal model 
We estimated heritability using linear mixed effect “animal models” with 
maximum likelihood (Fig. 1 – figure supplement 1D) in the R package MCMCglmm 
v2.5 [104; following guide by (105)].  Because the animal model makes inference of 
the parameter estimates to the base population, to compare heritability as it changed 
over time we estimated heritability in blocks of 5 generations F0-4, 5-9, 10-14, and 
15-19, separately for each selected line.  In testing each block, we used the full 
pedigree to build the relationship matrix but only phenotypes from the individuals in 
those generations.  As an alternative, we tested each block with a truncated 
pedigree, in which the first generation of each block is treated as unrelated (i.e., the 
base population).  The two methods produced similar results.  In all analyses, we 
standardized the composite trait 𝑙𝑛 𝑻𝑩!!.!"  (𝑻  = tibia length in mm; 𝑩 = cube-root 
body mass in ∛g; see Simulating selection response: infinitesimal model with linkage 
in main text) within each generation and line to account for fluctuations in mean and 
variance (38).  The phenotypic variance was partitioned as VP = fixed effects + VA + 
VR, where fixed effects were sex, age, and litter size, VA was additive genetic 
variance, and VR was residual variance. Heritability was estimated as h2 = VA /( VA + 
VR).  
 
Enrichment for genes with functional impact on limb development 
To determine what types of molecular changes may have mediated the 
selection response, we performed a gene set enrichment analysis.  We asked if the 
outlier loci found in the Longshanks lines were enriched for genes affecting limb 
development (as indicated by their knockout phenotypes) and found increasingly 
significant enrichment as the allele frequency shift ∆z2 cut-off became increasingly 
stringent (Fig. 3 – figure supplement 1A).  The “limb/digital/tail” category of affected 
anatomical systems in the Mouse Genomic Informatics Gene Expression Database 
(59) showed the greatest excess of observed-to-expected ratio out of all 28 
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phenotype categories (the excluded “normal” category also showed no enrichment).  
In contrast, genes showing knock-out phenotypes in most other categories did not 
show similar enrichment as ∆z2 became more stringent (Fig. 3 – figure supplement 
1A).  For genes expressed in limb tissue, there was a similar, but weaker increase, 
with the enrichment only appearing at higher ∆z2 cut-off.  We did not observe similar 
enrichment using data and thresholds derived from Ctrl (Fig. 3 – figure supplement 
1A, lower panels).  To investigate the impact on regulatory sequences, we obtained 
21,211 limb enhancers predicted by ENCODE chromatin profile at a stage 
immediately preceding bone formation (Theiler Stage 23, at approximately 
embryonic day E14.5) (87).  We found likewise an enrichment throughout the range 
of significance cut-offs (Fig. 3 – figure supplement 1A).  Again, there was no similar 
enrichment in Ctrl.   
 
Clustering with loci associated with human height 
Since tibia lengths directly affect human height, we tested if an association 
exists between loci controlling human height (61) and a set of 810 loci at the P ≤ 
0.05 significance level under HINF, no LD described here.  After remapping the human 
loci to their orthologous mouse positions (n = 655 out of 697 total height loci; data 
from the GIANT Consortium), we detected significant clustering with the 810 peak 
loci (mean pairwise distance to remapped height loci: 1.41 Mbp vs. mean 1.69 Mbp 
from 1000 permutations of shuffled peak loci, range: 1.45–1.93 Mbp; n = 655 height 
loci and 810 peak loci; P < 0.001, permutations).  We interpret this clustering to 
suggest that a shared and conserved genetic program exist between human height 
and tibia length and/or body mass. 
 
Genome-wide analysis of the role of coding vs. cis-acting changes in response 
to selection 
We examined the potential functional impact of coding or regulatory changes 
as a function of ∆z2 in all three lines.  For coding changes, we tracked the functional 
consequences of coding SNPs of moderate to high impact (missense mutations, 
gain or loss of stop codons, or frame-shifts).  Whereas we found only mixed 
evidence of increased coding changes as ∆z2 increased in the LS lines, there was a 
depletion of coding changes in Ctrl line as ∆z2 increased, possibly due to purifying or 
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background selection (Fig. 3 – figure supplement 1B; linear regression, LS1: P ≤ 
0.015, slope > 0; LS2: P = 0.62, n.s., slope ≈ 0; Ctrl: P ≤ 5.72×10-9, slope < 0).   
For regulatory changes, we used sequence conservation in limb enhancers 
overlapping a SNP as a proxy for functional impact.  In contrast to the situation for 
coding changes, where the correlations differed between LS1 and LS2, the potential 
impact of regulatory changes increased significantly as a function of ∆z2 in both LS 
lines (Fig. 3 – figure supplement 1B): within limb enhancers, SNP-flanking 
sequences became increasingly conserved at highly differentiated SNPs (phastCons 
conservation score, ranging from 0 to 1 for unconserved to completely conserved 
positions; linear regression, log-scale, P < 1.05×10-9 for both, slopes > 0).  This 
relationship also exists for the Ctrl line, albeit principally from lower ∆z2 and 
conservation values (P < 0.8×10-3, slope > 0; Fig. 3 – figure supplement 1B).  Taken 
together, our enrichment analysis suggests that while both coding and regulatory 
changes were selected in the Longshanks experiment, the overall selection 
response may depend more consistently on cis-regulatory changes, especially for 
developmental regulators involved in limb, bone and/or cartilage development (Table 
1; Supplementary File 3; c.f. Supplementary File 4 for coding changes).  This is a 
key prediction of the “cis-regulatory hypothesis”, especially in its original scope on 
morphological traits (106). 
 
Genes with amino acid changes of potentially major impact 
We have further identified 12 candidate genes with likely functional impact on 
limb development due to specific amino acid changes showing large frequency shifts 
(albeit only one, Fbn2, cleared the stringent P ≤ 0.05 HINF, max LD threshold; 6 in LS1, 
9 in LS2, of which 3 were shared; Supplementary File 4).  Consistent with strong 
selection for tibia development, all 12 genes show limb or tail phenotypes when 
knocked out, e.g., “short limbs” for the collagen gene Col27a1 knockout.  Most of 
these genes encode for structural cellular components, e.g., myosin, fibrillin and 
collagen (Myo10; Fbn2; and Col27a1 respectively), with Fuz (fuzzy planar cell 
polarity protein) being the only classical developmental regulator gene.  All but one 
of these genes have also been shown to have widespread pleiotropic effects with 
broad expression domains, and their knockouts were often lethal (eight out of 12) 
and/or exhibit defects in additional organ systems (11 out of 12).  Based on this 
observation, we anticipate that the phenotypic impact of these selected coding 
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missense SNPs (n.b. not knockout) would not be restricted to tibia or bone 
development. 
 
Molecular dissection of Gli3, a candidate limb regulator, reveal gain-of-
function cis-acting changes  
We anticipated that genes related to major limb patterning, like Gli3, may 
contribute to the selection response (107, 108).  We thus performed an in-depth 
molecular dissection of Gli3, an important early limb developmental regulator on 
chromosome 13 (Chr13; Fig. 4 – figure supplement 1A).  This locus showed a 
substantial shift in minor allele frequency of up to 0.42 in LS1 (∆q, 98th quantile 
genome-wide, but below the HINF, max LD threshold to qualify as a discrete major 
locus).  We performed functional validation of Gli3, given its limb function (109) and 
considering that Gli3 could be among the many minor loci in the polygenic 
background contributing to the selection response in LS1.   
At the Gli3 locus we could only find conservative amino acid changes (D1090E 
and I1326V) that are unlikely to impact protein function.  Because the signal in LS1 
was stronger in the 5’ flanking intergenic region, we examined the Gli3 cis-regulatory 
topologically associating domain (TADs, which mark chromosome segments with 
shared gene regulatory logic) (22) and identified putative enhancers using chromatin 
modification marks from the ENCODE project and our own ATAC-Seq data (Fig. 4 – 
figure supplement 1B) (28, 90).  Four putative enhancers carried SNPs with large 
allele frequency changes.  Among them, an upstream putative enhancer G2 (956 bp) 
carried 6 SNPs along with two 1- and 3-bp insertion/deletion (“indel”) with putative 
functional impact due to predicted gain or loss in transcription factor binding sites 
(Fig. 4 – figure supplement 1C).  We tested the G2 putative enhancer in a transgenic 
reporter assay by placing its sequence as a tandem duplicate upstream of a lacZ 
reporter gene (see Methods for details).  We found that only the F17 LS1 allele was 
able to drive consistent lacZ expression in the developing limb buds (Fig. 4 – figure 
supplement 1D).  Importantly, this enhancer was active not only in the shaft of the 
limb bud but also in the anterior hand/foot plate, a major domain of Gli3 expression 
and function (Fig. 4 – figure supplement 1A).  Furthermore, substitution of the 
enhancer sequence with the F0 allele (10 differences out of 956 or 960 bp) abolished 
lacZ expression (Fig. 4 – figure supplement 1D).  This showed that 10 or fewer 
changes within this novel enhancer sequence were sufficient to convert the inactive 
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F0 allele into an active limb enhancer corresponding to the selected F17 allele 
(“gain-of-function”), suggesting that a standing genetic variant of the F17 allele may 
have been selectively favoured because it drove stronger expression of Gli3, a gene 
essential for tibia development (110) [but see (111)]. 
 
Estimating the selection coefficient of the top-ranking locus, Nkx3-2, from 
changes in allele frequency  
The significant locus on Chr5 containing Nkx3-2 shows strong changes in SNP 
frequency in both LS1 and LS2.  Here, we estimate the strength of selection on this 
locus, and the corresponding effect on the selected trait.  We approximate by 
assuming two alternative alleles, and find the selection coefficient implied the 
observed parallel changes in allele frequency; we then set bounds on this estimate 
that take account of random drift.  Finally, we use simulations that condition on the 
known pedigree to estimate the effect on the trait required to cause the observed 
strong frequency changes; these show that linked selection has little effect on the 
single-locus estimates. 
We see strong and parallel changes in allele frequency at multiple steps.  
There are 14 non-overlapping 10kb windows that have a mean square change in 
arc-sin transformed allele frequency of ∆𝑧! >   2 in both LS1 and LS2, spanning a 
260 kbp region and including 807 SNP.  SNP frequencies are tightly clustered, 
corresponding to two alternative haplotypes (Fig. 5A & Fig. 5 – figure supplement 
1A).  The initial (untransformed) allele frequencies average q0 = 0.18, 0.17 in LS1, 
LS2, respectively, and the final frequencies average q17 = 0.84, 0.98, respectively 
(also see Fig. 5 – figure supplement 1A, lower panel).  These frequencies depend on 
the arbitrary threshold for which windows to include.  However, this makes little 
difference, relative to the wide bounds on our estimates. 
Under constant selection, 𝑙𝑜𝑔 !! changes linearly with time, at a rate equal to the 
selection coefficient, 𝑠 .  Therefore, a naive estimate of selection is given by 𝑠 = !! log !!"!!" !!!!  (21)  thus, 𝑠 =0.19, 0.32 for q in LS1, LS2, and averages 0.26.  Here, 
males and females with longest tibia are chosen to breed; the strength of selection 
on an additive allele depends on the fraction selected and the within-family trait 
variance.  The former is kept constant, and there is little loss of variance due to drift 
(𝐹~0.17). Thus, assuming constant selection is reasonable (Fig. 5B), unless there is 
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strong dominance. 
To set bounds on this estimate, we must account for random drift.  The 
predicted loss of diversity over 17 generations, based on the pedigree, is 𝐹=0.173, 
0.175 for LS1, LS2, which corresponds to an effective size 𝑁! = 44.9, 44.4 , 
respectively (note that due to differences in estimation methodology, this 𝑁! differs 
slightly from that mentioned in Fig. 1 – figure supplement 2 but is largely consistent).  
Therefore, we calculate the matrix of transition probabilities for a Wright–Fisher 
population with 2𝑁 rounded to 90, 89 copies for LS1, LS2, over a range of selection, 𝑠.  This yields the probability that the number of copies would change from the 
rounded values of 16/90 to 75/90 in LS1, and from 14/89 to 87/89 in LS2—that is, 
the likelihood of 𝑠, given the observed changes in allele frequency, and the known 𝑁!.  There is no significant loss of likelihood by assuming the same selection in both 
lines; overall, 𝑠 = 0.24 (limits 0.13–0.36; Fig. 5 – figure supplement 1B). 
 
Estimating the selection coefficient, accounting for linked loci 
The estimates above using the simple approach do not account for selection on 
linked loci, and do not give the effect on the composite trait.  We therefore simulated 
conditional on the pedigree and on the actual selection regime, as described above, 
but including an additive allele with effect A at the candidate locus on Chr5.  The 
genetic variance associated with the unlinked infinitesimal background, and across 
Chr5, were reduced in proportion, to keep the overall heritability the same as before 𝑉!/ 𝑉! + 𝑉! =  0.539.  The selection coefficient inferred from the simulated changes 
in allele frequency was approximately proportional to the effect on the trait, with best 
fit 𝑠 = 0.41𝐴/ 𝑉! (Fig. 5 – figure supplement 1C, left).  Assuming this relationship, 
we can compare the mean and standard deviation of allele frequency from 
simulations with linked selection, with that predicted by the single locus Wright–
Fisher model (points vs. line in Fig. 5 – figure supplement 1C, middle & right). These 
agree well, showing that linked selection does not appreciably change the 
distribution of allele frequencies at a single locus.  This is consistent with Fig. 1 – 
figure supplement 2D, which shows that linked selection only inflates the tail of the 
allele frequency distribution, an effect that would not be detectable at a single locus. 
Combining our estimates of the selection coefficient with the relation               𝑠 = 0.41𝐴/ 𝑉!,  we estimate that the locus on Chr5 has effect  𝐴 = 0.59 𝑉!, with       
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2-unit support limits 0.32 𝑉! to 0.87 𝑉!.  This single locus is responsible for ~9.4% of 
the total selection response (limits 3.6–15.5%).  
This analysis does not allow for the inflation of effect that might arise from 
multiple testing.  This is hard to estimate, because it depends on the distribution of 
effects across the genome, and also on the excess variation in estimates due to LD 
in the founder population.  However, we note that if the effect of this locus is large 
enough that it would certainly be detected in this study, then there is no estimation 
bias from this source. We also assume that there are two haplotypes, each with a 
definite effect.  There might in fact be heterogeneity in the effects of each haplotype, 
for two reasons.  First, this region might have had heterogeneous effects in the 
founder population, with multiple alleles at multiple causal loci.  Second, as 
recombination breaks up the founder genomes, blocks of genome would become 
associated with different backgrounds.  To the extent that genetic variation is spread 
evenly over an infinitesimal background, this latter effect is accounted for by our 
simulations, and has little consequence.  However, we have not tested whether the 
data might be explained by more than two alleles, possibly at more than one discrete 
locus.  Testing such complex models would be challenging, and we do not believe 
that such test would have much power.  However, the estimates of selection made 
here should be regarded as effective values that may reflect a more complex reality. 
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Estimating the contribution of the Nkx3-2 locus using an animal model 
We used a linear mixed “animal model” to estimate the effect of the enhancer 
N3 (of the major locus in Nkx3-2) on the composite selected trait 𝑙𝑛 𝑻𝑩!!.!" , see L. 
129 and Fig. 1 – figure supplement 2A. The model was: 
VP = fixed effects + VA + VR  
where: 
fixed effects = sex, generation, litter size (i.e., number of siblings in 
family), genotype at N3 (0, 1, or 2 copies of F17 allele), and replicate 
line 
VA = additive genetic variance 
VR = residual variance  
 
We found a small but significant effect of the genotype at enhancer N3 on the 
composite trait (mean effect = 0.0036; 95% CI: 0.00069–0.0064; P=0.017).  Given 
the same body mass 𝑩, the mean effect corresponds to 0.36% increase in tibia 
length per copy of the F17 allele, or ~1% of the variance in tibia length at generation 
F01.  The observed increase of this allele from ~0.18 to 0.91, averaged over the two 
lines, implies that it accounts for ~4% of the total selection response.  This is within 
the confidence limits in the main text, based on the change in SNP frequency (3.6–
15.5%) and note that the latter may be biased upwards by ascertainment.  However, 
the exact effect of the allele is difficult to pinpoint in any given generation or 
population due the nature of the composite trait and change in variance in the 
composite trait over generations.  
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2.2.11 Supplementary Figures: 
 
 
 
 
Fig. 1 – figure supplement 1.  Artificial selection allowed detailed 
reconstruction of selection parameters.  Rapid response to selection produced 
mice with progressively longer tibiae (A) and slightly lower body weight (B) within 20 
generations.  Having complete records throughout the selection experiment makes it 
possible to reconstruct the selection response for both phenotypes and genotypes in 
detail.  Individuals varied in tibia length in both Longshanks lines (LS1, left; LS2, 
right).  Lines connect parents to their offspring.  The actual selection depended on 
the within-family and within-sex rank order of the tibia length-to-body mass (cube 
root) ratio (see (13) for details).  The overall selection response was immediate and 
rapid for tibia length (A), suggesting a selection response that depended on standing 
variation among the founders (black lines show the best fitting quadratic function, 
with shading indicating 95% confidence interval; adjusted R2 = 0.61 for LS1; 0.43 for 
LS2).  Strong selection response led to rapid increase in tibia length.  In contrast, 
there was only minor decrease in body weight over the course of the experiment.  
(C) Trajectory in selection response shows decoupling of correlation between tibia 
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length and body mass.  Despite overall correlation between tibia length and body 
mass (grey arrow and major axes in confidence envelopes), cumulative trait 
displacement over the 20 generations (expressed in s. d. units at F1; arrows, dots 
and 95% confidence envelopes, color-coded according to generation) showed 
persistent increase in tibia length with only minor change in body mass along the 
general direction of selection pressure (black arrows from F1; vector length and 
directions based on logistic regression).  This shows that the Longshanks selection 
experiment was successful in specifically selecting for increased tibia length while 
keeping relatively unchanged body mass.  (D) Despite persistent and strong 
selection, heritability for the composite trait 𝑙𝑛 𝑻𝑩!!.!"  (𝑻 = tibia length in mm; 𝑩 = 
cube-root body mass in ∛g) (see Simulating selection response: infinitesimal model 
with linkage in main text) was maintained over 20 generations.  Heritability was 
estimated by a linear mixed “animal model” in which the phenotypic variance was 
partitioned as VP = fixed effects + VA + VR, where fixed effects were sex, age, and 
litter size, VA was additive genetic variance, and VR was residual variance. 
Heritability was estimated as h2 = VA /( VA + VR).  Each tested block used the full 
pedigree but only phenotypic information from individuals within the block.  We 
tested an alternate model for each block using truncated pedigrees wherein the first 
generation of each block was assumed to be unrelated, but found similar results. 
  
	  	   86 
 
 
 
	  	   87 
Fig. 1 – figure supplement 2.  Simulating selection on pedigrees.  This figure 
summarizes the results from our analyses to determine parameters used during the 
simulation. For full detail, see Supplementary Notes, section “Major considerations in 
constructing the simulations”.  (A) Finding the correct 𝜙 value for the composite trait 𝑙𝑛 𝑻𝑩! .  In each simulated family, offsprings are split by sex and ranked by their 
composite trait.  Due to occasional use of back-up crosses, the average rank of 
actual breeders is greater than 1.  We vary 𝜙 to find the value where actual breeders 
in the LS lines have the best (lowest) rank.  We find 𝜙 = -0.571 to show the best 
match for males and 0.605 for females.  For subsequent analyses we set 𝜙 to be -
0.57. (B) Increase in inbreeding over the course of the Longshanks experiment.  The 
lines show the change in identity between two alleles between diploid individuals, 𝐹!, 
over 20 generations, as calculated from the pedigree (light shade); an average of 50 
neutral simulations without selection (dotted line); or the average of 50 simulation 
replicates with selection intensity at 𝑉!/𝑉! = 0.584 (𝜃 = 1; thick, dark line).  While the 𝐹!  trajectories based on pedigree or neutral simulations are indistinguishable, 
inbreeding increases slightly faster under selection (thick line).  The black line shows 
the increase in identity expected under a Wright–Fisher model with the actual 
population sizes; under this model, 𝐹!   and 𝐹!   are close to each other, and to 1− (1− !!!!)!,  with 𝑁! equal to the harmonic mean, 24.8.  The large dot (with error 
bar showing the interquartile range among chromosomes) at right show the actual 𝐹!, estimated from the decline in average 2𝑝(1− 𝑝) over 17 generations. Small filled 
dots show the estimates from each of the 20 chromosomes.  Open dots show 40 
replicate simulations, made with the same pedigree and the same selection 
response 𝜃 = 1 and sub-sampling from the simulated chromosome according to the 
actual map length of each of the mouse chromosomes (46).  The simulation agrees 
well with the observed genome-wide average.  Most of the observed data from 
chromosomes fall within a range comparable to simulated replicates (compare large 
dot with open dots), with LD being the likely source of this excess variance.  (C) 
Three different schemes to seed founder haplotypes.  We simulate founder 
haplotypes that are consistent with observed genotypes (shown here as black, white 
and grey dots as the two homozygous and the heterozygous states) by directly 
sampling from founder individuals in each LS line.  Under the linkage equilibrium 
scheme, we sample from the list of allele counts at all SNPs.  This produces founder 
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haplotypes that carry no linkage disequilibrium (“no LD”).  Under the random 
assignment scheme, we sample according to each individual (shown as “diplotypes” 
within the box for easy comparison).  At heterozygote sites in each individual 
(arrowheads), we randomly assign the alleles to the two haplotypes.  This produces 
founder haplotypes that show minimal LD that is consistent with the observed 
genotypes (“min LD”).  Under the “max LD” assignment scheme, we also sample 
according to each individual, except that we consistently assign its haplotypes 1 and 
2 with reference (white) and alternate (black) alleles, respectively.  This maximizes 
LD in the founder haplotypes (“max LD”).  (D) Simulated vs. expected allele 
frequency shifts.  The distribution of minor allele frequencies q0 at generation 17 is 
compared with the distribution expected with no selection (blue) or with selection 
(red), given a frequency of 1, 4, 12 or 28 minor alleles out of 56 founding alleles. The 
black line shows the diffusion limit, calculated for scaled time !"!!, with 𝑁! estimated to 
be 51.7 and 48 in LS1 and LS2 respectively, from the rate of increase in 𝐹 , 
calculated from the pedigree in panel A above. (E) Significance threshold values 
under varying LD from 100 simulated replicates (blue: no selection; red: observed 
selection response in the actual experiment, 𝜃 = 1; see panel C on LD assignment 
methods).  In order to account for non-independence of adjacent windows due to 
linkage, a distribution of genome-wide maximum ∆z2 was used to determine the 
significance threshold at each LD level.  ∆z2 is the square of arc-sin transformed 
allele frequency difference between F0 and F17; this has an expected variance of 
1/2Ne per generation, independent of starting frequency, and ranges from 0 to π2.  
As seen in previous panels, increasing selection pressure does produce greater 
shifts in ∆z2 despite using the same pedigree due to a relatively greater proportion of 
additive genetic variance 𝑉!.  However, a far greater impact on ∆z2 is due to changes 
in LD.  This is because weak associations between large numbers of SNP can 
greatly inflate the variance of ∆z2.  Of the three LD levels, “max LD” likely produced 
overly conservative thresholds, whereas “min LD” may lead to higher false positives.  
We have opted conservatively to use maximal LD in our analysis. 
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Fig. 2 – figure supplement 1.  Broad similarity in molecular diversity in the 
founder populations for the Longshanks lines and the Control line.  (A) Shown 
are the site frequency spectra from LS1, LS2 and Control lines at F0 (top; folded 
based on a global minor allele frequency or MAF ≤ 0.5) and F17 (bottom; unfolded, 
but tracking the same minor allele as in F0).  Overall the spectra were very similar to 
each other within each generation.  The Control population was mostly intermediate 
in the decay in the rarer alleles.  After 17 generations, the same alleles were 
generally more spread out, leading to more broadly distributed spectra.  There was 
again little overall difference between the Longshanks and Control lines.  (B) 
Variations between chromosomes (separate same-colored lines) shown in each 
population and generation.  The unfolded site frequency spectrum is shown based 
on the MAF assigned as in A. There is substantial variation between chromosomes, 
which shows increased distortions in F17. (C) Allele frequencies between the 
founder populations were very similar. Joint minor allele frequencies shown as box 
plots in 2% bands between the Control and LS1 (blue), LS2 (red); or the two LS lines 
(purple). Outliers were omitted for clarity.  The overall trends follow closely the parity 
line (grey line along the diagonal), except at frequencies very close to 0.5. Similar to 
the site frequency spectra in panel A, a small number of sites have a MAF above 0.5 
(grey box), because of the use of an overall MAF ≤ 0.5 to determine minor allele 
status to enable comparisons across lines.  Correlations between all pairwise 
combinations were around 0.93. 
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Fig. 2 – figure supplement 2.  Selected lines showed more extreme values of 
∆z2 than the Control line.  Histogram of within-line ∆z2 values in 10 kbp windows 
across the genome in the LS1, LS2, and Control.  Overall similarity is high across all 
3 lines, but there was an excess of large ∆z2 value starting from as low as < 0.1 π2 .  
This pattern becomes clearly distinct above the threshold value of 0.125 , which 
corresponds to the lenient significance threshold P ≤ 0.05 under HINF, no LD (inset).  
There were clearly an excess of windows in LS2 above the more stringent P ≤ 0.05 
threshold under HINF, max LD.  Such excess supports discrete loci contributing to 
selection response in LS2 that give rise to greater distortion of ∆z2 spectra.  
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Fig. 2 – figure supplement 3. Detailed ∆z2 profiles at the 8 Longshanks 
significant loci. For each significant locus, ∆z2 profiles are shown for Ctrl (grey), 
LS1 (blue) and LS2 (red).  Plots are shaded if the locus is significant in a given line.  
TADs within 250 kbp of the significant signals are shown as grey bars above each 
locus.  Above the TADs are highlighted genes whose knockout phenotypes belong to 
the following categories: “abnormal tibia morphology”, “short limb”, “short tibia”, 
“abnormal cartilage morphology”, “abnormal osteoblast morphology”.  The gene 
symbols are colored according to the gene function(s) in limb development (green), 
bone development (purple) or both (boxed).  Gene symbols marked by asterisks (*) 
have specifically reported “short tibia” or “short limb” knockout phenotypes.  All of the 
above categories show significant enrichment at the 8 loci (number of genes per 
category: 4–7, nominal P ≤ 0.03, see Supplementary Notes, section “Enrichment for 
genes with functional impact on limb development” for details on the permutation), 
except “abnormal cartilage morphology”, with 4 genes and a nominal P-value of 
0.083.  No overlap was found with any gene in these categories from the three 
significant loci from the Ctrl line. 
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Fig. 3 – figure supplement 1.  Loci associated with selection response in 
Longshanks lines show enrichment for limb function likely associated with 
cis-acting mechanisms.  (A) Gene set enrichment analysis of knock-out 
phenotypes (KO) showed that selection response (here shown as ∆z2 cut-off values, 
see Supplementary Methods for details on cut-off values and inclusion criteria) were 
found among topologically associating domains (TADs) containing limb and tail 
developmental genes (red solid lines) or genes with limb expression (red dotted 
lines) in LS lines (top) but not in Ctrl (bottom).  Among KO phenotypes, limb defects 
show the greatest excess out of 28 phenotypic categories (other grey lines, with 
other extreme categories labeled, the “normal” category is excluded here).  Among 
developmental enhancers for limb, heart, liver and brain tissue, we also observed an 
association with ∆z2 peaks in LS lines (top) for limb but not in Ctrl lines (bottom).  
The simulated significance thresholds based on HINF, max LD are also shown for 
reference (vertical grey lines).  The data from the LS line suggest that enrichment 
start to increase around P ≤ 0.5 threshold and remained largely stable by P ≤ 0.05, 
corresponding a cut-off of around 0.33 π2. (B) Coding vs. regulatory impact.  
Frequency of moderate to major coding changes (top panels, amino acid changes, 
frame-shifts or stop codons), or average conservation score of regulatory sequences 
immediately flanking SNPs (based on conservation among 60 eutherian mammals; 
bottom panels) were used as proxies to estimate the functional impact of coding and 
regulatory mutations, respectively.  In LS1, major coding changes became more 
common at high ∆z2 ranges; however the rate of SNPs with potentially major 
phenotype consequences did not increase in LS2 and in fact seems to decrease in 
Ctrl.  In contrast, regulatory changes showed increased conservation associated with 
greater allele frequency shifts or ∆z2 in all three lines, except that SNPs with large 
shifts and strong conservation were more abundant in LS1 and LS2.  Trend lines are 
shown with LOESS regression but statistical comparisons were performed using 
linear regressions. 
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Fig. 3 – figure supplement 2. Changes in ∆z2  across lines.  Shown are changes 
in ∆z2 in individual 10 kbp windows (all windows: circles; peak windows: diamonds).  
Generally there were no clear differences in ∆z2 along the axes except a slight skew 
toward higher values in LS2.  When taken as a joint LS1–LS2 comparison, however, 
we observed that many windows show shifts in both LS1 and LS2 (left panel; in 
purple).  In contrast, very few windows show parallelism in Ctrl–LS2 and Ctrl–LS1 
comparisons (middle two panels).  The right panel shows a single selected simulated 
replicate (selection pressure !!!! = 0.58; maximum LD) found to have among the 
greatest extent of parallel ∆z2 among the replicates.  The excess in parallel loci in 
observed results is clear both among the significant loci at P ≤ 0.05 under HINF, max LD 
and highly significant at the more relaxed HINF, no LD  threshold.   
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Fig. 4 – figure supplement 1.  An enhancer in chromosome 13 boosts Gli3 
expression during limb bud development.  (A) LS1 showed elevated ∆z2 in the 
intergenic region containing Gli3.  (B) Putative limb enhancers (grey bars) were 
identified through peaks from ATAC-Seq (top) and histone modifications (bottom 
tracks, data from ENCODE project).  Four of the enhancers contain mutations (in 
brackets) with significant allele frequency shifts between F0 and F17 in LS1 (red 
shading).  One of the enhancers located close to the peak ∆z2 signal (G2, 
arrowhead) containing 10 bp differences was chosen for transgenic reporter assay.  
(C) Analysis of individual mutations showed an average increase of 0.33 in allele 
frequency, with 6 mutated positions affecting predicted binding of transcription 
factors in the Gli3 pathway (including 3 additional copies of Gli3 binding site), all of 
which are predicted to boost the G2 enhancer activity.  (D) The F17 G2 enhancer 
variants together drove robust and consistent lacZ reporter gene expression at 
E12.5, recapitulating Gli3 expression in the developing fore- and hindlimb buds 
(right; see also Fig. 4 – figure supplement 2).  Substitution of 10 positions (F0 
haplotype) led to little observable expression in the limb buds (left).  These G2 
enhancer gain-of-function mutations (contrasting the major allele between F0 and 
F17) may confer an advantage under selection for increased tibia length. Scale bars: 
1 mm for both magnifications. 
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Fig. 4 – figure supplement 2. Gene expression patterns at the Gli3 and Nkx3-2 
candidate intervals.  (A) Gli3 expression was determined using in situ hybridization.  
Gli3 was robustly expressed during limb development in both developing fore- and 
hindlimb buds, especially in the autopod (hand/foot plate).  Lower panel shows 
expression of Nkx3-2 and its neighboring genes Rab28 and Bod1l.  The stronger 
expression of Nkx3-2 in the developing limb buds as well as the known role of Nkx3-
2 in bone maturation (30) strongly argues for Nkx3-2 being the gene underlying the 
selection response at the Chr5 locus. Scale bars: 1 mm for whole-mounts; 0.5 mm 
for limb buds. FL, forelimb; HL, hind limb; unless otherwise indicated by “L”, all 
images were taken from the right side. (B) We collected E12.5 embryos from each 
line and performed in situ hybridization to determine the sites and level of expression 
of Nkx3-2 and Rab28 in the Longshanks (right columns) and Control (left column) 
lines.  Both genes are expressed in similar sites overall and specifically in the 
developing fore- and hindlimb buds in the region of the presumptive zeugopods.  
These data indicate common sites of expression and rule out qualitative 
presence/absence differences in expression.  (C) Although the N1 enhancer pattern 
appear to differ from endogenous Nkx3-2 expression, it matches the pattern of Nkx3-
2 expression, as indicated in (30).  The use of a Nkx3-2 Cre-driver line suggested 
possibly undetected early expression of Nkx3-2 prior to bone formation in the limb 
buds (lineage tracing experiment using a Cre-driver and revealed through crossing to 
Rosa26R, a lacZ reporter line). Image modified from (30), reused with permission. 
Scale bar: 1mm. h, humerus; r, radius; u, ulna; ti, tibia; fi, fibula; sty, stylopod; z, 
zeugopod; a, autopod; scp, scapula; mt, metacarpals; d, digits. 
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Fig. 5 – figure supplement 1. Selection at the Nkx3-2 locus.  (A) Raw genotypes 
from the F0 and F17 generations from LS1 (left) and LS2 (right) are shown, clearly 
indicating the area under the selective sweep.  The genotype classes are shown as 
C57BL/6J homozygous (BL6, white), heterozygous (black) and alternate 
homozygous (dark grey).  Lower Panel: Tracking MAF from both lines show that the 
originally rare F0 allele (thin line) rose to high frequency at F17 (thick lines).  The 
plateau profile from both lines suggested that the same originally rare allele was 
segregating at in both founder populations and became very common by F17 in both 
lines (see raw genotypes).  Note that in LS2 F17 the region is fixed for the BL6 allele 
except the bottom-most individual).  (B) The log likelihood of the selection coefficient, 
s, for LS1 and LS2 (blue and red, respectively), based on transition probabilities for a 
Wright–Fisher population with the appropriate Ne.  The horizontal red line shows a 
loss of log likelihood of 2 units, which sets conventional 2-unit support limits.  (C) 
Simulations of an additive allele with effect A on the trait; 40 replicates for each value 
of A.  Left: The selection coefficient, estimated from the change in mean allele 
frequency, as a function of 𝐴/ 𝑉!; the line shows the least-squares fit 𝑠 = 0.41𝐴/ 𝑉! 
.  Middle: dots show the mean allele frequency at generation 17; the line shows the 
	  	   101 
prediction from the single-locus Wright–Fisher model, given 𝑠 = 0.41𝐴/ 𝑉!.  Right: 
the same, but for the standard deviation of allele frequency.   
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2.2.12 Supplementary Tables: 
 
 
 
 
Supplementary Table 1. Sequencing Summary.  For each line and generation, we 
individually barcoded all available individuals and pooled for sequencing.  We aimed 
for a sequencing depth of around 100x coverage for 50–64 haplotypes per sample.  
Since the CD-1 mice were founded by an original import of 7 inbred females and 2 
inbred males, we expect a maximum of 18 segregating haplotypes at any given 
locus.  This sequencing design should give sufficient coverage to recover haplotypes 
genome-wide.  Our successful genome-wide imputation results validated this 
strategy. 
  
!
Pool n Total reads 
Mapped 
Sequence 
(Gbp) 
Fold-
coverage 
(x) 
Median 
cov./Sample 
(x) 
Ctrl, F0 25 1,856,046,931 251.3 92.0 2.42 
LS1, F0 26 1,858,953,260 256.1 93.8 2.82 
LS2, F0 25 2,011,646,609 283.2 103.7 3.57 
Ctrl, F17 32 1,882,838,451 260.2 95.3 2.97 
LS1, F17 32 2,071,122,164 292.1 107.0 2.95 
LS2, F17 31 1,897,174,855 267.0 97.8 2.93 
Total sum 169 11,577,782,270 1609.9 589.5 2.91 
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Supplementary Table 2.  Pairwise FST and segregating sites (S) between 
populations.  As expected, there is a general trend of decrease in diversity after 17 
generations of breeding.  Globally, there was a 13% decrease in diversity, but F17 
populations still retained on average ~5.8M segregating SNPs (diagonal).  There 
was very little population differentiation, as indicated by low FST among the three 
founder populations, however FST increases by at least 100-fold among lines by 
generation F17 (above diagonal, orange boxes).  Within-line FST is intermediate in 
this respect, reaching about half of the differentiation observed between lines. 
 
 
!
S \ FST Ctrl F0 LS1 F0 LS2 F0 Ctrl F17 LS1 F17 LS2 F17 
Ctrl F0 6,642,764 0.00095 0.00176 0.06067 0.09601 0.10694 
LS1 
F0 
7,213,186 6,612,653 0.00100 0.07731 0.08045 0.10830 
LS2 
F0 
7,306,904 7,282,910 6,772,383 0.07535 0.09505 0.09634 
Ctrl 
F17 
7,101,376 7,118,072 7,227,135 5,847,708 0.17469 0.17942 
LS1 
F17 
7,121,979 7,062,183 7,214,508 6,795,919 5,813,162 0.17631 
LS2 
F17 
7,218,921 7,155,580 7,239,774 6,832,125 6,778,518 5,749,742 
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Supplementary Table 3.  Full details on the eight discrete loci.  Listed here are 
the eight loci shown in Table 1, with additional details on the core span and the TAD 
span used to identify candidate genes, and a full list of genes within the full span.   
 
 
 
Rk: ranking by s
Chr: Chromosome
Mbp: megabase pairs
s: selection coefficient
* Genes with short limb, short tibia or abnormal tibia knockout phenotypes
† Genes with cartilage or osteoblast morphology knockout phenotypes
Gene Genes within the TAD span
Supplementary File 3.  Full details on the eight discrete loci.  Listed here are the eight loci 
shown in Table 1, with additional details on the core span and the TAD span used to identify 
candidate genes, and a full list of genes within the full span.  
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Chrom: Chromosome 
KO: knock-out 
Dir.: directionality 
PUR: purifying 
DIV: diversifying 
 
 
 
Supplementary Table 4. Detected protein-coding changes with large allele 
frequency shift in amino acids.  Listed are genes carrying large frequency 
changing SNPs affecting amino acid residues. Highlighted cells indicate the line with 
greater frequency changes ≥ 0.34 (red text with shading).  Other suggestive changes 
are also shown with red numbers in unshaded cells.  The changed amino acids are 
marked using standard notations, with the directionality indicated as “purifying” or 
“diversifying” with respect to a 60-way protein sequence alignment with other 
placental mammals.  The conservation score based on phastCons was calculated at 
the SNP position itself, ranging from 0 (no conservation) to 1 (complete 
conservation) among the 60 placental mammals.  For each gene, reported knockout 
phenotypes of the “limbs/digits/tail” category is reported, along with whether lethality 
was reported in any of the alleles, excluding compound genotypes.  A summary of 
the mutant phenotype as reported by the Mouse Genome Informatics database is 
also included to highlight any systemic defects beyond the “limbs/digits/tail” category 
(lethal phenotypes reported in bold). 
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Chr: Chromosome 
For: forward 
Rev: reverse 
 
Supplementary Table 5. Oligonucleotides for in situ hybridization probes. 
 
 
 
 
 
VP: Viewpoint 
Chr: Chromosome 
 
Supplementary Table 6. Oligonucleotide primers for multiplexed 4C-seq of 
enhancer viewpoints at the Nkx3-2 locus.  The 4C-seq adapter and adapter-
specific primer sequences are given in (98). N2-DS denotes its location as 18 kbp 
downstream of the actual N2 enhancer.  All viewpoints are pointed towards Nkx3-2 
gene body (“+” strand). 
 
 
!
Gene Chr Start End Size Type Primer (5' - 3') 
Rab28 5 41,698,405 41,625,451 785 For AGGTGGCAAGATGTTGGATAAATAC 
     Rev GATCATCAAAGCTTGGAGCAGC 
Nkx3-2 5 41,763,877 41,762,039 579 For GCGATCCTCAACAAGAAAGAGGA 
     Rev GCGCTTCTTTCGCGGTTTAG 
Bod1l 5 41,832,764 41,828,797 873 For GATGCCATGTCAATCTTGGAAACC 
     Rev CACTGTGAGTTCGTCATCAGAATC 
!
VP Chr Start End Type Primer (5' - 3') 
N1 5 41,165,684 41,165,705 Biotin /5Biosg/GAGTTATCTCTATGGGAGAAGT 
 
5 41,165,733 41,165,752 Nested CTTGAGTTTGCCACCCAAAC 
N2-DS 5 41,403,983 41,404,002 Biotin /5Biosg/TGGCGATCTGAAGAACTAAG 
 
5 41,403,985 41,404,010 Nested GCGATCTGAAGAACTAAGAAGCTTAG 
N3 5 41,535,787 41,535,806 Biotin /5Biosg/GTGGTTGTAAGTAGCAGACA 
 
5 41,535,790 41,535,813 Nested GTTGTAAGTAGCAGACACAGAGAT 
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Enh: Enhancer 
Chr: chromosome 
For: forward 
Rev: reverse 
 
Supplementary Table 7. Oligonucleotide primers for amplifying the enhancers 
at the Nkx3-2 locus.  Each of the amplicons are tagged with SalI (forward) or XhoI 
(reverse) sites (underlined) for concatenation and flanked by EcoRV sites 
(underlined and bold) for insertion into the pBeta-lacZ-attBx2 reporter vector 
upstream of the β-globin minimal promoter. 
 
 
 
 
 
 
Chr: Chromosome 
For: forward 
Rev: reverse 
 
Supplementary Table 8. Oligonucleotide primers for allele-specific genotyping 
of the N3 enhancer.  The primers were designed to target two SNPs (bold) in the 
N3 enhancer, rs33219710 and rs33600994. 
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Chapter 3: Genetic mapping of species differences 
via in vitro crosses in mouse embryonic stem cells 
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3.2.1 Abstract: 
 
Discovering the genetic changes underlying species differences is a central 
goal in evolutionary genetics (1). However, hybrid crosses between species in 
mammals often suffer from hybrid sterility, greatly complicating genetic mapping of 
trait variation across species. Here we describe a simple, robust and transgene-free 
technique to generate “in vitro crosses” in hybrid mouse embryonic stem (ES) cells 
by inducing random mitotic crossovers with the drug ML216, which inhibits Bloom 
syndrome (BLM) (2). Starting with an interspecific F1 hybrid embryonic stem cell line 
between the Mus musculus laboratory mouse and Mus spretus (~1.5 million years of 
divergence) (3, 4), we demonstrate the feasibility of mapping the genetic basis of 
drug resistance to the anti-metabolite tioguanine to hypoxanthine-guanine 
phosphoribosyltransferase (Hprt) in as few as 6 days through “flow mapping”, by 
coupling in vitro crosses with fluorescence-activated cell sorting (FACS). We also 
show how our platform can enable direct study of developmental variation by re-
deriving embryos carrying recombinant hybrid genomes. We demonstrate how in 
vitro crosses can overcome major bottlenecks in mouse complex trait genetics and 
address fundamental questions in evolutionary biology that are otherwise intractable 
through traditional breeding due to high cost, small litter sizes and/or hybrid sterility. 
In doing so we describe an experimental platform towards studying evolutionary 
systems biology in mouse and potentially in human and other mammals, including 
cross-species hybrids. 
 
3.2.2 Keywords: Interspecific hybrids; mitotic recombination; genetics 
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3.2.3 Significance Statement: 
 
How species differ from each other is a key question in biology. But genetic 
mapping between species often fail because of sterile hybrid crosses. Here we have 
developed a novel technique called in vitro recombination to circumvent breeding. 
We induce genetic reshuffling through mitotic recombination with the drug ML216 
and mapped trait variations in a dish. Starting with hybrid embryonic stem cells 
between the Mus musculus laboratory mouse and Mus spretus spanning ~1.5 million 
years of divergence, we show it is possible to map the gene responsible for 
differential resistance to the drug tioguanine in as few as 6 days. Our technique 
opens up novel experimental avenues in genetic mapping across mouse species 
and potential applications in personalized medicine. 
 
 
3.2.4 Introduction: 
 
Discovering the genetic changes underlying species differences is a central 
goal in evolutionary genetics (1). However, hybrid crosses between even recently 
diverged species in animals often suffer from hybrid sterility (1, 4), greatly 
complicating genetic mapping of trait variation, especially in mammals. On the other 
hand, within-species genetic mapping has been tremendously successful in linking 
genetic polymorphisms to trait variations in innumerable organisms since the early 
twentieth century (5–7). Genetic mapping typically involves breeding and analyzing 
mapping panels to identify genetic loci controlling trait variations, or quantitative trait 
loci (QTL). The ability to disentangle linked genetic associations determines mapping 
resolution and is largely dependent on the number of meiotic crossovers. 
Accordingly, researchers are driven to create ever-larger mapping populations 
and/or accumulating recombination over at least two, often many generations to 
achieve gene-level mapping resolutions (8–10). In the mouse, genetic studies are 
complicated by the relatively long generation times and small litter sizes, which often 
decline with increased inbreeding. Consequently, compared to yeast, worms and 
Arabidopsis (8–10), genetic mapping in the mouse requires far greater resources, 
yet relatively few traits have been mapped to the gene level (but see landmark 
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studies identifying Tlr4 and Prdm9) (11, 12). This challenge was particularly acute for 
crosses at or beyond the species level, where hybrid sterility often makes it 
impossible to generate a panel in the first place. Nonetheless, the potential to reveal 
unique biology occurring at the species boundaries in mammalian evolution makes 
such panels worthy attempts, even allowing for lower mapping resolution (13–17). 
This is because evolutionary changes in trait architecture (even at the cellular or 
tissue level) can reveal much about the underlying evolutionary process. Should 
genetic exchange in hybrid animal genomes become feasible, direct genetic 
mapping of species differences would become routinely possible. 
We set out to establish a universal method that allows genetic mapping in 
mammals without breeding, even across divergent species with viable but otherwise 
sterile hybrids. We opted to use mouse ES cells to take advantage of the full 
spectrum of genetic manipulations available in tissue culture. A minimal system will 
have the two following features: an ability to induce on-demand extensive genetic 
exchange; and genetic (and trait) variation such as those found in F1 hybrid ES cells, 
ideally between species. 
Intriguingly, the technique to create genetic variation through recombination 
has been in broad use in the mouse genetics community, albeit never explicitly in F1 
hybrid ES cells with the goal of genetic mapping. In 2004, two independent groups 
showed that recessive, biallelic mutants could be reliably recovered in mouse ES 
cells without breeding by suppressing Bloom Syndrome (Blm; Fig. 1A) (18, 19). Yusa 
and coworkers showed that these recessive mutants arose via mitotic recombination 
between homologous chromosomes (20). We reasoned that the same mechanism 
could be leveraged to generate genome-wide random mitotic recombination. This 
mechanism enabled the creation of panels of arbitrary size carrying recombinant 
genomes, while avoiding the limitations of hybrid sterility or inbreeding depression 
(Fig. 1B). 
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3.2.5 Results: 
 
To test if BLM inhibition could lead to elevated homologous recombination rates 
in mitosis, we inhibited BLM in a number of mouse ES cell lines using a recently 
discovered small molecule inhibitor ML216 (Fig. 1C) (2). As a first test, we started 
with F1 ES cells between the laboratory mouse strains C57BL/6J (“BL6” in short) 
and 129 that carried a targeted transgene as a hemizygous allele at the GtRosa26 
locus on distal Chromosome 6. We estimated homologous recombination by 
counting colony survival under fialuridine (FIAU) treatment, which selected against 
the transgene consisting of hygromycin phosphotransferase–thymidine kinase 
(HyTK) and a green fluorescent protein (GFP; Fig. S1). We found that BLM inhibition 
led to highly elevated rates of homologous recombination, as revealed by increased 
numbers of FIAU-resistant colonies (Fig. 1C; in vitro recombination rate: 2.9×10-4 per 
cell per generation) and the appearance of mosaic GFP expression within a colony 
(Fig. 2A, right panels). This is consistent with previously reported rates under Blm 
suppression or disruption (targeted tetracycline inhibition or knockout alleles: 2.3–
4.2×10-4; vs. wildtype rates between 8.5×10-6–2.3×10-5) (18, 19). The small molecule 
BLM inhibitor ML216 offers unique experimental advantages, because its application 
is simple, rapid and reversible, eliminating the use of transgenes against Blm (18, 
19) or repeated transfections of small interfering RNA to achieve continued 
suppression of Blm. Importantly, elevated homologous recombination under BLM 
inhibition is not associated with increased aneuploidy (N=154 metaphase spreads; 
Mann-Whitney U test, W=1871, h1>0, n.s.; Fig. S2A). Further, ML216-treated ES 
cells retained robust expression of NANOG, a key stemness marker (Fig. S3). 
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Fig. 1. In vitro recombination via Bloom syndrome suppression. (A) Bloom 
syndrome (Blm) encodes a helicase normally active during mitosis. Loss of Blm 
activity leads to increased improper sister chromatid exchange as well as 
recombination between homologous chromosomes. Mitotic recombination can give 
rise to recombinant diploid daughter cells with loss of heterozygosity (LOH) between 
the breakpoint and the telomeres. (B) In vitro recombination (IVR) allowed the 
circumvention of hybrid sterility in crosses between the laboratory mouse, e.g., 
C57BL/6J (BL6) and a murine sister species Mus spretus (SPRET). (BL6 x 
SPRET)F1 hybrid mice were viable and allowed derivation of F1 ES cells despite 
male sterility (3). Applying IVR to F1 ES cells allowed rapid and efficient generation 
of recombinant ES cell panels for genetic mapping. Scale bar = 50 µm. (C) Efficiency 
of IVR was estimated by colony survival assay. We estimated recombination rate 
between homologous chromosomes with cells hemizygous for a dominant selectable 
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marker (hygromycin phosphotransferase-thymidine kinase, abbreviated HyTK, 
green). We induced IVR by adding a small molecule BLM inhibitor ML216 (2) to the 
culturing medium for 1 or 5 days (d). Under fialuridine (FIAU) negative selection, 
cells having undergone mitotic recombination to become homozygous for the 
wildtype BL6 alleles (blue) survived; while non-recombined cells or recombinant cells 
retaining the HyTK transgene metabolized FIAU, resulting in cell death due to 
misincorporation of toxic nucleotide analogues (top and middle cells with red 
chromosomes). Under ML216 treatment (25 µM), IVR rate was estimated to be 
2.9×10-4 per cell per generation, yielding 800–1500 FIAU-resistant colonies per 
million following treatment. 
 
 
To determine the frequency and distribution of mitotic crossovers under ML216-
mediated BLM inhibition, we sequenced and compared the genomes of 11 clones 
that survived ganciclovir selection (a FIAU alternative; Fig. 2B). We also treated F1 
hybrid ES cells derived from BL6 and Mus castaneus (diverged ~1 million years ago; 
CAST/EiJ, abbreviated to CAST) (21) with ML216 but otherwise grown without 
selection. Using the transgene-free (BL6 x CAST)F1 line (21), we screened 46 
randomly-picked ML216-treated clones for LOH recombinants and recovered 
recombinants in both BL6/BL6 and CAST/CAST directions on Chromosome 1. 
Sequencing of representative clones revealed conversion from F1 heterozygous 
genotypes towards both homozygous genotypes at the telomeres (Fig. 2C, clones 21 
and 50, note also additional recombination on Chromosome 13). In contrast, control 
non-recombinant clones retained heterozygosity at the telomeres (clone 54 and 56). 
But even here we discovered a single clone carrying additional internal recombinants 
on Chromosome 1 (Fig. 2C). 
Genome-wide sequencing of the recombinants revealed several striking 
patterns. First, crossover breakpoints were distributed along the entire chromosome 
(Fig. 2B), suggesting recombinants can be used for interval mapping. Second, 
ganciclovir selection significantly enriched for recombinant chromosomes compared 
to unselected conditions (N=11 out of 11 vs. 9 out of 826; Fisher Exact Test, 
P < 2.2×10-16), with the recombination map biased strongly by the location of the 
selection cassette (all 11 crossovers were centromeric to Chromosome 6, 113 Mbp, 
Fig. 2B). This is presumably because chromosome segments telomeric to the 
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cassette had no effect on selection. In our subsequent experiments on natural 
variations, this centromeric bias became a useful signature for trait mapping. Third, 
crossovers created by mitotic recombination usually occurred only on one or few 
chromosomes at a time (Fig. 2 B and C; Fig. S4)(20,22), unlike in meiosis with 
typically one crossover per chromosome arm. Taken together, the data show that 
BLM inhibition efficiently generated in vitro recombination (IVR) across wide 
evolutionary distance and IVR ES cell panels may constitute genetically distinct 
lineages suitable for genetic mapping. 
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Fig. 2. Widespread in vitro recombination across a range of evolutionary 
divergence. (A) ES cell colonies displayed mosaic GFP expression within a colony 
when cultured with ML216, but not under control conditions, consistent with 
homologous recombination and loss of GFP through IVR. Recombination between 
homologous chromosomes could result in daughter cells with two wildtype (BL6 
allele, dark) or transgenic copies (129 allele, bright). Early recombination events 
followed by random cell loss during clonal expansion could produce completely dark 
colonies. Scale bar = 100 µm. (B) After expansion under negative selection against 
the transgene (both ganciclovir and FIAU kill cells expressing HyTK), 11 ganciclovir-
resistant and GFP-negative colonies were whole genome sequenced. Selection 
favoured loss of transgene (homozygous BL6/BL6 genotypes) at distal Chromosome 
6. In contrast to normal meiotic recombination (averaging 1 or more crossovers per 
chromosome pair), mitotic recombination typically affected only a single 
chromosome pair: much of the genome remained heterozygous (yellow), with the 
exception of the transgene-carrying chromosome 6 (mostly BL6/BL6, blue) and the 
single 129 Chromosome X (male, 129, red). Mitotic recombination events converted 
genotypes telomeric to the breakpoint towards homozygosity (LOH, yellow to blue). 
(C) IVR also occurred in cells carrying divergent genomes with no transgenes. (BL6 
x CAST)F1 hybrid ES cells were treated with ML216 and screened by PCR 
genotyping at diagnostic telomeric markers. Selected clones (two recombinant and 
control clones each) were whole genome sequenced, showing recombination events 
towards both homozygous genotypes, consistent with PCR genotype screening 
results (total breakpoints per clone ranged from 0–2). Additional recombination 
events were also recovered, even though the Chromosome 1 telomeric marker 
remained heterozygous (clone 54). These clones also carried non-recombined 
chromosomes (e.g., Chromosome 6, fully heterozygous, yellow). 
 
 
Our experiments to determine IVR rate demonstrated that the collective 
location of recombination breakpoints could reveal the position of the selectable 
transgene (HyTK or GFP), with the major difference that under mitotic recombination 
the critical interval was defined only on the centromeric side. To further illustrate the 
potential of this approach, we used IVR to map naturally-occurring variations. One 
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classical polymorphism is the 25 to 75-fold increased activity of the Mus spretus “a” 
allele of hypoxanthine-guanine phosphoribosyltransferase (Hprta) compared to the 
laboratory mouse Hprtb allele (23). Importantly, HPRT metabolizes the anti-
metabolite tioguanine (6-TG) and causes cytotoxicity. It should be noted that beside 
the known Hprt polymorphism, tioguanine susceptibility itself has not been previously 
mapped genetically within or between mouse species. Here, we expected ES cells 
carrying Hprta to be highly susceptible to 6-TG treatment, whereas Hprtb/b or Hprt-/- 
ES cells should survive far higher 6-TG concentrations (Fig. S5). We set out to map 
the QTL for differential 6-TG susceptibility using a bulk segregant assay simply by 
comparing allele frequencies across the genome between pools of 6-TG susceptible 
and resistant ES cells. 
We first confirmed the absence of chromosome-scale rearrangements between 
the parental strains that could preclude mapping using the de novo assembled 
genomes of the parental strains made available by the Wellcome Trust Sanger 
Institute (BL6 and SPRET/EiJ, abbreviated to SPRET here) (24, 25). We generated 
IVR panels by treating a female (BL6 x SPRET)F1 hybrid ES cell line (“S18”) (3) with 
ML216 over 5, 10 and 21 days (d; Fig. 3A). The use of a female ES cell line, which 
carried two active X chromosomes prior to the onset of X inactivation during 
differentiation (26), allowed direct selection on the alternative Hprta and Hprtb alleles. 
After confirming biallelic Hprt expression in S18 cells using quantitative PCR, we 
treated control and IVR S18 cells with 6-TG and determined cell viability via a 4’,6-
diamidino-2-phenylindole (DAPI) exclusion assay. Damaged cells with ruptured 
membrane exhibited rapid uptake of DAPI, a feature unaffected by ML216 treatment, 
and were distinguishable by fluorescent-activated cell sorting (FACS; “Live” 
proportions under ML216 treatment vs. “Live” proportions under 6-TG treatment, N = 
5 paired treatments; Kruskal-Wallis test, 𝜒2 = 13.17, d.f.= 1, P < 0.0003; Fig. 3A; Fig. 
S6). We separately recovered and sequenced each “Resistant” (6-TGR) and 
“Susceptible” (6-TGS) pool (Fig. 3A). Under both 5d and 21d ML216 treatment, a 
large skew towards enriched SPRET coverage was observed on Chromosome X in 
the 6-TGS relative to the 6-TGR pool (Fig. 3 A and B). This was in stark contrast to 
the genomic background, which showed little deviation from equal SPRET and BL6 
contributions (normalized SPRET coverage for Chromosome X: 1.10, 95% 
confidence interval: 1.02–1.19; autosomes: 0.998, conf. int.: 0.986–1.01). The 
genome-wide peak SPRET enrichment window was found on Chromosome X, 53 
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Mbp, and it contained the Hprt gene itself (normalized SPRET coverage in 6-TGS 
pool, 1 Mbp window: 1.19, conf. int.: 1.09–1.28). Here, our forward genetic mapping 
for 6-TG susceptibility clearly identified a single locus, suggesting that 6-TG 
susceptibility depended only on Hprt genotypes. To confirm the role of Hprt in 
mediating differential 6-TG susceptibility beyond bulk sequencing, we also 
sequenced 46 individual 6-TGR IVR clones after 10d ML216 treatment to determine 
their recombination breakpoints (Fig. 3C). Echoing the skewed crossovers patterns 
centromeric to the HyTK selection cassette (Fig. 2B), we observed more SPRET-to-
BL6 than BL6-to-SPRET centromeric recombinants (N = 35 vs. 8, P ≤ 2 × 10-5, exact 
binomial test, h1≥ h0) and also ruled out aneuploidy or deletion of Hprta as major 
contributors to 6-TG resistance. We note, however, that despite the strongly skewed 
ratio of 27 BL6/BL6 homozygous clones at the Hprt locus out of 46 total recovered 
clones, we still observed 9 heterozygotes and 10 SPRET/SPRET homozygous 
clones (BL6/BL6 58.6%; Chi-squared test using observed allele counts, 𝜒2 = 13.17, 
d.f. = 2, P ≤ 0.002). Close examination of our flow cytometry data suggests that the 
original DAPI-only FACS gating may not be sufficiently exclusive (as opposed to 
gating using additional channels, Fig. 3A and S6). Other alternative explanations 
may be a quantitative, rather than absolute allelic difference in susceptibility to 
25 µM 6-TG treatment (Fig. S5); or other mutation(s) at Hprt or elsewhere leading to 
6-TG resistance (18). Taken together, we conclude that we were able to perform 
forward genetic mapping using IVR and recover Hprt as the gene underlying 6-TG 
susceptibility differences between BL6 and SPRET. 
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Fig. 3. In vitro genetic mapping of variation in tioguanine susceptibility 
between divergent species. (A) A female ES cell line S18 derived from a Mus 
spretus and C57BL/6N F1 interspecific hybrid was treated with ML216 (25 µM) and 
subjected to the anti-metabolite tioguanine (6-TG) for 1d prior to fluorescence-
activated cell sorting (FACS). ES cells were evaluated for viability based on 4’,6-
diamidino-2-phenylindole (DAPI) exclusion. Resistant and susceptible (6-TGR and 6-
TGS) sub-populations were gated conservatively (shaded arrows) and pooled for 
sequencing. Individual clones from the 10d ML216 treatment were cultured and 
whole genome sequenced. (B) Skewed allelic contributions between the 6-TGR and 
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6-TGS pools suggested that the SPRET allele on Chromosome X conferred 6-TG 
susceptibility. Allele frequencies were normalized against 6-TGR sample as an 
internal ML216 treatment control. Plotted are per megabase mean SPRET allele 
frequencies ± s.e.m. after 5 d and 21 d ML216 treatment. In both cases, the 
genome-wide peak window contains the Hprt gene with the SPRET allele showing 
significantly increased susceptibility. (C) Individual 6-TGR clones following 10 d 
ML216 treatment were sequenced to determine recombination breakpoints. 
Crossovers in clones surviving 6-TG treatment recombined significantly more likely 
in the SPRET-to-BL6 direction (S>B = 37; B>S = 5; P ≤ 2×10-5) between the 
centromere and Hprt, consistent with strong selection favouring the BL6 Hprtb allele. 
In contrast, only 3 additional crossovers were detected telomeric to Hprt. At Hprt, 
most 6-TG surviving clones are homozygous for the Hprtb allele (27 vs. 9 
heterozygotes and 10 Hprta homozygotes). 
 
 
The ability to easily circumvent hybrid sterility in evolutionarily divergent murine 
species led us to ask what developmental phenotypes may arise from such 
otherwise inaccessible genetic configurations (M. spretus–laboratory mouse hybrid 
males are sterile, following Haldane’s rule. Backcrosses using female hybrids are 
possible but extremely challenging) (17). Assaying developmental phenotypes from 
evolutionarily divergent hybrid ES cells is non-trivial, because hybrid sterility makes 
conventional re-derivation impossible due to the lack of germ line transmission in the 
chimera generation. Instead, we directly produced fully ES cell-derived founder 
animals using laser-assisted morula injection (27) with two karyotypically normal but 
genetically distinct IVR ES cell lines along with control, non-recombined S18 cells 
(IVR 1 and 2; Fig. S2; Fig. S7; Movies S1–3). We succeeded in obtaining multiple 
embryos per line at embryonic (E) 14.5d of development (N=36, 24 from IVR lines 
vs. N=9 untreated S18 line). Using high-resolution micro-computer tomography 
(microCT), we observed that the embryos from the untreated clones showed 
uniformly normal development, whereas embryos from both IVR lines showed both 
normal development and dramatic craniofacial and neural tube closure defects (2 
abnormal embryos out of 4 scanned embryos in IVR line 1; 2 out of 7 in line 2; and 0 
out of 6 from the original S18 line; Fig. 4; Fig. S8; Movies S1–3). Neural tube and 
craniofacial defects are among the most common developmental defects due to the 
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complex coordination of cell migration and cell–cell communications, which may be 
impaired due to novel genetic combinations in the IVR lines (Fig. S7). Besides major 
developmental defects, we also made 3D measurements from various organs, 
including sub-regions of the brain, the heart and the liver, in individual embryos from 
each ES cell line. This approach illustrates for the first time the potential and 
feasibility of characterizing, or given an expanded IVR panel, mapping the genetic 
basis of evolutionary developmental variation using recombinants from divergent 
species. 
 
 
 
 
Fig. 4. Accessing developmental phenotypes in recombinants between 
evolutionarily divergent species. Embryos at mid-gestation (14.5 d after 
fertilization) with nearly exclusive ES cell contribution were derived from non-
recombinant F1 S18 ES cells (A) and IVR lines 1 (B) and 2 (C). Embryos were 
dissected, contrast-stained and scanned using X-ray micro-computer tomography at 
9.4 µm resolution. The high scanning resolution allowed identification and precise 
measurements of individual organs (colorized here). Major developmental 
craniofacial and neural tube closure defects were observed in the IVR lines (B, 
caudal view with arrowhead indicates neural tube lesion). Scale bar = 200 µm. 
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3.2.6 Discussion: 
 
A central goal of evolutionary genetics is to identify how mutations arose during 
evolution and influenced phenotypes. For many organisms, a major barrier has been 
the inability to reliably generate diverse and large mapping panels of sufficient 
evolutionary diversity. Here we describe a simple and robust method to make “in 
vitro crosses”, resulting in functionally intercross panels from otherwise sterile 
interspecific hybrid crosses. Being able to bring forth genetic diversity in a petri dish 
creates the unique opportunity to conduct mouse genetic mapping at unprecedented 
speeds with “flow mapping” (similar to “X-QTL” in yeast (28)) or arbitrarily large 
panels unmatched by most other model organisms, except possibly yeast (22, 28). 
As renewable stem cells, IVR panels can be expanded, archived and shared, 
offering a cellular resource with many of the advantages sought from traditional 
community resources such as recombinant inbred line panels. Further, we have 
shown that our IVR method works in a broad range of ES cells. With millions of 
potentially recombinant (thus genetically distinct) ES cells in a petri dish, we 
demonstrated how IVR enabled mapping of QTLs for drug resistance in as few as 6 
days (with an estimated total of 5 doublings over 5 days). Putting this in context, 
such an experiment using traditional mouse crosses would have taken 450 days, 
based on the typical mouse generation time of 90 days, assuming that hybrid sterility 
could be overcome and allowing for selfing.  
Rather than a challenge to current organismal genetic mapping methods, we 
see IVR as a complementary extension. In the mouse, the largest organismal 
recombinant inbred (RI) panel BXD contains “only” ~160 lines (with most published 
work based on the ~35 original BXD strains) (29) and attempts in generating panels 
incorporating greater divergences encountered enormous challenges (30). 
Nevertheless, mouse RI resources still represented some of the most powerful tools 
available to dissect system genetics in the mouse, the prime biomedical model 
organism (31). Seen in this light, IVR represents an alternative approach that could 
greatly extend the available renewable resources, not least because the genotype 
combinations between divergent species are hitherto impossible to obtain in the first 
place. 
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Recently, Sadhu and coworkers have also achieved a major advance in genetic 
mapping using CRISPR/Cas9-mediated mitotic recombination in yeast (22). In 
contrast to CRISPR targeting, our transgene-free approach offers the simplicity of 
inducing genome-wide recombinants by the simple addition of a single inexpensive 
small molecule to the tissue culture medium. Going forward, we envision a 
combined, complementary approach to IVR: using BLM inhibition for mapping panel 
generations and efficient QTL identification, then switching to targeted transgene-
based screening or CRISPR/Cas9-based IVR for fine-scale mapping. 
We are currently working on improving the efficiency of IVR panel creation from 
hybrid cell lines and developing robust phenotyping protocols, in order to make 
mapping interspecific trait differences in mouse or other mammals using in vitro 
recombination routine. In addition to the traits we have investigated, Mus spretus and 
the Mus musculus laboratory mouse differ in a number of distinct traits, such as 
longevity and telomere lengths (32), cancer and inflammation resistance (33, 34) and 
metabolism (35). Many of these traits have tissue or cellular models suitable for IVR 
mapping panels or flow mapping through fluorescent detection of specific proteins or 
metabolites. Future experiments may also probe even greater evolutionary 
divergence: early work has shown that F1 hybrids spanning as much as 6 million 
years between Mus musculus and Mus caroli was viable (36). Given active 
development in single-cell genomics and disease modeling from patient-specific 
induced pluripotent stem cells (iPSC), including organoids or organ-on-a-chip 
microfluidics systems, we anticipate that the in vitro recombinant platform can be 
broadly applied to mouse, human or even other species to accelerate the 
identification of the genetic basis of many traits and diseases. 
 
 
3.2.7 Materials and Methods: 
 
Animal Care and Use  
All animal experiments have been approved by the applicable animal welfare 
ethics committees: Faculty of Sciences, Ghent University, Belgium (reference 
number 06/022); and Landesdirektion Sachsen, Germany, permit number 24-
9168.11-9/2012-5. 
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Cell Culture  
Table S1 summarizes the ES cell lines used in this study. Unless otherwise 
stated, ES cell lines were cultured on SNL76/7-4 feeder cells in Attachment Factor 
(AF)-coated plates under 2i medium, supplemented with LIF (see SI Methods for 
details). 
 
BLM Inhibition using ML216  
BLM inhibition was performed using 25 µM ML216 (Sigma Aldrich) in 2i/LIF 
media on inactivated feeders.  
 
Generation of HyTK-EGFP-Neo cell line  
Starting with G4 ROSALUC B12 ES cells (37), we replaced the cassette at the 
GtRosa26 locus with a cassette carrying two selectable markers, HyTK and 
enhanced green fluorescent protein (EGFP, selectable in fluorescence-assisted cell 
sorting; Fig. S1; see SI Methods for details). Successful replacement of the cassette 
was confirmed through selection using geneticin (G148; ThermoFisherScientific) and 
genotyping.  
 
Colony Survival Assay 
HyTK-EGFP-Neo cells were seeded at a density of 5×105 per 10 cm AF/feeder 
plate, followed by 25 µM ML216 treatment for 1 or 5 d. Prior to the start of negative 
selection, cells were re-plated at 2×105 per 10 cm AF/feeder plate and FIAU (0.2 µM, 
Sigma Aldrich) or ganciclovir (10 µM, Sigma Aldrich) selection was applied for 5 d. 
Colonies were stained with the Alkaline phosphatase kit (EMD Millipore, Billerica, 
MA, USA), photographed and counted to determine survival rates. The entire 
procedure was repeated multiple times and the survival colony counts averaged to 
determine IVR rate. 
 
Screening for Spontaneous Recombinant ES Cell Colonies  
Cells were treated with ML216 for 2 d at 5 µM, then 3 d at 25 µM. Cells were 
then re-plated and cultured for 5 d in 2i/LIF without ML216. One hundred and eighty-
nine colonies were randomly picked (without selection), of which 136 were screened 
with multiplexed genotyping. 
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Multiplexed genotyping for detection of loss-of-heterozygosity (LOH) 
 Diagnostic markers between BL6, CAST and SPRET strains at tips of each 
chromosome were designed to track the presence of each allele. The markers were 
amplified with fluorescence-tagged primers as proposed in (38) (see SI Methods and 
Table S2 for details). The PCR reactions were pooled at equimolar proportions and 
analyzed with a 3730xl DNA Analyzer capillary sequencer (ThermoFisher Scientific, 
Germany) and scored for conversion from heterozygous into homozygous genotypes 
(LOH) at the tips of each chromosome. 
 
6-TG treatment and DAPI exclusion assay  
Prior to the main experiments, killing curves for 6-tioguanine (Sigma Aldrich) 
was performed using WST-1 assay (Roche) according to the manufacturer’s 
instructions (Fig. S5). For the main experiments, S18 ES cell line was cultured for 5, 
10 or 21 d with 25 µM ML216. Following the designated ML216 treatment, the cells 
were re-plated and treated with 25 µM 6-TG in 2i/LIF. We determined “live/dead” cell 
viability using 4’,6-diamidino-2-phenylindole (DAPI) staining (1 µg/mL, Sigma 
Aldrich) after 1 d of 25 µM 6-TG treatment.   
 
Fluorescence-Activated Cell Sorting (FACS)  
Flow cytometry was performed using an Aria II Cell Sorter (Becton Dickinson 
GmbH, Heidelberg, Germany). We defined the 6-TGR and 6-TGS populations using 
the DAPI exclusion assay in reference ES cell populations. In sorting experiments, 
ML216-treated or control 6-TGR and 6-TGS population were recovered for 
sequencing. For quantification, we performed post-hoc analysis using the R 
Bioconductor package flowCore (39), principally by clustering using the forward 
scatter area (FSC-A) and DAPI/Pacific Blue-A channels into “Live” and “Dead” 
clusters using mclust v5.2 (40, 41) in 6-TG-treated experiments, considering ML216-
treated and controls separately (Fig. S6).   
 
Sequencing and analysis pipeline  
Sequencing libraries for high-throughput sequencing were generated using 
Nextera DNA Library Prep Kit (Illumina, Inc., San Diego, USA) according to 
manufacturer’s recommendations or equivalent purified Tn5 transposase as 
described in (42). Each sample (FACS-sorted clones, single colonies or pooled cells) 
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was barcoded through PCR extension using an i7-index primer (N701-N763) and the 
N501 i5-index primer. Pooled libraries were sequenced by a HiSeq 3000 (Illumina) 
and analyzed using a custom pipeline (see SI Methods for details). We performed 
genotyping based on allelic coverage per megabase using known informative 
variants between the BL6, CAST and SPRET strains (Mouse Genomes Project 
version 3 dbSNP v137 release)(25). Scripts are available at: 
https://github.com/evolgenomics/HybridMiX . 
 
Laser-assisted morula injection  
Fully ES cell-derived embryos were obtained through injection into 8-cell stage 
embryos (morulae) as described in (27). At 14 d after the injection and subsequent 
embryo transfer into surrogates (approximating developmental stage E14.5), the 
gestation was terminated and embryos were dissected and fixed with 4% 
paraformaldehyde for microCT scanning.  
 
Micro computer-tomography (microCT)  
Soft tissue X-ray contrast staining was done via 4 d perfusion in 25% Lugol’s, 
or iodine potassium iodide solution. Then the embryos were rehydrated, mounted in 
1% agarose and scanned with a Skyscan 1173 instrument (Bruker Corporation, 
Billerica, MA, USA) at 9.96 micron resolution (0.5 mm aluminium filter, energy at 70 
kV and 110 µA). Image analysis, segmentation and visualizations were performed 
using Amira v6.2.0 (FEI, Hillsboro, OR, USA) with the XImagePAQ extension 6.2. 
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3.2.10 Supplementary Text: 
 
Major differences between mitotic and meiotic mapping  
As a novel mapping system, we observed a number of key differences between 
IVR and conventional meiotic genetic mapping. First, recombination tends to occur 
as loss-of-heterozygosity between the breakpoint and the telomeres. Unlike 
conventional breeding with random assortment, under IVR in F1 hybrids, outcrosses 
are not possible. As a result, we tend to observe only heterozygous genotypes near 
the centromere, with informative crossovers almost always found between the 
centromere and a selectable QTL but not on the telomeric side. This asymmetry 
often led to a plateau in the association profiles from the QTL towards the telomeres 
on a given chromosome (Fig. 2B and 3C), an effect also reported elsewhere (21). As 
a consequence, interval mapping in IVR analogous to those in meiotic panels yields 
excellent genetic resolution on the centromeric side but poor resolution on the 
telomeric side (see distribution of crossover directions and breakpoints in Fig. 3C 
and (21). Second, access to common tissue culture methods under IVR greatly 
mitigates typical concerns such as panel sizes and power calculation in generating 
meiotic mapping panels. Since it is trivial to freeze samples and introduce selectable 
markers at any given locus or targeted chromosome breaks with a CRISPR/Cas9 
panel (21) with ES cells under tissue culture conditions, refinement of mapping 
resolution under IVR no longer depends on the diminishing return of breeding and 
screening for increasingly rare informative recombinants. To underscore this point, 
our flow mapping experiment for 6-TG susceptibility identified the single region 
containing the known causal Hprt gene within weeks. Third, while it is true that 
mitotic recombination as used in IVR depends on error-prone repair of double-strand 
breaks that could affect phenotype through chromosome rearrangements and new 
mutations at breakpoints, two observations from our results may moderate this 
concern. One, we did not observe elevated aneuploidy under ML216 treatment, 
suggesting that IVR did not elevate rates of chromosome rearrangements (Fig. S2). 
Two, millions of variants already exist in our (BL6 x CAST) F1 or (BL6 x SPRET) F1 
lines. These variants vastly outnumber any new mutations generated through IVR. 
Assuming a typical spectrum of mutation effects, these parental variants likely would 
contribute far more to trait variance than new mutations arising in a specific line. 
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Since genetic mapping depends on testing for different genotypic effect of an allele 
across all lines carrying the same genotype at loci that are typically megabases 
away from a random double-strand breakpoint, it is reasonable to expect that the 
mutagenic effect of mitotic recombination should have a rather limited impact on 
genetic mapping. Under the flow mapping design, the mutagenic effect of mitotic 
recombination is further diluted, because millions, if not tens of millions of cells in 
bulk population cultures are phenotyped and sequenced as pools. This conclusion is 
supported by our ability to locate and map various transgenes or QTLs in this current 
study. We are nonetheless in the process to formally characterize the relative 
contribution to trait variation due to the mutagenic effects of IVR and that of the 
parental genomes. 
 
3.2.11 Supplementary Materials and Methods: 
 
Animal Care and Use  
All experimental procedures described in this study have been approved by the 
applicable University institutional ethics committee for animal welfare at the Faculty 
of Sciences, Ghent University, Belgium, (reference number 06/022); or local 
competent authority: Landesdirektion Sachsen, Germany, permit number 24-
9168.11-9/2012-5. 
 
Reference genome assembly  
All co-ordinates in the mouse genome refer to Mus musculus reference mm10, 
which is derived from GRCm38. Sequence data have been deposited in the GEO 
database under accession number PRJNA390071. 
 
Cell Culture  
Unless otherwise stated, murine stem cell lines have been cultured on 
Attachment Factor Protein (AF) (ThermoFisherScientific, Schwerte, Germany) 
coated cell culture dishes on inactivated SNL 76/7-4 feeder cells (“feeder” plates; 
SCRC-1050, ATCC, Middlesex, United Kingdom) and using 2i/LIF media as follows: 
KnockOut Serum Replacement (ThermoFisherScientific), KnockOut DMEM 
(ThermoFisherScientific), 2-Mercaptoethanol, 1000x, 55 mM 
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(ThermoFisherScientific); MEM Non-Essential Amino Acids Solution, 100x 
(ThermoFisherScientific); GlutaMAX Supplement, 100x (ThermoFisherScientific); 3 
µM GSK-3 inhibitor CHIR99021 (Sigma Aldrich, Munich, Germany); 1 µM MEK 
inhibitor PD0325901 (Sigma Aldrich); insulin solution, human (Sigma Aldrich), 1000 
U/mL recombinant mouse LIF (expressed in-house). Unless otherwise stated, cell 
culture media was replaced daily. 
 
BLM inhibition using ML216  
BLM inhibition was performed using 25 µM ML216 (Sigma Aldrich) in 2i/LIF 
media on inactivated feeders. Killing curves for ML216 was performed using the 
WST-1 assay (Roche, Basel, Switzerland) according to the manufacturer’s 
instructions. 
 
Plasmid construction  
The pMK11 plasmid was constructed by blunt-end ligation of the pRMCE-DV1 
plasmid’s backbone, after excision of its chloramphenicol–ccdB cassette between 
the EcoRV and SbfI sites, and replacing it with the HindIII-excised hygromycin 
phosphotransferase-thymidine kinase cassette (HyTK) from the RV-L3-HyTK-2L 
plasmid (43) (Plasmid # 11684, Addgene, Cambridge, USA). The final pMK11 
construct contained flanking FRT wt and FRT mutant sites for recombinase-
mediated cassette exchange detailed below. 
 
Generation of HyTK-EGFP-Neo cell line  
G4 ROSALUC B12 ES cells (37) were co-transfected with pMK11 described 
above and FLP mRNA (StemMACS Flp Recombinase, Miltenyi Biotec, Bergisch 
Gladbach, Germany) or pCAG-Flpo (44) (Plasmid # 60662, Addgene) using 
Lipofectamine 2000 (ThermoFisherScientific). We replaced the cassette at the 
GtRosa26 locus with a cassette carrying two selectable markers, HyTK and 
enhanced green fluorescent protein (EGFP, selectable in fluorescence-assisted cell 
sorting; Fig. S1). Successful replacement of the cassette with a re-activated 
neomycin resistance gene was selected for with 200 µg/mL geneticin (G148; 
ThermoFisherScientific). Resistant colonies were picked after 7 days (d) of selection 
and further expanded. Correct replacement was confirmed by junction PCR with 
primers SA_loxP_Rev: 5’–GCGGCCTCGACTCTACGATA–3’ and 
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ROSA26_3HA_F_BamHI: 5’–GCGGGATCCCCTCGTGATCTGCAACTCC–3’. The 
presence of an intact BL6 wildtype allele was confirmed by an alternative reverse 
primer oIMR8545 5’–AAAGTCGCTCTGAGTTGTTA–3’. PCR was performed as a 
quantitative PCR reaction. See “RNA Extraction, Reverse Transcription and “Real 
Time PCR” section below for more details. 
 
Colony Survival Assay  
HyTK-EGFP-Neo cells were seeded at a density of 5×105 per 10 cm AF/feeder 
plate. Eight hours (h) following the plating, 25 µM ML216 treatment was initiated and 
continued for 1 or 5 d. Prior to the start of negative selection, cells were re-plated at 
2×105 per 10 cm AF/feeder plate and FIAU (0.2 µM, Sigma Aldrich) or ganciclovir 
(10 µM, Sigma Aldrich) selection was initiated after 1d and continued for 5d. 
In order to determine the plating efficiency after ML216 treatment, cells were 
plated at 1×103 per 6 cm AF/feeder dish. Colonies were stained with the Alkaline 
phosphatase kit (EMD Millipore, Billerica, MA, USA). Before the application of 
negative selection, 20 random views of each plate were taken using an EVOS FL 
Cell Imaging System (ThermoFisherScientific) and counted using Fiji v2.0.0-rc-
54/1.51h (45). 
 
Screening for spontaneous recombinant ES cell colonies  
Cells were plated at a density of 1×105 per 3.5 cm AF plate. Treatment with 5 
µM ML216 was initiated 16 h after plating, continued for 2d and then followed by 3d 
of 25 µM ML216 treatment. Cells were then re-plated on a 10 cm AF plate and 
cultured for 5d in 2i/LIF without ML216. One hundred and eighty-nine colonies were 
randomly picked and 153 were expanded for multiplexed genotyping. 
 
Multiplexed genotyping for detection of loss-of-heterozygosity (LOH) 
Diagnostic insertions or deletions (indels) between BL6, CAST and SPRET 
strains that are greater than 20bp in length and located within the most distal 10Mbp 
of each chromosome were filtered from the publicly available variant panel from the 
Mouse Genomes Project made available by the Wellcome Trust Sanger Centre (v5 
dbSNP v142 release) (23, 24) using VCFtools v0.1.14 (46). Automated primer 
design was carried out with Primer3 v.1.1.3 using the following parameters: 
PRIMER_OPT_SIZE=20; PRIMER_MIN_SIZE=18; PRIMER_PRODUCT_OPT_SIZE=300; 
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PRIMER_PRODUCT_SIZE_RANGE=250-400;  
PRIMER_MAX_SIZE=23; PRIMER_NUM_NS_ACCEPTED=1; 
PRIMER_LEFT_MIN_TM=58 PRIMER_LEFT_MAX_TM=62; 
PRIMER_RIGHT_MIN_TM=58; PRIMER_RIGHT_MAX_TM=62; 
PRIMER_MAX_DIFF_TM=2; PRIMER_MIN_GC=45.0; PRIMER_MAX_GC=85.0; 
PRIMER_MAX_POLY_X=3; PRIMER_SELF_ANY=4. Among indels with successfully 
designed primer pairs, the most telomeric amplicons were chosen and an extension 
was added to either the forward (M13F) or reverse (M13R-46) oligonucleotide to 
allow for easy fluorophore incorporation as described (38). The amplicon sizes were 
further optimized following pilot capillary sequencer runs to avoid amplicon size 
overlap in a multiplexed run. All primers and expected fragment sizes are listed in 
Table S1.  
For genotyping of cell colonies, primers pairs were pooled into 4 multiplexed 
PCR reactions. Group 1 (Chr1, Chr7, Chr13, Chr14 and Chr18) and Group 2 (Chr3, 
Chr6, Chr16, Chr17 and Chr19) primer mixes contained 2 and 4 µM of forward and 
reverse primers, respectively, for each listed chromosome plus 20 µM of the 
universal FAM-labeled M13F_FAM primer. Chromosomes 13 and 17 primers were 
mixed at 6 and 12 µM concentration. For Group 3 (Chr2, Chr4, Chr5, Chr11, ChrX) 
and Group 4 (Chr8, Chr9, Chr10, Chr12, Chr15) mixes, the forward and reverse 
primers were mixed at 4 and 2 µM concentration, along with the HEX-labelled M13R-
46_HEX primer at a concentration of 20 µM. QIAGEN Multiplex PCR Plus Kit 
(Qiagen, Hilden, Germany) was used according to manufacturer’s recommendations 
(including the addition of 5× Q-Solution) at 10 µL final reaction volume with 3 to 10 
ng of DNA per PCR reaction. The PCR program used was: 95°C for 15 min, then 52 
cycles of 94°C for 30 s; Group-specific annealing temperature for 2.5 min; and 72 ºC 
for 1 min; followed by a final extension at 72°C for 30 min and hold at 4 ºC. The 
group-specific annealing temperatures were: Group 1: 63°C; Group 2: 63.8°C; Group 
3: 57°C; and Group 4: 64°C. Then the PCR reactions were pooled at equal 1 µL 
proportions and analyzed with a 3730xl DNA Analyzer capillary sequencer 
(ThermoFisher Scientific, Germany) using the fragment analysis program with the 
G5-RCT Dye Set. Electropherogram traces were analyzed with the Microsatellite 
Plugin in Geneious v7.1.9 (47). 
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6-TG treatment and DAPI exclusion assay  
Prior to the main experiments, killing curves for 6-tioguanine (Sigma Aldrich) 
was performed using WST-1 assay (Roche) according to the manufacturer’s 
instructions (Fig. S5). For the main experiments, S18 ES cell line was cultured for 5, 
10 or 21d with 25 µM ML216 prior the treatment with 25 µM 6-TG in 2i/LIF starting 
from an initial seeding concentration of 1×105 cell per 3.5 cm AF plate. To avoid 
overcrowding, at day 3 of the ML216 treatment colonies were dissociated using 
Accutase Cell Dissociation Reagent (ThermoFisherScientific) and re-seeded on a 10 
cm AF-plate. At day 5, the cells were moved to a 15 cm AF plate prior to 6-TG 
treatment. After 16 h, 6-TG in 2i/LIF was added at a concentration of 25 µM. From 
each plate 2.5×104 cells were used to continue the experiment until day 10 or 21. 
4’,6-diamidino-2-phenylindole (DAPI) staining (1 µg/mL, Sigma Aldrich) was 
employed for “live/dead” cell viability determination after 1d of 25 µM 6-TG 
treatment. Briefly, ES cells were treated with ML216 and/or 6-TG to induce IVR and 
cell death, respectively. Colonies were dissociated using Accutase and re-
suspended in phosphate buffered saline (PBS) within 1 h of analytical or preparative 
fluorescence-activated cell sorting (FACS). For details on FACS see below. 
 
Fluorescence-Activated Cell Sorting (FACS) 
Flow cytometry was performed at the University Clinic Tübingen Dermatology 
Clinic FACS Core Facility using an Aria II Cell Sorter (Becton Dickinson GmbH, 
Heidelberg, Germany). To determine cell viability, we performed the DAPI exclusion 
assay. After excluding cell aggregates, we defined the 6-TGR and 6-TGS populations 
using conservative interval gates based on evaluating the data from reference flow 
experiments with 6-TG-treated DAPI-stained ES cells. For cell population 
evaluations, flow cytometry data was exported from BD FACSDiva Software v8.0.1 
(Becton Dickinson). We carried out basic data handling and log10 transformation 
using the R Bioconductor package flowCore (39). Since live and dead cells cluster 
also in other measurements, we took both forward scatter area (FSC-A) and DAPI 
into account for our quantification, rather than using a simple interval gate on the 
DAPI/Pacific Blue-A channel. We defined data-driven “Live” and “Dead” clusters 
using mclust v5.2 (40, 41) in 6-TG-treated experiments, considering ML216-treated 
and controls separately. We then classified each cell in to the “Live” and “Dead” 
clusters, applying a 5% uncertainty cut-off. “Live” and “Dead” proportions were then 
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calculated from the confidently assigned cells. Data was visualized using the 
package flowViz (48) (Fig. S5). 
 
RNA Extraction, Reverse Transcription, and Real Time PCR  
RNA was isolated using TRIzol Reagent (ThermoFisherScientific) with a single-
step method following (49). Complementary DNA (cDNA) was generated using High-
Capacity cDNA Reverse transcription kit (ThermoFisherScientific) with 500 ng of 
RNA per reaction according to the manufacturer’s instructions. The newly 
synthesized cDNA (20 µl reaction) was diluted 5-fold and quantitative PCR (qPCR) 
was performed with SYBR-select Master Mix for CFX (ThermoFisherScientific) using 
a CFX384 Real-Time PCR system instrument (BioRad, Munich, Germany). We used 
the following primers for allele-specific amplification and detection:  
Hprta (SPRET) forward: 5’–CAAAGCCTAAGAGCATGAGCGC–3’,  
reverse: 5’–CAGAGGGAACTGATAGGCTGGC–3’, amplicon size: 229bp;  
Hprtb (BL6) forward: 5’–GCCAAATACAAAGCCTAAGATGAGCG–3’,  
reverse: 5’–CCAGCCTACCCTCTGGTAGATTG–3’, amplicon size: 236bp. The 
standard CFX mode for Tm ≥ 60°C was used, with the following thermocycling 
program: 50ºC for 2 min, 95ºC for 2 min, followed by 35 cycles of 95ºC for 15 s, 60ºC 
for 1 min. Melting curve analysis over 80 steps of 0.5ºC increments was performed 
and curves inspected to ensure uniform annealing. 
 
Immunofluorescence staining  
ES cells were cultured for 3d on 12 mm cover glasses pre-coated with AF and 
feeder layer. Cells where then fixed 10 min in 4% paraformaldehyde, permeabilized 
10 min in 0.25% Triton X, blocked in 5% serum for 1 h at room temperature. ES cell 
colonies were stained with anti-Nanog (1:100, rabbit, Cat # ab80892, Abcam, 
Cambridge, UK) antibodies for 2 h at room temperature and conjugated secondary 
antibody (1:400, anti-rabbit Alexa 467) for 1 h at room temperature. Nuclei were 
counter-stained for 5 min with DAPI at 1 µg/mL, mounted with ProLong Diamond 
Antifade Mountant (ThermoFisherScientific) and imaged using an AXIOVERT 200M 
inverted microscope (Zeiss, Oberkochen, Germany)  
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Karyotyping  
Metaphase spreads were prepared from Control and ML216-treated ES cells 
under 2i conditions (5d culture for treatment on the original S18 background, 2d for 
the IVR lines 1 and 2; see Cell Culture above for detailed description of culturing 
conditions). Metaphase spreads were prepared essentially as described in (50) with 
the following modifications. Cells were initially plated at a density of 2×105 cells per 
10 cm AF-coated culture dish. Spreads were mounted with ProLong Diamond 
Antifade Mountant (ThermoFisherScientific). Metaphase chromosomes were imaged 
with a 63x objective in a Zeiss APOTOME AXIO Imager.Z1 (Zeiss) equipped with an 
Orca-flash4.0 digital camera (C11440-22CU, Hamamatsu, Herrsching am 
Ammersee, Germany) and coupled to HCImage v4.3.5.8 image acquisition software. 
Chromosomes were anonymized and independently counted twice manually in Fiji 
v2.0.0-rc-54/1.51h using the multi-point tool. 
 
Sequencing and analysis pipeline  
Sequencing libraries for high-throughput sequencing were generated using 
Nextera DNA Library Prep Kit (Illumina, Inc., San Diego, USA) according to 
manufacturer’s recommendations or using equivalent Tn5 transposase expressed in-
house as previously described (42). Briefly, genomic DNA was extracted from FACS-
sorted clones, single colonies or pooled samples by standard Protease K digestion 
(New England Biolabs GmbH, Frankfurt am Main, Germany) followed by AmpureXP 
bead (Beckman Coulter GmbH, Krefeld, Germany) purification. Extracted high-
molecular weight DNA was “tagmented” by commercial or purified Tn5-transposase. 
Each tagmented DNA sample was then PCR amplified with Q5 High-Fidelity DNA 
Polymerase (New England Biolabs) using barcoded i7-index primer (N701-N763) 
and the N501 i5-index primer. Pooled libraries were sequenced by a HiSeq 3000 
(Illumina) at the Genome Core Facility at the MPI Tübingen Campus. Sequenced 
data were processed using a custom pipeline consisting of data clean-up, mapping, 
base-calling and analysis based upon fastQC v0.10.1 (51); trimmomatic v0.33 (52); 
bwa v0.7.10-r789 (53); GATK v3.4-0-gf196186 modules MarkDuplicates and 
IndelRealignment (54, 55); samtools v1.2 (56, 57); bcftools v1.2 (58); and R v 3.2.0 
(59). Genotype calls were performed against known informative single and multiple 
nucleotide variants between C57BL/6NJ, CAST/EiJ and SPRET/EiJ strains made 
available by the Wellcome Trust Sanger Centre (Mouse Genomes Project version 3 
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dbSNP v137 release) (25). Coverage depths for the reference and alternative alleles 
were calculated based on the DP4 field in the variant VCF files. For flow mapping, 
each pool was sequenced to an average of 9.8x coverage of the mouse genome, 
corresponding to an average of 100272 ± 32692 read-depth over informative SNPs 
in each of 1 Mbp bin, our analytical unit for flow mapping. For individual clones, each 
clone were sequenced to an average of 0.95x, yielding on average 1841 ± 1159 
reads per 1 Mbp bin. Crossover breakpoints were called by TIGER (60), using 
default parameters. Custom Perl scripts were used to process files prior to plotting 
and visualization in R. Scripts have been deposited in the following repository: 
https://github.com/evolgenomics/HybridMiX. 
 
Statistical analysis  
Chromosome loci affecting 6-TG susceptibility were evaluated using the 
following statistical methods: smoothing function, window-based analyses. For the 
smoothing function, we first calculated the raw SPRET excess using the following 
formula: (SPRET – BL6) / (SPRET + BL6) fraction in each adjacent megabase 
window. Then in cases with two contrasting 6-TGR and 6-TGS pools (5d and 21d 
ML216 treatments), a differential SPRET excess was calculated by subtraction (6-
TGS – 6-TGR). Otherwise the raw SPRET excess for the sole pool (6-TGR after 10d 
ML216 treatment) was reported. Then a LOESS smoothing function with 10% span 
was applied along the chromosome to obtain both the fit and standard error of the 
estimates. We then reported the regions in the genome with a LOESS fit that is 
greater than 1 s.e.m. away from 0 as coloured bars in Fig. 3C (a 0 indicates no bias 
for either SPRET or BL6 reads). Between the 5d and 21d ML216 treatments we 
found only such bias on ChrX, with one of the common region overlapping Hprt (5d: 
49–60 Mbp; 10d: 42–169 Mbp; 21d: 24–81 Mbp) and additional telomeric regions 
(Fig. 3C). For the window-based analysis, we broke each one megabase window 
into up to a hundred 10 kbp bins and estimated the SPRET bias. We separately 
obtained a genome-wide outlier threshold at P ≤ 0.05 (after applying Bonferroni 
correction). Any window lying greater than 1 s.e.m. beyond the threshold are 
considered genome-wide significant (Fig. S6A). All but one outlier windows in any 
treatment are found on ChrX, with the main cluster falling in the same region 
containing Hprt. Both methods converge towards the same area on ChrX, indicating 
the known role of Hprt in mediating 6-TG susceptibility. 
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Laser-assisted morula injection  
ES cell-derived embryos were obtained essentially as previously described in 
(27). Briefly, female C57BL/6NCrl mice were mated and host embryos harvested. ES 
cells from untreated S18 line and two IVR lines were injected into 8-cell stage 
embryos (morulae) after perforation of the zona pellucida with a laser pulse. The 
introduction of excess ES cells were expected to produce embryos with fully ES cell 
contributions. This was confirmed using coat-colour analysis from previous injections 
performed under R.N. After incubation for 1.5–2 h, injected embryos were 
transferred into the oviducts of E0.5 pseudo-pregnant CD1-ICR female foster mice. 
The host mice were monitored for recovery and development. At 14d after the 
embryo transfer (approximating developmental stage E14.5), the gestation was 
terminated and embryos were individually dissected, fixed with 4% 
paraformaldehyde for 45 min and stored in PBS. All manipulations were performed 
by R.N. or under R.N.’s supervision at the Transgenic Core Facility at the Max 
Planck Institute of Cell Biology and Genetics, Dresden, Germany. Due to sample 
preparation and fixation, genotyping of microCT-scanned embryos were not 
performed. Instead, control (unscanned) embryos were dissociated and genotyped 
at diagnostic loci using Taqman probes designed to specifically anneal to allele-
specific polymorphisms on Chr14 and ChrX (Fig. S7 and Table S1). Quantitative 
real-time PCR was performed on C1000 Touch Thermal Cycler (Bio-Rad) with 
TaqMan Universal Master Mix II, with UNG (Life Technologies), 20 ng template DNA 
and 1x PrimeTime qPCR Assay. Genomic DNA controls from SPRET and BL6 mice 
were used in mixed pool of known proportions. At this point we cannot formally rule 
out that ES cell contributions to the embryo proper can be incomplete due to reasons 
related to lower ES cell viability (e.g., genetic incompatibilities) compared to typical 
results from morulae injections involving only laboratory strains (27).   
 
Micro computer-tomography (microCT)  
Prior to scanning, embryos were perfused for 4d in 25% Lugol’s, or iodine 
potassium iodide solution. Contrast-stained embryos were rehydrated and mounted 
in 1% low-melting agarose and scanned with a Skyscan 1173 instrument (Control 
software version 1.6, Build 15; Bruker Corporation, Billerica, MA, USA) at 9.96 
micron (µm) resolution using a 0.5 mm aluminium filter with energy settings at 70 kV 
and 110 µA. Volume reconstructions were performed using NRecon v.1.6.10.4 
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(Bruker Corporation) using parameters determined based on fine-tuning for each 
scan (misalignment correction: 23–30; beam-hardening correction: 25%; ring-artifact 
correction: 10; no smoothing). Image analysis, segmentation and visualizations were 
performed using Amira v6.2.0 (FEI, Hillsboro, OR, USA) with the XImagePAQ 
extension 6.2. 
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3.2.13 Supplementary Figures: 
 
 
 
 
 
 
 
 
Fig. S1.  Site-specific integration of a versatile selection reporter cassette into 
the G4 ROSALUC ES cell line. Utilizing the recombination-mediated cassette 
exchange (RMCE) technique, the targeting vector was inserted by a Flp-
recombinase into the ROSALUC allele as previously described (37).  The vector 
introduced the hygromycin phosphotransferase-thymidine kinase (HyTK) fusion 
selectable marker, the enhanced green fluorescent protein (EGFP) and the 
phosphoglycerate kinase 1 (PGK) promoter, thus restoring the expression of the 
latent neomycin resistance gene upon the successful integration of the vector into 
the ROSALUC allele.  Figure modified from (37). 
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Fig. S2.  Normal karyotypes were maintained under culturing and IVR 
treatment.  (A) Representative metaphase spreads from S18 line under control and 
ML216 treatment show normal karyotype of 2n = 40.  (B) After confirmed IVR 
treatment, selected lines 1 and 2 were chosen for re-derivation.  The karyotypes of 
both lines are also normal with high levels of euploidy.  Whole embryos derived from 
laser-assisted morulae injection results showed that the S18 line, and IVR lines 1 
and 2 are broadly competent to differentiate into diverse cell lineages (Fig. 4, S7 & 
S8). 
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Fig. S3.  ML216 treatment is compatible with ES cell culturing.  (A) 
Determination of cell survival under culturing with varying ML216 concentrations.  It 
should be noted that rather than a selection treatment or kill curve, here our interest 
is to determine the highest concentration that is compatible with good survival.  
Based on the results 25 µM (grey, n.s.) was chosen. (B) To determine if ML216 
treatment affect ES cell colony viability and maintenance of stemness, we cultured 
ES cells strains G4 Rosaluc [(BL6 x 129S) F1] and S18 [(BL6 x SPRET) F1] under 
control 2i/LIF and 25 µM ML216 plus 2i/LIF conditions for 3 days.  Both control and 
ML216 treated colonies showed good colony morphology, cell density and robust 
stem cell marker NANOG expression in both ES cell lines.   We concluded that 
ML216 induction of in vitro recombination is compatible with ES cell culturing across 
considerable evolutionary divergence. Scale bar = 200 µm.  
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Fig. S4.  Multiplexed PCR genotyping screen for spontaneous recombinants.  
Hybrid ES cells [(BL6 x CAST) F1 hybrid line “E14”] were treated with ML216 and 
screened by multiplexed PCR genotyping at diagnostic markers within the last 
10Mbp of each autosome chromosome (see Methods & Table S1).  Amplified 
fragment sizes were determined using a capillary sequencer.  The markers were 
designed such that they show staggered fragment sizes, allowing clear identification 
using fragment analysis software.  Shown above are the electropherogram traces 
corresponding to the clones shown in Fig. 2, out of 46 total clones.  The blue (FAM) 
and green (HEX) channels are shown separately for each sample, adjusted 
according to size standards (LIZ, orange, in basepairs.  Fluorescence levels are 
shown on arbitrary units on the Y-axis).  Genotype calls corresponding to BL6 (solid 
circles) and CAST or SPRET (open circles) alleles for each chromosome are shown 
underneath the called peaks (markers were designed for both outgroups.  Only E14 
analyses are included in this study).  Missing genotypes indicative of recombination 
or LOH events are indicated in red.  Chromosome 14 calls were removed due to 
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invariant calls in all samples, including untreated F1 hybrid cells.  This approach 
allowed us to rapidly screen through many colonies to detect possible recombinants.  
Notably, whole genome sequencing results suggested that in addition to the typical 
recombination events recovered by this multiplexed fragment analysis, further 
recombination events may occur elsewhere in the genome.  
 
 
 
 
Fig. S5.  Optimal 6-TG concentration for differential Hprt-dependent 
cytotoxicity.  (Left) Concentration for 6-TG treatment was determined by treating 
ES cells with concentrations ranging from 1.5 to 200 µM.  Cell survival were 
determined by a colorimetric WST-1 absorbance assay.  ES cells carrying different 
Hprt-a, -b or null alleles on various genetic backgrounds were assayed in duplicates 
over 24, 48 or 72 hours (Hprta/b on (BL6 x SPRET)F1 S18 background: red; Hprtb/b 
on R1/E 129X1/129S1 background: blue; and Hprt-/- on AB2.2 129S5 background: 
grey).  Absorbance values were normalized against control treatment of no 6-TG 
after subtracting blank measurements.  We chose 25 µM 6-TG treatment for 
subsequent experiments for the strong survival difference between cells carrying 
Hprta and those carrying Hprtb or null genotypes after 48 h.  To ensure genome 
	  	   155 
integrity for sequencing in flow mapping, we performed FACS already after 24 h of 
25 µM 6-TG treatment together with a more sensitive DAPI exclusion cell viability 
assay.  Plotted values are normalized mean between replicates ± s.d. 
(Right) S18 cells under various treatments were analyzed by flow cytometry to 
determine if ML216 (25 µM) treatment induces cell death.  Under ML216 treatment 
alone, cells show robust viability (second column).  Only after 1 d 6-TG (25 µM) 
treatment do the cells exhibit greatly increased cell death, as shown by the increased 
proportion of the “Dead” population (third column; red).  Notably, combined ML216 
and 6-TG treatment appears to mitigate cell damage and death, as indicated by the 
increased proportion of the “Live” population (third vs. fourth column; blue). 
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Fig. S6. Flow mapping localization of SPRET bias signal to a region on ChrX 
overlapping Hprt. (A) Raw sequencing read counts matching the BL6 (reference) or 
SPRET alleles from 6-TGS and 6-TGR pools were binned into 10 kbp windows and 
the fraction of SPRET bias was calculated as the difference between SPRET and 
BL6 read counts out of the total in each window, which are themselves grouped into 
1 Mbp windows. For the 5d and 21d ML216 treatments, we plotted the differential 
SPRET bias between the two pools (6-TGS – 6-TGR). For the 10 d ML216 treatment 
we plotted the raw SPRET bias since only one 6-TGR pool was present. In both 
cases the SPRET bias estimates are represented by dots and lines showing ± 1 
s.e.m. The dots and lines are coloured according to treatment (5d ML216: brown; 
21d ML216: red; 10d ML216: light blue;) if they are significantly different from 0 as 
detailed below. Coloured dashed lines at around 0 show that the genome-wide 
average estimate in each treatment lie very close to no deviations between the 6-
TGS, and the 6-TGR pools (and from the original 1:1 contribution in each pool in the 
5d and 21d treatments, plots omitted for clarity). The outer dash lines indicate the 
critical values at P ≤ 0.05 (after applying the Bonferroni correction for multiple 
testing) given the observed genome-wide distribution of (differential) SPRET bias 
within the sample.  Note also that the data from the telomeric end of Chr14 were 
excluded (grey shading) due to consistent loss of the chromosome end and 
conversion towards SPRET genotypes in the S18 line regardless of ML216 or 6-TG 
treatment.  
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Both the 5d ML216 and the 21d ML216 pools show generally a very tight distribution 
on autosomes around 0.  At significant outlier windows, shading on the excess side 
(SPRET or BL6) highlight the region, with the shading extended if nearby windows 
are also significant. Across all autosomes, there is a single outlier window on Chr4: 
40Mbp in the 5d ML216 sample that is not matched by the other time points.  
However, on ChrX, there were many significant outlier windows, mostly in the 21d 
ML216 sample but also a few from the 5d ML216 treatment, with the main area of 
overlap around Hprt (53 Mbp, grey vertical line with arrowhead) from approximately 
48 Mbp to 68 Mbp, in the direction of expected Hprta increase activity (SPRET bias). 
In the 5d ML216 treatment the skew was less evident compared to the LOESS 
method shown in Fig. 3, due to the more conservative thresholds after correcting for 
multiple testing. Here, a single window near (but not overlapping) Hprt at 62 Mbp 
was significantly skewed in the SPRET direction and showed a frequency estimate 
consistent with its neighbouring windows, unlike the other more centromeric windows 
with significant skews. The significant window at 62Mbp falls within the common 
region across treatments. Due to the small sample size in the 10d ML216 (46 6-TGR 
clones) which can cause greater fluctuations in allele frequencies, we observed no 
outlier windows. However, from ChrX: 45Mbp onwards the frequency plateaus 
towards BL6 bias (blue shading). The combined area overlaps Hprt.  
(B) Individual 6-TGR clones following 10 d ML216 treatment were sequenced to 
determine recombination breakpoints.  Crossovers of the indicated directions as in 
Fig. 3C are shown here to allow matching with raw data. At Hprt, most 6-TG 
surviving clones are homozygous for the Hprtb allele (27 vs. 9 heterozygotes and 10 
Hprta homozygotes).   
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Fig. S7.  Genome-wide genotype of the two S18 IVR ES cell lines selected for 
embryo re-derivation.  High-confidence genotypes of each line for each 
chromosome are plotted as heterozygous (yellow) and the two BL6/BL6 (blue) and 
SPRET/SPRET (red) homozygous genotypes.   Low-coverage or repetitive regions 
were considered ambiguous (grey).  Both lines 1 and 2 showed substantial 
proportion of the genome carrying heterozygous genotypes, reflecting their F1 hybrid 
origin.  Because these lines were obtained through 6-TG selection, much of the 
observed recombinant genotypes belong to Chromosome X. In addition, we have 
observed chromosome instability at the distal end of Chromosome 14 (also see Fig. 
S4).  In addition, there are major genotypic differences between IVR lines 1 and 2 on 
chromosomes 6, 16 and 18, as well as X.  Such recombinant genotype would be 
difficult, if not impossible to obtain under conventional breeding.  These results 
illustrate the potential of applying IVR at expanded scale to investigate the genetic 
basis of species divergence. 
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Fig. S8.  Whole embryos derived from F1 hybrid S18 non-recombinant and IVR 
ES cells.  (Top) Embryos with almost exclusively ES cell contribution could be 
generated in the founder generation via laser-assisted morula injection.  This allowed 
phenotyping of organismal traits by circumvention of hybrid sterility.  Embryos were 
dissected in mid-gestation stage (approximately 14.5 days post-coitus, or embryonic 
E14.5), contrast-stained and scanned using X-ray micro-computer tomography 
(microCT) at 9.4 micron (µm) resolution.  The use of contrast staining allowed 
identification and precise measurements of individual organs (colorized here for 
clarity).  Embryos from non-recombinant S18 ES cells (left column) and two IVR ES 
cell lines were examined (columns 2–3 and 4–5 respectively).  Representative 
individuals displaying normal and abnormal developmental phenotypes are shown as 
whole embryos with representative sagittal and coronal sections.  In contrast to non-
recombinant S18-derived embryos, multiple embryos from each IVR lines showed 
major craniofacial and neural tube closure defects.  Despite a small sample size, 
such occurrence was highly atypical.  Notably, defects in cell migration and cell–cell 
communication are consistent with hybrid incompatibilities.  Following speciation, 
divergent genotype combinations carried by the same individuals have not been 
subjected to selection for compatible functions.  Consequently, hybrid 
incompatibilities often result in developmental defects.  Derivation of embryos from 
panels of IVR ES cell lines may allow genetic dissection of developmental variation 
arising from evolutionary divergences.  (Bottom) Volume measurements from 
individual organs were obtained and their distributions shown here, after excluding 
embryos with defects.  There are no statistically significant differences between 
embryos derived from different ES cell lines.  With increased sample size certain 
organs, such as heart, lung and liver, may be good candidates to screen for 
consistent trait differences between lines. 
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3.2.14 Supplementary Tables:  
 
Table S1. Oligonucleotide primers for multiplexed genotyping of sub-telomeric 
markers. Each pair of primers carry an extension (underlined) to allow easy 
attachment of a third, universal fluorophore-conjugated primer for fragment analysis 
in a capillary sequencer as described in (10). 
 
